DUPONT DE NEMOURS, INC., 10-K filed on 2/15/2024
Annual Report
v3.24.0.1
Cover - USD ($)
$ in Billions
 12 Months Ended
Dec. 31, 2023
Feb. 13, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38196    
Entity Registrant Name DUPONT DE NEMOURS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 81-1224539    
Entity Address, Address Line One 974 Centre Road    
Entity Address, Address Line Two Building 730    
Entity Address, City or Town Wilmington    
Entity Address, State or Province DE    
Entity Address, Postal Zip Code 19805    
City Area Code 302    
Local Phone Number 295-5783    
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol DD    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 33
Entity Common Stock, Shares Outstanding   417,582,864  
Documents Incorporated by Reference
Part III: Proxy Statement for the 2024 Annual Meeting of Stockholders to be filed not later than 120 days after the end of the fiscal year covered by this Form 10-K.
    
Entity Central Index Key 0001666700    
Amendment Flag false    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
v3.24.0.1
Audit Information
 12 Months Ended
Dec. 31, 2023
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Philadelphia, Pennsylvania
Auditor Firm ID 238
v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net sales $ 12,068 $ 13,017 $ 12,566
Cost of sales 7,835 8,402 7,971
Research and development expenses 508 536 557
Selling, general and administrative expenses 1,408 1,467 1,602
Amortization of intangibles 600 590 566
Restructuring and asset related charges - net 146 155 50
Goodwill impairment charge 804 0 0
Acquisition, integration and separation costs 20 193 81
Equity in earnings of nonconsolidated affiliates 51 75 85
Sundry income (expense) - net 102 191 145
Interest expense 396 492 525
Income from continuing operations before income taxes 504 1,448 1,444
(Benefit from) provision for income taxes on continuing operations (29) 387 237
Income from continuing operations, net of tax 533 1,061 1,207
(Loss) income from discontinued operations, net of tax (71) 4,856 5,308
Net income 462 5,917 6,515
Net income attributable to noncontrolling interests 39 49 48
Net income available for DuPont common stockholders $ 423 $ 5,868 $ 6,467
Per common share data:      
Earnings per common share from continuing operations - basic (in USD per share) $ 1.10 $ 2.02 $ 2.17
(Loss) earnings per common share from discontinued operations - basic (in USD per share) (0.16) 9.75 9.75
Earnings per common share - basic (in USD per share) 0.94 11.77 11.92
Earnings per common share from continuing operations - diluted (in USD per share) 1.09 2.02 2.16
(Loss) earnings per common share from discontinued operations - diluted (in USD per share) (0.16) 9.73 9.72
Earnings per common share - diluted (in USD per share) $ 0.94 $ 11.75 $ 11.89
Weighted-average common shares outstanding - basic (in shares) 449.9 498.5 542.7
Weighted-average common shares outstanding - diluted (in shares) 451.2 499.4 544.2
v3.24.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net income $ 462 $ 5,917 $ 6,515
Other comprehensive income (loss), net of tax      
Cumulative translation adjustments 38 (1,119) (755)
Pension and other post-employment benefit plans (92) 41 425
Derivative instruments (41) 61 56
Total other comprehensive loss (127) (850) (16)
Comprehensive income 335 5,067 6,499
Comprehensive income attributable to noncontrolling interests, net of tax 31 31 35
Comprehensive income attributable to DuPont 304 5,036 6,464
N&B      
Other comprehensive income (loss), net of tax      
Divestiture of a business segment 0 0 258
Mobility And Materials Businesses      
Other comprehensive income (loss), net of tax      
Divestiture of a business segment $ (32) $ 167 $ 0
v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 2,392 $ 3,662
Marketable securities 0 1,302
Restricted cash and cash equivalents 411 7
Accounts and notes receivable - net 2,370 2,518
Inventories 2,147 2,329
Prepaid and other current assets 194 161
Assets of discontinued operations 0 1,291
Total current assets 7,514 11,270
Property    
Property, plant and equipment 10,725 10,179
Less: Accumulated depreciation 4,841 4,448
Total property, plant and equipment - net 5,884 5,731
Other Assets    
Goodwill 16,720 16,663
Other intangible assets 5,814 5,495
Restricted cash and cash equivalents - noncurrent 0 103
Investments and noncurrent receivables 1,071 733
Deferred income tax assets 312 109
Deferred charges and other assets 1,237 1,251
Total other assets 25,154 24,354
Total Assets 38,552 41,355
Current Liabilities    
Short-term borrowings 0 300
Accounts payable 1,675 2,103
Income taxes payable 154 233
Accrued and other current liabilities 1,269 951
Liabilities of discontinued operations 0 146
Total current liabilities 3,098 3,733
Long-Term Debt 7,800 7,774
Other Noncurrent Liabilities    
Deferred income tax liabilities 1,130 1,158
Pension and other post-employment benefits - noncurrent 565 522
Other noncurrent obligations 1,234 1,151
Total other noncurrent liabilities 2,929 2,831
Total Liabilities 13,827 14,338
Commitments and contingent liabilities
Stockholders' Equity    
Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued 2023: 430,110,140 shares; 2022: 458,124,262 shares) 4 5
Additional paid-in capital 48,059 48,420
Accumulated deficit (22,874) (21,065)
Accumulated other comprehensive loss (910) (791)
Total DuPont stockholders' equity 24,279 26,569
Noncontrolling interests 446 448
Total equity 24,725 27,017
Total Liabilities and Equity $ 38,552 $ 41,355
v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Shares authorized (in shares) 1,666,666,667 1,666,666,667
Par value (in USD per share) $ 0.01 $ 0.01
Shares issued (in shares) 430,110,140 458,124,262
v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating Activities      
Net income $ 462 $ 5,917 $ 6,515
(Loss) income from discontinued operations (71) 4,856 5,308
Net income from continuing operations 533 1,061 1,207
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 1,147 1,135 1,112
Credit for deferred income tax and other tax related items (381) (157) (252)
Earnings of nonconsolidated affiliates less than dividends received 20 36 12
Net periodic pension benefit cost 31 2 3
Periodic benefit plan contributions (63) (66) (74)
Net gain on sales, businesses and investments (19) (78) (171)
Restructuring and asset related charges - net 146 155 50
Goodwill impairment charge 804 0 0
Inventory step-up amortization 0 0 12
Other net loss 128 16 177
Changes in assets and liabilities, net of effects of acquired and divested companies:      
Accounts and notes receivable 202 (79) (346)
Inventories 227 (215) (248)
Accounts payable (310) (138) 221
Other assets and liabilities, net (274) (423) 143
Cash provided by operating activities - continuing operations 2,191 1,249 1,846
Investing Activities      
Capital expenditures (619) (662) (788)
Proceeds from sales of property, businesses, and ownership interests in nonconsolidated affiliates, net of cash divested 1,244 10,951 797
Acquisitions of property and businesses, net of cash acquired (1,761) 5 (2,346)
Purchases of investments (32) (1,317) (2,001)
Proceeds from sales and maturities of investments 1,334 15 2,001
Other investing activities, net 6 12 39
Cash provided by (used for) investing activities - continuing operations 172 9,004 (2,298)
Financing Activities      
Changes in short-term borrowings 0 (150) 150
Proceeds from credit facility 0 600 0
Repayment of credit facility 0 (600) 0
Payments on long-term debt (300) (2,500) (5,000)
Purchases of common stock and forward contracts (2,000) (4,375) (2,143)
Proceeds from issuance of Company stock 27 88 115
Employee taxes paid for share-based payment arrangements (27) (27) (26)
Distributions to noncontrolling interests (37) (26) (29)
Dividends paid to stockholders (651) (652) (630)
Other financing activities, net (1) (4) (26)
Cash used for financing activities - continuing operations (2,989) (7,646) (7,589)
Cash Flows from Discontinued Operations      
Cash (used for) provided by operations - discontinued operations (273) (661) 435
Cash used for investing activities - discontinued operations (33) (81) (103)
Cash (used for) provided by financing activities - discontinued operations 0 (21) 1,082
Cash (used in) provided by discontinued operations (306) (763) 1,414
Effect of exchange rate changes on cash, cash equivalents and restricted cash (37) (148) (72)
(Decrease) increase in cash, cash equivalents and restricted cash (969) 1,696 (6,699)
Cash, cash equivalents and restricted cash from continuing operations, beginning of period 3,772 2,037 8,733
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period 0 39 42
Cash, cash equivalents and restricted cash at beginning of period 3,772 2,076 8,775
Cash, cash equivalents and restricted cash from continuing operations, end of period 2,803 3,772 2,037
Cash, cash equivalents and restricted cash from discontinued operations, end of period 0 0 39
Cash, cash equivalents and restricted cash at end of period 2,803 3,772 2,076
Supplemental cash flow information      
Interest, net of amounts capitalized - from continuing operations 408 494 497
Income taxes, net of refunds - from continuing operations 360 642 433
Interest, net of amounts capitalized - from discontinued operations 0 0 2
Income taxes, net of refunds - from discontinued operations $ 34 $ 202 $ 128
v3.24.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comp (Loss) Income
Treasury Stock
Non-controlling Interests
Beginning balance at Dec. 31, 2020 $ 39,070 $ 7 $ 50,039 $ (11,586) $ 44 $ 0 $ 566
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 6,515     6,467     48
Other comprehensive loss (16)       (3)   (13)
Dividends (630)   (630)        
Common stock issued/sold 115   115        
Stock-based compensation 49   49        
Contributions from non-controlling interests 84           84
Distributions to non-controlling interests (41)           (41)
Purchases of treasury stock (2,143)         (2,143)  
Retirement of treasury stock 0     (2,143)   2,143  
Split-off of N&B (15,955) (2)   (15,926)     (27)
Other 2   1 1      
Ending balance at Dec. 31, 2021 27,050 5 49,574 (23,187) 41 0 617
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 5,917     5,868     49
Other comprehensive loss (850)       (832)   (18)
Dividends (652)   (652)        
Common stock issued/sold 88   88        
Stock-based compensation 57   57        
Contributions from non-controlling interests 2           2
Distributions to non-controlling interests (36)           (36)
Purchases of treasury stock (3,725)         (3,725)  
Retirement of treasury stock 0     (3,725)   3,725  
Forward contracts for share repurchase (650)   (650)        
M&M Divestiture (167)           (167)
Other (17)   3 (21)     1
Ending balance at Dec. 31, 2022 27,017 5 48,420 (21,065) (791) 0 448
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 462     423     39
Other comprehensive loss (127)       (119)   (8)
Dividends (651)   (651)        
Common stock issued/sold 27   27        
Stock-based compensation 51   51        
Distributions to non-controlling interests (37)           (37)
Purchases of treasury stock (1,600)         (1,600)  
Excise tax on purchases of treasury stock (21)     (21)      
Retirement of treasury stock 0 (1)   (2,212)   2,213  
Forward contracts for share repurchase (400)   (400)        
Settlement of forward contracts for share repurchase 0   613     (613)  
Other 4   (1) 1     4
Ending balance at Dec. 31, 2023 $ 24,725 $ 4 $ 48,059 $ (22,874) $ (910) $ 0 $ 446
v3.24.0.1
Consolidated Statements of Equity (Parenthetical) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]      
Dividends declared (in USD per share) $ 1.44 $ 1.32 $ 1.20
v3.24.0.1
Schedule II—Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II—Valuation and Qualifying Accounts
Schedule II—Valuation and Qualifying Accounts
(In millions) for the years ended December 31,202320222021
Accounts Receivable—Allowance for Doubtful Receivables   
Balance at beginning of period$38 $28 $32 
Additions charged to expenses12 11 6 
Deductions from reserves1
(10)(1)(10)
Balance at end of period$40 $38 $28 
Inventory—Obsolescence Reserve
Balance at beginning of period$4 $6 $3 
Additions charged to expenses14 18 34 
Deductions from reserves2
(10)(20)(31)
Balance at end of period$8 $4 $6 
Deferred Tax Assets—Valuation Allowance   
Balance at beginning of period$703 $700 $617 
Additions 3, 4
47 125 152 
Deductions from reserves 3
(12)(122)(69)
Balance at end of period$738 $703 $700 
1.Deductions include write-offs, recoveries and currency translation adjustments.
2.Deductions include disposals and currency translation adjustments.
3.Additions and Deductions include currency translation adjustments.
4.Includes approximately $50 million related to the acquisition of Laird Performance Materials in 2021.
v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements of DuPont de Nemours, Inc. ("DuPont” or the "Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

The Consolidated Financial Statements include the accounts of the Company and subsidiaries in which a controlling interest is maintained. The Consolidated Financial Statements also include the accounts of joint ventures that are variable interest entities ("VIEs") in which the Company is the primary beneficiary due to the Company's power to direct the VIEs significant activities. For those consolidated subsidiaries in which the Company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the Company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The Company is also involved with certain joint ventures accounted for under the equity method of accounting that are VIEs. The Company is not the primary beneficiary, as the nature of the Company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the Company becomes the primary beneficiary. At December 31, 2023 and 2022, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Beginning in the second quarter of 2023, the Company has segregated the cash flows from discontinued operations from the cash flows from continuing operations in accordance with ASC 230, Statement of Cash Flows. The Consolidated Statements of Cash Flows have been recast for all periods to reflect the change in presentation.

DWDP Distributions
Effective August 31, 2017, E. I. du Pont de Nemours and Company ("EID") and The Dow Chemical Company ("TDCC") each merged with subsidiaries of DowDuPont Inc. (n/k/a "DuPont”) and, as a result, EID and TDCC became subsidiaries of the Company. On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary TDCC (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary EID (subsequently renamed EIDP, Inc. (n/k/a "EIDP")), (the “Corteva Distribution" and together with the Dow Distribution, the “DWDP Distributions”). Following the Corteva Distribution, DuPont holds the specialty products business as continuing operations. DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”) (for certain events prior to June 1, 2019, the Company may be referred to as DowDuPont). Beginning on June 3, 2019, the Company's common stock is traded on the New York Stock Exchange under the ticker symbol "DD."

N&B Transaction
On February 1, 2021, DuPont completed the separation and distribution of the Nutrition & Biosciences business segment (the "N&B Business"), and merger of Nutrition & Biosciences, Inc. (“N&B”), a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of International Flavors & Fragrances Inc. ("IFF"). The distribution was effected through an exchange offer (the “Exchange Offer”) and the consummation of the Exchange Offer was followed by the merger of N&B with a wholly owned subsidiary of IFF, with N&B surviving the merger as a wholly owned subsidiary of IFF (the “N&B Merger” and, together with the Exchange Offer, the “N&B Transaction”). See Note 4 for more information.

The results of operations of DuPont for the years ended December 31, 2021 reflect the historical financial results of N&B as discontinued operations. The comprehensive income related to N&B has not been segregated and is included in the Consolidated Statements of Comprehensive Income for the applicable period. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of N&B.

M&M Transactions
On November 1, 2022, DuPont completed the previously announced divestiture of the majority of its historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”), to Celanese Corporation (“Celanese”) for cash proceeds of $11.0 billion. On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). The Delrin® Divestiture and together with the M&M Divestiture, collectively the "M&M Divestitures” and the businesses in scope of the M&M Divestitures collectively the "M&M Businesses". See Note 4 for more information.
The financial position of DuPont as of December 31, 2022, present the businesses subsequently divested as part of the Delrin® Divestiture as discontinued operations. The results of operations for the year ended December 31, 2023, present the financial results of Delrin® as discontinued operations through November 1, 2023. The results of operations for the years ended December 31, 2022 and 2021, present the financial results of the M&M Businesses as discontinued operations. For the year ended December 31, 2023, the Consolidated Statements of Cash Flows present the cash flows of the Delrin® Divestiture as discontinued operations for activity. The Consolidated Statements of Cash Flows for the year ended December 31, 2022 and 2021, present the cash flows from the M&M Businesses as discontinued operations. The comprehensive income of the M&M Businesses has not been segregated and is included in the Consolidated Statements of Comprehensive Income for all periods presented. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses.

The Auto Adhesives & Fluids, MultibaseTM and Tedlar® product lines, previously reported within the historical Mobility & Materials segment, (the "Retained Businesses") are not included in the scope of the M&M Divestitures. In 2022, the Retained Businesses were realigned to Corporate & Other. The reporting changes have been retrospectively applied for all periods presented.

Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s Consolidated Financial Statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Cash and Cash Equivalents
Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest, which approximates fair value.

Restricted Cash and Cash Equivalents
Restricted cash and cash equivalents represents trust assets, cash held in escrow and cash within qualified settlement funds. These funds are restricted as to withdrawal or use under the terms of certain contractual agreements. Restricted cash is classified as a current or non-current asset based on the timing and nature of when or how the cash is expected to be used. See Note 7 and 16 for further information.

Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments.

Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The Company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1–Quoted market prices in active markets for identical assets or liabilities;
Level 2–Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3–Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.
Foreign Currency Translation
The Company's worldwide operations utilize the U.S. dollar ("USD") or local currency as the functional currency, where applicable. The Company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The Company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Interest Rate Swap Agreements
The Company has entered into a fixed-to-floating interest rate swap agreement to hedge changes in the fair value of the Company’s long-term debt due to interest rate movements. Under the terms of the agreement, the Company agrees to exchange, at specified intervals, fixed for floating interest amounts based on the agreed upon notional principal amount. The interest rate swaps are designated and carried as fair value hedges. Fair value hedge accounting has been applied and thus, changes in the fair value of these swaps and changes in the fair value of the related hedged portion of long-term debt will be presented and will net to zero in Sundry income (expense) – net in the Consolidated Statements of Operations.

Net Foreign Investment Hedge
The Company has entered into fixed-for-fixed cross currency swaps which are designated as a net investment hedge and has made an accounting policy election to account for the net investment hedge using the spot method. The Company has also elected to amortize the excluded components in interest expense in the related quarterly accounting period that such interest is accrued. The cross-currency swap is marked to market at each reporting date and any unrealized gains or losses are included in unrealized currency translation adjustments within "Accumulated other comprehensive loss" ("AOCL"), net of amounts associated with excluded components which are recognized in interest expense in the Consolidated Statements of Operations.

Inventories
The Company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method. The Company's inventories are generally accounted for under the average cost method. The Company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

In periods of abnormally low production, certain fixed costs normally absorbed into inventory are recorded directly to cost of sales in the period incurred.

Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.
Goodwill and Other Intangible Assets
The Company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value.

When testing goodwill for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If the carrying value of a reporting unit exceeds its fair value, an impairment loss is recognized in the amount by which the carrying value of the reporting unit exceeds its fair value, limited to the amount of goodwill at the reporting unit. The Company determines fair values for each of the reporting units using a combination of the income approach and/or market approach. Under the income approach, fair value is determined based on the net present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. Under the market approach, the Company selects peer sets based on close competitors and reviews the EBIT/EBITDA multiples to determine the fair value. When applicable, third-party purchase offers may be utilized to measure fair value. The Company applies a weighting to the market approach and income approach to determine the fair value. See Note 14 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually during the fourth quarter; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. When testing indefinite-lived intangible assets for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of indefinite-lived intangible assets is less than carrying value. If the Company chooses not to complete a qualitative assessment for indefinite-lived intangible assets or if the initial assessment indicates that it is more likely than not that the carrying value of indefinite-lived intangible assets exceeds the fair value, additional quantitative testing is required. Impairment exists when carrying value exceeds fair value. The Company's fair value methodology is primarily based on discounted cash flow techniques.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 20 years. The Company continually evaluates the reasonableness of the useful lives of these assets.

Impairment and Disposals of Long-Lived Assets
The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered for impairment when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss would be recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset group. The Company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies, including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed. Depreciation is recognized over the remaining useful life of the assets.

Acquisitions
In accordance with ASC 805, Business Combinations, acquisitions are recorded using the acquisition method of accounting. The Company includes the operating results of acquired entities from their respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired and liabilities assumed as of the acquisition date fair value, where applicable. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired and liabilities assumed is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred.

Leases
The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract, in accordance with ASC 842, Leases. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the Consolidated Balance Sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the Consolidated Balance Sheets. Finance lease ROU assets are included in "Property, plant and equipment - net" and the corresponding lease liabilities are included in "Long-term debt" on the Consolidated Balance Sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the Consolidated Statements of Operations, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.

The Company has leases in which it is the lessor, these leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease income is recorded in "Selling, general, and administrative expenses" and "Research and development expenses". See Note 17 for additional information regarding the Company's leases.

Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The Company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain or loss is reported in AOCL until it is cleared to earnings during the same period in which the hedged item affects earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in AOCL generally remains in AOCL until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

For derivative instruments designated as net investment hedges, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in AOCL. The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in "Accrued and other current liabilities" and "Other noncurrent obligations" at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as "Accounts and notes receivable - net."

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.
Revenue Recognition
The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the Company determines are within the scope of Revenue from Contracts with Customers (Topic 606), the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 5 for additional information on revenue recognition.

Cost of Sales
Cost of sales primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses. No amortization of intangibles is included within costs of sales.

Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, and enhancement of existing products.

Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Acquisition, Integration and Separation Costs
Acquisition, integration and separation costs primarily consist of financial advisory, information technology, legal, accounting, consulting, other professional advisory fees and other contractual transaction payments associated with the preparation and execution of activities related to strategic initiatives.

Litigation
Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Restructuring and Asset Related Charges
Charges for restructuring programs generally include targeted actions involving employee severance and related benefit costs, contract termination charges, and asset related charges, which include impairments or accelerated depreciation/amortization of long-lived assets associated with such actions. Employee severance and related benefit costs are provided to employees under the Company’s ongoing benefit arrangements. These charges are accrued during the period when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. Contract termination charges primarily reflect costs to terminate a contract before the end of its term or costs that will continue to be incurred under the contract for its remaining term without economic benefit to the Company. Asset related charges reflect impairments to long-lived assets and indefinite-lived intangible assets no longer deemed recoverable and depreciation/amortization of long-lived assets, which is accelerated over their remaining economic lives.

Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in "Income taxes payable" and the long-term portion is included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
v3.24.0.1
RECENT ACCOUNTING GUIDANCE
 12 Months Ended
Dec. 31, 2023
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING GUIDANCE RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In September 2022, the FASB issued Accounting Standards Update No. 2022-04, "Liabilities-Supplier Finance Programs (Subtopic 405-50)" ("ASU 2022-04") to enhance transparency about the use of supplier finance programs. The new guidance requires that a buyer in a supplier finance program provides additional qualitative and quantitative disclosures about its program including the nature of the program, activity during the period, changes from period to period, and the potential magnitude of the program. The amendments in ASU 2022-04 are effective for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the amendment on rollforward information which is effective prospectively for fiscal years beginning after December 15, 2023. The Company implemented the new disclosures, other than the rollforward information, as required in the first quarter of 2023. The disclosures around rollforward information will be implemented as required for the year-ended December 31, 2024. See Note 15 for more information.

In October 2021, the FASB issued Accounting Standards Update No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”), which requires contract assets and contract liabilities (i.e., unearned revenue) acquired in a business combination to be recognized and measured in accordance with ASC 606, Revenue from Contracts with Customers. Historically, the Company has recognized contract assets and contract liabilities at the acquisition date based on fair value estimates in accordance with ASC 805, Business Combinations. ASU 2021-08 is effective for interim and annual periods beginning after December 15, 2022 on a prospective basis, with early adoption permitted. The Company implemented the guidance as required during the first interim period for the year-ended December 31, 2023. The guidance did not have a significant impact.

Accounting Guidance Issued But Not Adopted at December 31, 2023
In November 2023, the FASB issued Accounting Standards Update No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07") to improve disclosure requirements about reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The new guidance requires disclosures of significant segment expenses provided to the Chief Operating Decision Maker ("CODM") and included in reported measures of segment profit and loss. Disclosure of the title and position of the CODM is required. The guidance requires interim and annual disclosures about a reportable segment's profit or loss and assets. Additionally, the guidance requires disclosure of other segment items by reportable segment including a description of its composition. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, on a retrospective basis. The disclosures will be implemented as required for the year-ended December 31, 2024. The Company is currently evaluating the impact of adopting this guidance.

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09") to improve transparency and disclosure requirements for the rate reconciliation, income taxes paid and other tax disclosures. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, on a prospective basis. The disclosures will be implemented as required for the year-ended December 31, 2025. The Company is currently evaluating the impact of adopting this guidance.
v3.24.0.1
ACQUISITIONS
 12 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS ACQUISITIONS
Spectrum Acquisition
On August 1, 2023, the Company completed the previously announced acquisition of Spectrum Plastics Group (“Spectrum”) from AEA Investors (the “Spectrum Acquisition”). Spectrum manufactures flexible packaging products, plastic and silicone extrusions, and components for the global industrial, food and medical business sectors. Spectrum is part of the Electronics & Industrial segment. The net purchase price was approximately $1,792 million, including a net upward adjustment of approximately $43.1 million for acquired cash and net working capital, among other items. The Company accounted for the acquisition in accordance with ASC 805, which requires the assets acquired and liabilities assumed to be recognized on the balance sheet at their fair values as of the acquisition date.

The table below presents the provisional fair values allocated to the assets acquired and liabilities assumed. The purchase accounting and purchase price allocation for Spectrum are substantially complete. However, the Company continues to refine the preliminary valuation of certain acquired assets and liabilities assumed, principally income tax related amounts, which could impact the amount of residual goodwill recorded. The Company will finalize the amounts recognized as it obtains the information necessary to complete the analysis, but no later than one year from the date of the acquisition. Final determination of the fair values may result in further adjustments to the values presented in the following table:
Spectrum Assets Acquired and Liabilities Assumed on August 1, 2023
Estimated
fair value as previously reported 1
Measurement period adjustments 2
Estimated fair value adjusted
In millions
Fair value of assets acquired
Cash and cash equivalents$31 $— $31 
Accounts and notes receivable68 — 68 
Inventories52 — 52 
Property, plant and equipment125 — 125 
Other intangible assets1,032 (116)916 
Deferred charges and other assets34 — 34 
Total Assets Acquired$1,342 $(116)$1,226 
Fair value of liabilities assumed
Accounts payable$21 $— $21 
Income taxes payable17 — 17 
Deferred income tax liabilities206 (29)177 
Other noncurrent liabilities37 — 37 
Total Liabilities Assumed$281 $(29)$252 
Goodwill731 87 818 
Total Consideration$1,792 $— $1,792 
1.As previously reported in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023.
2.The Company recorded measurement period adjustments in the fourth quarter of 2023 to reflect changes in preliminary valuation assumptions for customer relationships. All measurement period adjustments were offset against goodwill.

The significant fair value adjustments included in the allocation of purchase price are discussed below.

Other Intangible Assets
Other intangible assets with definite lives include acquired customer-related intangible assets of $772 million, developed technology of $126 million and trademark/tradename of $18 million. Acquired customer-related intangible assets, developed technology, and trademark/tradename have useful lives of 20 years, 15 years, and 5 years, respectively. The preliminary customer-related intangible assets' fair value was determined using the multi-period excess earnings method while the preliminary developed technology and trademark/tradename fair values were determined utilizing the relief from royalty method. The determination and allocation of fair value of other intangibles assets assumed is based on various assumptions and valuation methodologies requiring considerable management judgment, including estimates based on historical information, current market data and future expectations.
Goodwill
The excess of the consideration for Spectrum over the preliminary net fair value of assets acquired and liabilities assumed resulted in the provisional recognition of $818 million of goodwill, which has been assigned to the Electronics & Industrial segment. Goodwill is primarily attributable to the optimization of the combined Electronics & Industrial segment and Spectrum businesses’ global activities across sales and manufacturing, as well as expected future customer relationships. Spectrum goodwill will not be deductible for U.S. tax purposes.

Total net sales included in the Consolidated Statements of Income for the year ended December 31, 2023 are $185 million. The Company evaluated the disclosure requirements under ASC 805 and determined Spectrum was not considered a material business combination for purposes of disclosing the earnings of Spectrum since the date of acquisition or supplemental pro forma information.

Terminated Intended Rogers Corporation Acquisition
On November 1, 2022, the Company announced the termination of the agreement to acquire all the outstanding shares of Rogers Corporation (“Rogers”) for about $5.2 billion, as DuPont and Rogers were unable to obtain timely clearance from all the required regulators ("Terminated Intended Rogers Corporation Acquisition"). DuPont paid Rogers a termination fee of $162.5 million in accordance with the agreement on November 2, 2022. The termination fee was recognized as a charge in the fourth quarter of 2022 and recorded in the "Acquisition, integration and separation costs" within the Consolidated Statements of Operations.

Acquisition, Integration and Separation Costs
Acquisition, integration and separation costs primarily consist of financial advisory, information technology, legal, accounting, consulting, other professional advisory fees and other contractual transaction payments. For the year ended December 31, 2023, these costs were primarily related to the Spectrum Acquisition. For the year ended December 31, 2022 these costs were primarily related to costs associated with the Terminated Intended Rogers Acquisition, including the $162.5 million termination fee, the divestiture of the Biomaterials business unit and the prior year acquisition of Laird PM. Comparatively, for the year ended December 31, 2021 these costs were primarily related to the acquisition of Laird PM and the divestitures of the Biomaterials, Clean Technologies and Solamet® business units.

These costs are recorded within "Acquisition, integration and separation costs" within the Consolidated Statements of Operations.
(In millions) For the years ended December 31, 202320222021
Acquisition, integration and separation costs$20 $193 $81 
v3.24.0.1
DIVESTITURES
 12 Months Ended
Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]  
DIVESTITURES DIVESTITURES
Mobility & Materials Divestitures
On November 1, 2022, (the "Transaction Date") DuPont completed the previously announced divestiture of the majority of the historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”). The Company had previously entered into a Transaction Agreement (the "Transaction Agreement") with Celanese Corporation ("Celanese") on February 17, 2022, for consideration of $11.0 billion. Cash received on the Transaction Date, as adjusted for preliminary and other adjustments, was $11.0 billion. These adjustments include approximately $0.5 billion of cash transferred with the M&M Divestiture business for which DuPont was reimbursed at closing resulting in net proceeds of $10.5 billion.

The Company also announced on February 18, 2022, that its Board of Directors approved the divestiture of the Delrin® acetal homopolymer (H-POM) business, subject to entry into a definitive agreement and satisfaction of customary closing conditions, (the Delrin® business together with the M&M Divestiture businesses, the "M&M Businesses”). On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). DuPont received cash proceeds of approximately $1.28 billion, which includes certain customary transaction adjustments, a note receivable in the amount of $350 million and acquired a 19.9 percent non-controlling equity interest in Derby Group Holdings LLC, (“Derby”). The customary transaction adjustments primarily relate to $27 million of cash transferred with the Delrin® Divestiture for which DuPont was reimbursed at closing resulting in net cash proceeds of $1.25 billion. TJC, through its subsidiaries, holds the 80.1 percent controlling interest in Derby. The Company accounts for its equity interest in Derby as an equity method investment based upon its non-controlling equity interest, its $350 million intra-entity note receivable owed by an indirect, wholly owned subsidiary of Derby and its representation on the Derby board of directors. The note receivable has a maturity date of November 2031. The Company has limited continuing involvement with Derby including short term transition service agreements and insignificant sales to the Delrin® business.

As a result of the Delrin® Divestiture, and included as part of the $419 million gain on the sale, the Company initially recognized the 19.9 percent equity interest and the $350 million note receivable at fair values of $121 million and $224 million, respectively, which are recorded in "Investments and noncurrent receivables" in the Consolidated Balance Sheets. The fair value of the equity interest was determined using the enterprise value based on sales proceeds and a market approach primarily based on restricted stock studies. The fair value of the note receivable was determined using a market approach primarily based on current market interest rates for similar credit facilities and the duration of the note. The financial results of Derby, subsequent to the transaction date, will be included in DuPont's Consolidated Financial Statements with a three-month lag, using the equity method of accounting and with intercompany profits eliminated in accordance with DuPont’s accounting policy. As such, no equity earnings of non-consolidated affiliates were recorded for the year ended December 31, 2023. As of December 31, 2023, the carrying values of the retained equity investment and note receivable were $121 million and $228 million, respectively.

For the year ended December 31, 2023, Company recognized non-cash interest income on the note receivable of $4 million, reported in "Sundry income (expense) - net" on the Consolidated Statement of Operations, and accreted to the carrying value of the note receivable. TJC's valuations of acquired assets and liabilities assumed are in process and are not reflected as of December 31, 2023.

The Company determined the sales of the M&M Businesses represent a strategic shift that has a major effect on the Company’s operations and results. For the years ended December 31, 2023 and 2022 the Company recognized an after-tax gain of $480 million and $5 billion, respectively, recorded in "(Loss) income from discontinued operations, net of tax" in the Company's Consolidated Statement Operations. For the year ended December 31, 2023, $419 million is related to the gain on the sale of Delrin®, which is included in the Consolidated Statements of Cash Flows.
The results of operations of the M&M Businesses are presented as discontinued operations as summarized below for all periods. The M&M Divestiture is reflected through the Transaction Date and the Delrin® Divestiture is reflected through November 1, 2023:
For the Years Ended December 31,
In millions202320222021
Net sales$460 $3,532 $4,087 
Cost of sales295 2,712 2,832 
Research and development expenses3 46 61 
Selling, general and administrative expenses2 127 253 
Amortization of intangibles— 28 159 
Restructuring and asset related charges - net— — 5 
Acquisition, integration and separation costs 1
195 555 52 
Equity in earnings of nonconsolidated affiliates— (9)9 
Sundry income (expense) - net9 4 18 
(Loss) income from discontinued operations before income taxes$(26)$59 $752 
Provision for income taxes on discontinued operations31 128 155 
(Loss) income from discontinued operations, net of tax$(57)$(69)$597 
Net (loss) income from discontinued operations attributable to noncontrolling interests— (4)18 
Gain on sale, net of tax 2
480 5,024 — 
Income from discontinued operations attributable to DuPont stockholders, net of tax$423 $4,959 $579 
1. Includes costs related to the M&M Divestitures for all periods presented.
2. Gain includes purchase price adjustments related to the M&M Divestitures in 2023.

Assets and liabilities held for sale as of December 31, 2022, represent only those related to Delrin®. The following table summarizes the major classes of assets and liabilities of the M&M Businesses classified as held for sale presented as discontinued operations as of December 31, 2022:
In millionsDecember 31, 2022
Assets
Accounts and notes receivable - net$75 
Inventories104 
Other current assets6 
Property, plant and equipment - net256 
Goodwill405 
Other intangible assets338 
Deferred income tax assets36 
Deferred charges and other assets71 
Total assets of discontinued operations$1,291 
Liabilities
Accounts payable$78 
Accrued and other current liabilities8 
Deferred income tax liabilities53 
Pension and other post employment benefits - noncurrent5 
Other noncurrent liabilities2 
Total liabilities of discontinued operations$146 

During the first quarter of 2022 after meeting the criteria to be classified as held for sale, the Company performed impairment analyses and allocated goodwill to the M&M Divestiture and Delrin® disposal groups and no impairments were identified. Refer to Note 14 for additional information. During each reporting period that the M&M Divestiture and Delrin® disposal groups were classified as held for sale, the Company assessed whether the fair value less cost to sell were less than the carrying value of each disposal group.
Pursuant to the Transaction Agreement, liabilities and assets related to the M&M Divestiture could not be directly assumed by Celanese and as a result, transferred by way of indemnification between both parties. In addition, pursuant to the Transaction Agreement, DuPont indemnifies Celanese against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the transaction.

N&B Transaction
On February 1, 2021, DuPont completed the separation and distribution of the N&B Business, and merger of N&B, a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of IFF. The distribution was effected through an exchange offer (the "Exchange Offer") where, on the terms and subject to the conditions of the Exchange Offer, eligible participating DuPont stockholders had the option to tender all, some or none of their shares of common stock, par value $0.01 per share, of DuPont (the “DuPont Common Stock”) for a number of shares of common stock, par value $0.01 per share, of N&B (the “N&B Common Stock”) and which resulted in all shares of N&B Common Stock being distributed to DuPont stockholders that participated in the Exchange Offer. The consummation of the Exchange Offer was followed by the merger of N&B with a wholly owned subsidiary of IFF, with N&B surviving the merger as a wholly owned subsidiary of IFF (the “N&B Merger” and, together with the Exchange Offer, the “N&B Transaction”). The N&B Transaction was subject to IFF shareholder approval, customary regulatory approvals, tax authority rulings including a favorable private letter ruling from the U.S. Internal Revenue Service which confirms the N&B Transaction to be free of U.S. federal income tax, and expiration of the public exchange offer. DuPont does not have an ownership interest in IFF as a result of the N&B Transaction.

In the Exchange Offer, DuPont accepted approximately 197.4 million shares of its common stock in exchange for about 141.7 million shares of N&B Common Stock. As a result, DuPont reduced its common stock outstanding by 197.4 million shares of DuPont Common Stock. In the N&B Merger, each share of N&B Common Stock was automatically converted into the right to receive one share of IFF common stock, par value $0.125 per share, based on the terms of the N&B Merger Agreement.

The results of operations of N&B are presented as discontinued operations as summarized below:
(In millions) For the year ended December 31,2021
Net sales$507 
Cost of sales354 
Research and development expenses21 
Selling, general and administrative expenses47 
Amortization of intangibles38 
Restructuring and asset related charges - net1 
Integration and separation costs172 
Sundry income (expense) - net8 
Interest expense13 
Loss from discontinued operations before income taxes(131)
Benefit from income taxes on discontinued operations(21)
Loss from discontinued operations, net of tax(110)
Income from discontinued operations attributable to noncontrolling interests, net of tax— 
Non-taxable gain on split-off4,920 
Income from discontinued operations attributable to DuPont stockholders, net of tax$4,810 

In connection with and in accordance with the terms of the N&B Transaction, prior to consummation of the Exchange Offer and the N&B Merger, DuPont received a one-time cash payment of approximately $7.3 billion, (the "Special Cash Payment"). The special cash payment was partially funded by an offering of $6.25 billion of senior unsecured notes (the “N&B Notes Offering”). The net proceeds of approximately $6.2 billion from the N&B Notes Offering were deposited into an escrow account and at December 31, 2020 are reflected as restricted cash in the Company’s Consolidated Balance Sheets. In order to fund the remainder of the Special Cash Payment, on February 1, 2021, N&B borrowed $1.25 billion under a senior unsecured term loan agreement (the "N&B Term Loan"). The obligations and liabilities associated with the N&B Notes Offering and N&B Term Loan were separated from the Company on February 1, 2021 upon consummation of the N&B Transaction.

N&B Transaction Agreements
In connection with the N&B Transaction the Company entered into the following, among other agreements, N&B Separation and Distribution Agreement and the N&B Merger Agreement, effective December 15, 2019, and the N&B Tax Matters Agreement effective February 1, 2021.
Other Discontinued Operations Activity
The Company recorded a loss from discontinued operations, net of tax, of $71 million for the year ended December 31, 2023 and income from discontinued operations of $4,856 million and $5,308 million for the years ended December 31, 2022 and 2021, respectively.

Discontinued operations activity consists of the following:
For the Years Ended December 31,
In millions202320222021
M&M Divestitures$423 $4,955 $597 
N&B Transaction— — 4,810 
MOU Activity 1
(426)(74)(76)
Other 2
(68)(25)(23)
(Loss) income from discontinued operations, net of tax$(71)$4,856 $5,308 
1.Includes the activity subject to the binding Memorandum of Understanding (“MOU”) between Chemours, Corteva, EIDP and the Company. The year ended December 31, 2023 includes a charge related to the Water District Settlement Agreement, as defined in Note 16.
2.Primarily related to the DWDP Separation and Distribution Agreement and Letter Agreement between Corteva Inc ("Corteva"), E. I. du Pont de Nemours and Company ("EIDP"). For additional information on these matters, refer to Note 16.

Biomaterials
In May 2022, the Company completed the sale of its Biomaterials business unit, which included the Company's equity method investment in DuPont Tate & Lyle Bio Products, to the Huafon Group. Total consideration received related to the sale was approximately $240 million. For the year ended December 31, 2022, a pre-tax gain of $26 million ($21 million net of tax) was recorded in "Sundry income (expense) - net" in the Company's Consolidated Statements of Operations. For the years ended December 31, 2022 and 2021, the results of operations of the Biomaterials business unit are reported in Corporate & Other.

Sale of Clean Technologies
On December 31, 2021, the Company completed the sale of its Clean Technologies business unit, which was part of Corporate & Other. Total consideration related to the sale of the business is approximately $510 million, with cash proceeds of about $500 million reflecting adjustments for customary closing costs as defined within the purchase agreement. For the year ended December 31, 2021, a pre-tax loss of $3 million ($39 million loss net of tax, primarily driven by nondeductible goodwill) on the disposition was recorded in "Sundry income (expense) - net" in the Company's Consolidated Statements of Operations.

Sale of Solamet®
On June 30, 2021, the Company completed the sale of its Solamet® business unit, which was part of Corporate & Other. Total consideration received related to the sale of the business was approximately $190 million. For the year ended December 31, 2021, a pre-tax gain of $140 million ($105 million net of tax) was recorded in "Sundry income (expense) - net" in the Company's Consolidated Statements of Operations.
v3.24.0.1
REVENUE
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenue Recognition
Products
Substantially all of DuPont's revenue is derived from product sales. Product sales consist of sales of DuPont's products to supply manufacturers and distributors. DuPont considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year.

Revenue from product sales is recognized when the customer obtains control of the Company’s product, which occurs at a point in time, usually upon shipment, with payment terms typically in the range of 30 to 60 days after invoicing depending on business and geographic region. The Company elected the practical expedient to not adjust the amount of consideration for the effects of a significant financing component for all instances in which the period between payment and transfer of the goods will be one year or less. When the Company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company elected to use the practical expedient to expense cash and non-cash sales incentives as the amortization period for the costs to obtain the contract would have been one year or less.

The transaction price includes estimates for reductions in revenue from customer rebates and rights of return on product sales. These amounts are estimated based upon the most likely amount of consideration to which the customer will be entitled. All estimates are based on historical experience, anticipated performance, and the Company’s best judgment at the time to the extent it is probable, that a significant reversal of revenue recognized will not occur. All estimates for variable consideration are reassessed periodically.

For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. Refer to Note 23 for the breakout of net sales by geographic region.
Net Trade Revenue by Segment and Business or Major Product Line202320222021
(In millions) For the years ended December 31,
Industrial Solutions 1
$2,061 $1,954 $1,890 
Interconnect Solutions1,422 1,742 1,617 
Semiconductor Technologies1,854 2,221 2,047 
Electronics & Industrial$5,337 $5,917 $5,554 
Safety Solutions$2,519 $2,649 $2,567 
Shelter Solutions1,655 1,815 1,615 
Water Solutions1,459 1,493 1,370 
Water & Protection$5,633 $5,957 $5,552 
Retained Businesses 2
$1,098 $1,067 $958 
Other 3
— 76 502 
Corporate & Other$1,098 $1,143 $1,460 
Total$12,068 $13,017 $12,566 
1.Net sales attributed to Spectrum, a component of Electronics & Industrial and presented within Industrial Solutions, was $185 million for the year ended December 31, 2023.
2.Net sales reflected in Retained Businesses includes the Auto Adhesives & Fluids, MultibaseTM and Tedlar® businesses.
3.Net sales reflected in Other include activity of certain divested businesses including Biomaterials, Clean Technologies and Solamet®.
Contract Balances
From time to time, the Company enters into arrangements in which it receives payments from customers based upon contractual billing schedules. The Company records accounts receivables when the right to consideration becomes unconditional. Contract liabilities primarily reflect deferred revenue from advance payment for product that the Company has received from customers. The Company classifies deferred revenue as current or noncurrent based on the timing of when the Company expects to recognize revenue.

Revenue recognized for the years ended December 31, 2023 and 2022 from amounts included in contract liabilities at the beginning of the period was insignificant. The Company did not recognize any asset impairment charges related to contract assets during the period.
Contract BalancesDecember 31, 2023December 31, 2022
In millions
Accounts receivable - trade 1
$1,543 $1,593 
Deferred revenue - current 2
$1 $11 
Deferred revenue - non-current 3
$22 $8 
1.Included in "Accounts and notes receivable - net" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
v3.24.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET
 12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND ASSET RELATED CHARGES - NET RESTRUCTURING AND ASSET RELATED CHARGES - NET
The Company records restructuring liabilities that represent nonrecurring charges in connection with simplifying certain organizational structures and operations, including operations related to transformational projects such as divestitures and acquisitions. Charges for restructuring programs and asset related charges, which includes asset impairments, were $146 million, $155 million and $50 million for the years ended December 31, 2023, 2022 and 2021, respectively. These charges were recorded in "Restructuring and asset related charges - net" in the Consolidated Statements of Operations. The total liability related to restructuring programs was $107 million and $67 million at December 31, 2023 and December 31, 2022, respectively, recorded in "Accrued and other current liabilities" in the Consolidated Balance Sheets. Restructuring activity consists of the following programs:

2023-2024 Restructuring Program
In December 2023, the Company approved targeted restructuring actions to capture near-term cost reductions due to macroeconomic factors as well as to further simplify certain organizational structures following the Spectrum acquisition and Delrin® Divestiture (the "2023-2024 Restructuring Program"). For the year ended December 31, 2023, DuPont recorded a pre-tax charge related to the 2023-2024 Restructuring Program in the amount of $110 million, recognized in "Restructuring and asset related charges - net" in the Company's Consolidated Statements of Operations, comprised of $80 million of severance and related benefit costs and asset related charges of $30 million. The Company expects the program to be substantially complete by the end of 2024.

The following table summarizes the charges incurred by segment related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring Program Charges by Segment2023
(In millions) For the Year Ended December 31,
Electronics & Industrial$21 
Water & Protection57 
Corporate & Other32 
Total$110 
The following table summarizes the activities related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring ProgramSeverance and Related Benefit CostAsset Related ChargesTotal
In millions
Reserve balance at December 31, 2022$— $— $— 
Restructuring charges80 30 110 
Charges against the reserve(1)(30)(31)
Reserve balance at December 31, 2023$79 $— $79 
At December 31, 2023, total liabilities related to the 2023-2024 Restructuring Program were $79 million for severance and related benefit costs, recognized in "Accrued and other current liabilities" in the Consolidated Balance Sheets.

2022 Restructuring Program
In October 2022, the Company approved targeted restructuring actions to capture near-term cost reductions and to further simplify certain organizational structures following the M&M Divestitures (the "2022 Restructuring Program"). The Company recorded a pre-tax charge related to the 2022 Restructuring Program in the amount of $96 million inception-to-date, comprised of $82 million of severance and related benefit costs and asset related charges of $14 million.

The following table summarizes the charges incurred by segment related to the 2022 Restructuring Program:
2022 Restructuring Program Charges by Segment20232022
(In millions) For the years ended December 31,
Electronics & Industrial$29 $23 
Water & Protection(2)16 
Corporate & Other8 22 
Total$35 $61 

At December 31, 2023 and 2022, total liabilities related to the 2022 Restructuring Program were $27 million and $57 million for severance and related benefit costs, recognized in "Accrued and other current liabilities" in the Consolidated Balance Sheets. Actions related to the 2022 Restructuring Program are substantially complete.

2021 Restructuring Actions
In October 2021, the Company approved targeted restructuring actions to capture near term cost reductions (the "2021 Restructuring Actions"). The Company recorded pre-tax restructuring charges of $47 million inception-to-date, consisting of severance and related benefit costs of $27 million and asset related charges of $20 million.

The following table summarizes the charges incurred by segment related to the 2021 Restructuring Actions:
2021 Restructuring Actions Charges by Segment202320222021
(In millions) For the years ended December 31,
Electronics & Industrial$(1)$2 $5 
Water & Protection— 1 32 
Corporate & Other2 (3)9 
Total$1 $— $46 

At December 31, 2023 and 2022, total liabilities related to the 2021 Restructuring Actions were $1 million and $7 million, respectively, for severance and related benefit costs, recognized in "Accrued and other current liabilities" in the Consolidated Balance Sheets. Actions related to the 2021 Restructuring Program are substantially complete.

Equity Method Investment Impairment Related Charges
In connection with the M&M Divestitures, in the first quarter of 2022 a portion of an equity method investment was reclassified to “Assets of discontinued operations” within the Consolidated Balance Sheets. The reclassification served as a triggering event requiring the Company to perform an impairment analysis on the retained portion of the equity method investment held within “Investments and noncurrent receivables” on the Consolidated Balance Sheets. The fair value of the retained equity method investment was estimated using a discounted cash flow model (a form of the income approach). The Company's assumptions in estimating fair value utilize Level 3 inputs and include projected revenue, gross margins, EBITDA margins, the weighted average costs of capital, and terminal growth rates. The Company determined the fair value of the retained equity method investment was below the carrying value and had no expectation the fair value would recover in the short-term due to the current economic environment. As a result, the Company concluded the impairment was other-than-temporary and, in March 2022, recorded a pre-tax impairment charge of $94 million ($65 million net of tax) in “Restructuring and asset related charges - net” in the Consolidated Statements of Operations for the year ended December 31, 2022 related to the Electronics & Industrial segment. No impairment was required to be recorded for the portion of the equity method investment previously included within “Assets of discontinued operations.”
v3.24.0.1
SUPPLEMENTARY INFORMATION
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION
Sundry Income (Expense) - Net
(In millions) For the years ended December 31,202320222021
Non-operating pension and other post-employment benefit ("OPEB") (credit) costs$(9)$28 $30 
Interest income 1
155 50 12 
Net gain on divestiture and sales of other assets and investments 2, 3, 4
19 78 171 
Foreign exchange (losses) gains, net(73)15 (53)
Miscellaneous income (expenses) - net 5, 6
10 20 (15)
Sundry income (expense) - net$102 $191 $145 
1.The year ended December 31, 2023 includes interest on cash and marketable securities at a higher interest rate than the prior years and non-cash interest income of $4 million related to the $350 million Delrin® related party note receivable. Refer to Note 4 for additional information.
2.The year ended December 31, 2023 primarily reflects income related to a land sale within the Water & Protection segment and gain adjustments from previously divested businesses.
3.The year ended December 31, 2022 primarily reflects income of $26 million related to the gain on sale of the Biomaterials business unit and income of $37 million related to the sale of a land use right within the Water & Protection segment.
4.The year ended December 31, 2021 primarily reflects income of $140 million related to the gain on sale of the Solamet® business unit and $28 million related to the gain on sale of assets within the Electronics & Industrial segment.
5.The year ended December 31, 2022 includes $13 million related to government grants.
6.The year ended December 31, 2021 includes an impairment charge of approximately $15 million related to an asset sale.

Cash, Cash Equivalents and Restricted Cash
At December 31, 2023, the Company had restricted cash of $411 million within “Restricted cash and cash equivalents” in the Condensed Consolidated Balance Sheets, the majority of the balance is attributable to the Water District Settlement Fund. At December 31, 2022, the Company had restricted cash of $103 million, within the “Restricted cash and cash equivalents - noncurrent”, which a majority is related to the MOU escrow account deposits. Additional information can be found in Note 16.

Accrued and Other Current Liabilities
"Accrued and other current liabilities" in the Consolidated Balance Sheets were $1,269 million at December 31, 2023 and $951 million at December 31, 2022. "Accrued and other current liabilities" at December 31, 2023 includes approximately $405 million related to a settlement agreement further discussed in Note 16. Accrued payroll, which is a component of "Accrued and other current liabilities" was $250 million at December 31, 2023 and $291 million at December 31, 2022. No other component of "Accrued and other current liabilities" was more than five percent of total current liabilities at December 31, 2023 and 2022.
v3.24.0.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes 202320222021
(In millions) For the years ended December 31,
(Loss) income from continuing operations before income taxes
Domestic$(695)$(308)$(293)
Foreign1,199 1,756 1,737 
Income from continuing operations before income taxes$504 $1,448 $1,444 
Current tax expense
Federal$80 $211 $73 
State and local9 7 17 
Foreign 246 373 406 
Total current tax expense$335 $591 $496 
Deferred tax (benefit) expense
Federal $(24)$(191)$(105)
State and local(27)(16)(79)
Foreign (313)3 (75)
Total deferred tax benefit$(364)$(204)$(259)
(Benefit from) provision for income taxes on continuing operations(29)387 237 
Net income from continuing operations$533 $1,061 $1,207 

Reconciliation to U.S. Statutory Rate For the years ended December 31,
202320222021
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Equity earning effect(1.2)0.2 (0.5)
Foreign income taxed at rates other than the statutory U.S. federal income tax rate4.9 (3.9)(7.8)
U.S. tax effect of foreign earnings and dividends13.0 5.0 4.4 
Unrecognized tax benefits(0.1)1.0 0.6 
Acquisitions, divestitures and ownership restructuring activities 1
(64.4)2.5 6.3 
Exchange gains/losses 2
(1.1)0.4 (2.2)
State and local income taxes(2.8)0.2 (3.3)
Change in valuation allowance— — (0.4)
Goodwill impairments 33.5 — — 
Stock-based compensation(1.0)(0.2)0.1 
Foreign-derived intangible income (FDII)(6.0)(2.0)(2.1)
Other - net(1.6)2.5 0.3 
Effective tax rate(5.8)%26.7 %16.4 %
1.Includes a net tax benefit of $324 million and a net tax expense of $22 million in connection with internal restructurings involving foreign subsidiaries for the years ended December 31, 2023 and 2021.
2. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized.
Deferred Tax Balances at December 31,20232022
(In millions)
Deferred tax assets:
Tax loss and credit carryforwards 1
$870 $768 
Lease liability 116 101 
Pension and postretirement benefit obligations46 55 
Unrealized exchange (losses) gains, net(17)16 
Other accruals and reserves131 139 
Research and development218 197 
Inventory16 18 
Other – net202 146 
Gross deferred tax assets$1,582 $1,440 
Valuation allowances 1
(738)(703)
Total deferred tax assets$844 $737 
Deferred tax liabilities:
Investments 2
(204)(290)
Operating lease asset(116)(101)
Property(343)(272)
Intangibles(999)(1,123)
Total deferred tax liabilities$(1,662)$(1,786)
Total net deferred tax liability$(818)$(1,049)
1.Primarily related to recorded tax benefits and the non-realizability of tax loss and carryforwards from operations in the United States, Europe and Asia Pacific.
2.The Company reclassified a portion of its investments balance related to the impact of internal restructuring in 2023.

Included in the 2023 and 2022 deferred tax asset and liability amounts above is $410 million and $370 million, respectively, of a net deferred tax liability related to the Company’s investment in DuPont Specialty Products USA, LLC, which is a partnership for U.S. federal income tax purposes. The Company and its subsidiaries own in aggregate 100 percent of DuPont Specialty Products USA, LLC and the assets and liabilities of DuPont Specialty Products USA, LLC are included in the Consolidated Financial Statements of the Company.
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions) As of December 31,20232022
Operating loss carryforwards
Expire within 5 years$40 $34 
Expire after 5 years or indefinite expiration624 604 
Total operating loss carryforwards$664 $638 
Tax credit carryforwards
Expire within 5 years$37 $26 
Expire after 5 years or indefinite expiration169 104 
Total tax credit carryforwards$206 $130 
Total Operating Loss and Tax Credit Carryforwards$870 $768 
Total Gross Unrecognized Tax Benefits202320222021
(In millions)
Total unrecognized tax benefits at January 1,$470 $351 $432 
Decreases related to positions taken on items from prior years(4)(4)(18)
Increases related to positions taken on items from prior years3 4 5 
Increases related to positions taken in the current year18 164 11 
Settlement of uncertain tax positions with tax authorities(10)(10)(1)
Decreases due to expiration of statutes of limitations(9)— — 
Exchange loss (gain) 5 (9)(14)
Divestiture of N&B— — (64)
Divestiture of M&M— (26)— 
Total unrecognized tax benefits at December 31, 1
$473 $470 $351 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate of continuing operations $329 $338 $303 
Total amount of interest and penalties (benefit) recognized in "Provision for (benefit from) income taxes on continuing operations"$8 $3 $(3)
Total accrual for interest and penalties associated with unrecognized tax benefits$28 $16 $13 
1.Total unrecognized tax benefits includes $141 million, $128 million and $46 million of benefits related to discontinued operations at December 31, 2023, 2022 and 2021.

Each year the Company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities. The impact, if any, of these audits to the Company’s unrecognized tax benefits is not estimable. Positions challenged by the tax authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's results of operations.

Tax years that remain subject to examination for the Company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2023
Earliest Open Year
Jurisdiction
Brazil2019
Canada2017
China2013
Denmark2018
Germany2015
Japan2017
The Netherlands2018
Switzerland2018
United States:
Federal income tax 1
2012
State and local income tax2012
1. The U.S. Federal income tax jurisdiction is open back to 2012 with respect to EIDP pursuant to the DWDP Tax Matters Agreement.

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be permanently invested amounted to $6,495 million as of December 31, 2023. In addition to the U.S. federal tax imposed by the Tax Cuts and Jobs Act ("The Act") on all accumulated unrepatriated earnings through December 31, 2017, The Act introduced additional U.S. federal tax on foreign earnings, effective as of January 1, 2018. The undistributed foreign earnings at December 31, 2023 may still be subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. It is not practicable to calculate the unrecognized deferred tax liability on undistributed foreign earnings due to the complexity of the hypothetical calculation.
2023 Internal Restructurings
The Company recorded a deferred tax benefit of $324 million for the year ended December 31, 2023, in connection with certain internal restructurings. These restructurings in certain instances relied upon legal entity and asset valuations. The aforementioned tax benefit is included in “(Benefit from) provision for income taxes on continuing operations” in the Consolidated Statements of Operations.

M&M Divestitures
The Company recorded a net tax expense of $21 million and $127 million for the year ended December 31, 2023 and 2022, respectively, in connection with certain internal restructurings. These restructurings involve both legal entities within the M&M Businesses and legal entities retained by DuPont after the close of the M&M Divestiture to Celanese, and in certain instances relied upon legal entity valuations. The aforementioned net tax expense is included in “Income from discontinued operations, net of tax” in the Consolidated Statements of Operations. See Note 4 for additional information on the M&M Divestitures.

Laird PM Acquisition
In connection with the integration of Laird PM, the Company completed certain internal restructurings that were determined to be tax free under the applicable sections of the Internal Revenue Code. If the aforementioned transactions were to fail to qualify for non-recognition treatment for U.S. federal income tax purposes, then the Company could be subject to significant tax liability.

N&B Transaction
Certain internal distributions and reorganizations that occurred during 2021 and 2020 in preparation for the N&B Transaction and the external distribution in 2021 qualified as tax-free transactions under the applicable sections of the Internal Revenue Code. If the aforementioned transactions were to fail to qualify for non-recognition treatment for U.S. federal income tax purposes, then the Company could be subject to significant tax liability. Under the N&B Tax Matters Agreement, the Company would generally be allocated such liability and not be indemnified, unless certain non qualifying actions are undertaken by N&B or IFF. To the extent that the Company is responsible for any such liability, there could be a material adverse impact on the Company's business, financial condition, results of operations and cash flows in future reporting periods.

DWDP
For periods between the DWDP Merger and the DWDP Distributions, DuPont's consolidated federal income tax group and consolidated tax return included the Dow and Corteva entities. Generally, the consolidated tax liability of the DuPont U.S. tax group for each year was apportioned among the members of the consolidated group in accordance with the terms of the Amended and Restated DWDP Tax Matters Agreement. DuPont, Corteva and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with the Amended and Restated DWDP Tax Matters Agreement.
v3.24.0.1
EARNINGS PER SHARE CALCULATIONS
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
EARNINGS PER SHARE CALCULATIONS EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for the years ended December 31, 2023, 2022 and 2021:
Net Income for Earnings Per Share Calculations - Basic & Diluted
In millions
202320222021
Income from continuing operations, net of tax$533 $1,061 $1,207 
Net income from continuing operations attributable to noncontrolling interests39 53 30 
Income from continuing operations attributable to common stockholders$494 $1,008 $1,177 
(Loss) income from discontinued operations, net of tax(71)4,856 5,308 
Net (loss) income from discontinued operations attributable to noncontrolling interests— (4)18 
(Loss) income from discontinued operations attributable to common stockholders(71)4,860 5,290 
Net income available to common stockholders$423 $5,868 $6,467 
Earnings Per Share Calculations - Basic
Dollars per share
202320222021
Earnings from continuing operations attributable to common stockholders$1.10 $2.02 $2.17 
(Loss) earnings from discontinued operations, net of tax(0.16)9.75 9.75 
Earnings available to common stockholders 1
$0.94 $11.77 $11.92 
Earnings Per Share Calculations - Diluted
Dollars per share
202320222021
Earnings from continuing operations attributable to common stockholders$1.09 $2.02 $2.16 
(Loss) earnings from discontinued operations, net of tax(0.16)9.73 9.72 
Earnings available to common stockholders 1
$0.94 $11.75 $11.89 
Share Count Information
Shares in Millions
202320222021
Weighted-average common shares - basic449.9 498.5 542.7 
Plus dilutive effect of equity compensation plans1.3 0.9 1.5 
Weighted-average common shares - diluted451.2 499.4 544.2 
Stock options, restricted stock units, and performance-based restricted stock units excluded from EPS calculations 2
2.6 4.1 2.8 
1. Earnings per share amounts are computed independently for income from continuing operations, income from discontinued operations and net income attributable to common stockholders. As a result, the per share amounts from continuing operations and discontinued operations may not equal the total per share amounts for net income attributable to common stockholders.
2. These outstanding options to purchase shares of common stock, restricted stock units and performance based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
v3.24.0.1
ACCOUNTS AND NOTES RECEIVABLE - NET
 12 Months Ended
Dec. 31, 2023
Receivables [Abstract]  
ACCOUNTS AND NOTES RECEIVABLE - NET ACCOUNTS AND NOTES RECEIVABLE - NET
In millionsDecember 31, 2023December 31, 2022
Accounts receivable – trade 1
$1,513 $1,567 
Income tax receivable301 235 
Other 2
556 716 
Total accounts and notes receivable - net$2,370 $2,518 
1.Accounts receivable – trade is net of allowances of $40 million at December 31, 2023 and $38 million at December 31, 2022. Allowances are equal to the estimated uncollectible amounts and current expected credit loss. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.
2.Other includes receivables in relation to value added tax, indemnification assets, general sales tax and other taxes, and other receivables. No individual group represents more than ten percent of total receivables.
Accounts receivable are carried at amounts that approximate fair value.
v3.24.0.1
INVENTORIES
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
INVENTORIES INVENTORIES
In millionsDecember 31, 2023December 31, 2022
Finished goods $1,184 $1,299 
Work in process 487 522 
Raw materials 350 388 
Supplies126 120 
Total inventories$2,147 $2,329 
v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT, AND EQUIPMENT PROPERTY, PLANT, AND EQUIPMENT
Estimated Useful Lives (Years)December 31, 2023December 31, 2022
In millions
Land and land improvements1-25$449 $432 
Buildings1-502,121 1,968 
Machinery, equipment, and other1-257,306 6,714 
Construction in progress849 1,065 
Total property, plant and equipment$10,725 $10,179 
Total accumulated depreciation$4,841 $4,448 
Total property, plant and equipment - net$5,884 $5,731 

In millions202320222021
Depreciation expense$547 $545 $546 
v3.24.0.1
NONCONSOLIDATED AFFILIATES
 12 Months Ended
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
NONCONSOLIDATED AFFILIATES NONCONSOLIDATED AFFILIATES
The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates") are recorded in "Investments and other noncurrent receivables" in the Consolidated Balance Sheets. The Company's net investment in nonconsolidated affiliates at December 31, 2023 and December 31, 2022 is $788 million and $686 million, respectively. In the fourth quarter of 2023, the Company acquired an equity interest in Derby Group Holdings LLC ("Derby"). See Note 4 and below for further information. In the first quarter of 2022, the Company recorded an other-than-temporary impairment on an equity method investment. See Note 6 for more information.

The Company's dividends received from nonconsolidated affiliates is shown in the following table:
Dividends Received from Nonconsolidated Affiliates202320222021
(In millions) For the years ended December 31,
Dividends from nonconsolidated affiliates$71 $103 $98 

The Company had an ownership interest in seven nonconsolidated affiliates, with ownership interest (direct and indirect) ranging from 19.9 percent to 50 percent at December 31, 2023.

Sales to nonconsolidated affiliates represented less than 2 percent of total net sales for the years ended December 31, 2023, 2022 and 2021. Purchases from nonconsolidated affiliates represented less than 3 percent of “Cost of sales” for the years ended December 31, 2023 and 2022 and less than 4 percent for the year ended December 31, 2021.

Derby Equity Interest
As a result of the Delrin® Divestiture, on November 1, 2023, the Company received a 19.9 percent non-controlling equity interest in Derby Group Holdings LLC, (“Derby”). The financial results of Derby, subsequent to the transaction date, will be included in DuPont's Consolidated Financial Statements with a three-month lag, using the equity method of accounting and with intercompany profits eliminated in accordance with DuPont’s accounting policy. As such, no equity earnings of non-consolidated affiliates were recorded for the year ended December 31, 2023. As of December 31, 2023, the carrying values of the retained equity investment and note receivable were $121 million and $228 million, respectively. Refer to Note 4 for further information.
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
The following table summarizes changes in the carrying amount of goodwill for the years ended December 31, 2023 and 2022.
Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Balance at December 31, 2021$9,583 $6,801 $597 $16,981 
Currency Translation Adjustment(186)(145)(5)(336)
Other— — 18 18 
Balance at December 31, 2022$9,397 $6,656 $610 $16,663 
Goodwill recognized for Spectrum Acquisition 1
818 — — 818 
Currency Translation Adjustment(10)48 5 43 
Impairment— (804)— (804)
Balance at December 31, 2023$10,205 $5,900 $615 $16,720 
1.On August 1, 2023, DuPont completed the acquisition of Spectrum, which is included in the Electronics & Industrial segment. See Note 3 for additional information.

The Company tests goodwill for impairment annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value is below carrying value. As a result of the related acquisition method of accounting in connection with the DWDP Merger, EIDP’s assets and liabilities were measured at fair value resulting in increases to the Company’s goodwill and other intangible assets. The fair value valuation increased the risk that any declines in financial projections, including changes to key assumptions, could have a material, negative impact on the fair value of the Company’s reporting units and assets, and therefore could result in an impairment. The Company’s significant assumptions in these analyses include projected revenue, gross margins, selling, administrative, research and development expenses (SARD), capital expenditures, the weighted average cost of capital, the terminal growth rates, and the tax rate for the income approach and projected EBITDA and derived multiples from comparable market transactions for the market approach.
The Company's estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategies. Should future cash flows differ materially from the Company's estimate, or should there be a future market downturn, the Company may be required to perform additional impairment analyses that could result in a non-cash goodwill impairment charge.

As part of its annual impairment test at October 1, 2023, the Company performed qualitative testing on six of its reporting units and performed quantitative testing on two of its reporting units. The qualitative evaluation is an assessment of factors, including reporting unit or asset specific operating results and cost factors, as well as industry, market and macroeconomic conditions, to determine whether it is more likely than not (more than 50 percent) that the fair value of a reporting unit or asset is less than the respective carrying amount, including goodwill. The results of the qualitative assessments indicated that it is not more likely than not that the fair values of the six reporting units were less than their carrying values. For the two reporting units tested by applying the quantitative assessment, the Company used a combination of discounted cash flow models (a form of the income approach) and the Guideline Public Company Method (a form of the market approach). As of October 1, 2023, as previously disclosed, the estimated fair value of the Protection reporting unit (aggregation of the Safety and Shelter businesses), within the Water & Protection segment, exceeded its carrying value by less than 5 percent and the carrying amount of goodwill within this reporting unit was $5.5 billion. No impairments were identified in any of the reporting units as part of the Company’s annual impairment assessment.

In connection with the preparation of the full year 2023 financial statements, the continuation of previously disclosed challenging macroeconomic environment in the residential, non-residential, and the repair and remodel construction markets, as well as incremental channel inventory destocking in healthcare and industrial end-markets served as a triggering event requiring the Company to perform an impairment analysis of the goodwill associated with its Protection reporting unit as of December 31, 2023 The Company performed quantitative testing on the Protection reporting unit using a combination of discounted cash flow models (a form of the income approach) and the Guideline Public Company Method (a form of the market approach). As a result of the analysis performed, the Company concluded that the carrying amount of the Protection reporting unit exceeded its fair value resulting in a non-cash goodwill impairment charge of $804 million, which is recorded within “Goodwill impairment charge” on the Consolidated Statements of Operations for the year ended December 31, 2023. This reporting unit remains at risk for future impairment due to the fair value now being equal to the carrying value as a result of the recorded impairment. Should macroeconomic conditions worsen, resulting in further recovery delays, or other events occur indicating that the estimated future cash flows of the reporting unit have further declined and the reporting unit is unable to meet or exceed its projections from 2024 and other future years, the Company may be required to record future non-cash impairment charges related to goodwill. As of December 31, 2023, the remaining carrying amount of goodwill within the Protection reporting unit was $4.8 billion.

During the first quarter of 2022, in conjunction with the announcement of the M&M Divestitures, the Company realigned the Retained Businesses, previously within the historic Mobility & Materials segment, to Corporate & Other (the "2022 Realignment"). The announcement of the M&M Divestitures and 2022 Realignment served as triggering events requiring the Company to perform impairment analyses related to goodwill carried by the impacted reporting units as of March 1, 2022. Goodwill impairment analyses were performed for reporting units impacted in the historic Mobility & Materials segment prior to the realignment, and no impairments were identified. As part of the 2022 Realignment, the Company assessed and re-defined certain reporting units effective March 1, 2022, including a reallocation of goodwill on a relative fair value basis, as applicable, to the newly identified reporting units and M&M Divestitures disposal groups. Goodwill impairment analyses were performed for the new reporting units reported within Corporate & Other and no impairments were identified. The fair values of the reporting units and the M&M Divestitures disposal groups were estimated using a combination of a discounted cash flow model and/or market approach.
Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
December 31, 2023December 31, 2022
In millionsGross
Carrying
Amount		Accum AmortNetGross Carrying AmountAccum AmortNet
Intangible assets with finite lives:
  Developed technology $2,079 $(1,092)$987 $1,955 $(913)$1,042 
  Trademarks/tradenames
924 (414)510 906 (349)557 
  Customer-related5,815 (2,329)3,486 5,454 (2,389)3,065 
  Other 28 (1)27 54 (27)27 
Total other intangible assets with finite lives$8,846 $(3,836)$5,010 $8,369 $(3,678)$4,691 
Intangible assets with indefinite lives:
  Trademarks/tradenames
804 — 804 804 — 804 
Total other intangible assets with indefinite lives$804 $— $804 $804 $— $804 
Total$9,650 $(3,836)$5,814 $9,173 $(3,678)$5,495 

During the fiscal year 2023, the Company retired fully amortized assets of $399 million of customer-related intangible assets and $25 million of other intangible assets.

During fiscal year 2022, the Company retired fully amortized assets of $390 million of developed technology, $210 million of trademarks/tradenames, $121 million of customer-related intangible assets, and $53 million of other intangible assets.

As part of the 2022 Realignment, the Company reallocated its intangible assets with indefinite lives to align with the new segment structure. This served as a triggering event requiring the Company to perform an impairment analysis related to intangible assets with indefinite lives carried by its historic Mobility & Materials segment as of March 1, 2022, prior to the realignment. Subsequent to the realignment, impairment analyses were then performed for the intangible assets with indefinite lives reported in Corporate & Other. No impairments were identified as a result of the analyses described above.

The following table provides the net carrying value of other intangible assets by segment:
Net Intangibles by SegmentDecember 31, 2023December 31, 2022
In millions
Electronics & Industrial 1
$3,521 $2,976 
Water & Protection2,206 2,424 
Corporate & Other87 95 
Total$5,814 $5,495 
1.Includes intangible assets acquired as part of the Spectrum Acquisition. See Note 3 for additional information.

Total estimated amortization expense for the next five fiscal years is as follows:
Estimated Amortization Expense
In millions
2024$601 
2025$555 
2026$528 
2027$480 
2028$427 
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS
The following tables summarizes the Company's short-term borrowings, long-term debt and finance lease obligations:
Short-Term BorrowingsDecember 31, 2023December 31, 2022
(In millions)
Long-term debt due within one year$— $300 

Long-Term DebtDecember 31, 2023
December 31, 2022
In millionsAmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures 1:
  Final maturity 2023$— — %$300 5.72 %
  Final maturity 20251,850 4.49 %1,850 4.49 %
  Final maturity 20282,250 4.73 %2,250 4.73 %
  Final maturity 2029 and thereafter 2
3,741 5.46 %3,729 5.48 %
Other facilities:
Finance lease obligations10 1 
Less: Unamortized debt discount and issuance costs51 56 
Less: Long-term debt due within one year
— 300 
Total $7,800 $7,774 
1.Represents senior unsecured notes (the "2018 Senior Notes"), which are senior unsecured obligations of the Company.
2.Includes fair value hedging adjustment of $59 million and $71 million at December 31, 2023 and 2022, respectively, related to the Company's interest rate swap agreements. See Note 21 for additional information.

In November 2023, the $300 million Floating Rate Senior Unsecured Notes matured and was repaid at par plus the accrued and unpaid interest. The Company funded the repayment with cash on hand.

In November 2022, the Company redeemed in full its fixed-rate long-term senior unsecured notes of $2.5 billion due 2023 at a redemption price equal to 100 percent of the aggregate principal amount plus the accrued and unpaid interest. The redemption was funded with the proceeds from the M&M Divestiture.

Principal payments of long-term debt for the five succeeding fiscal years are as follows:
Maturities of Long-Term Debt for Next Five Years at December 31, 2023Total
In millions
2024$— 
2025$1,850 
2026$— 
2027$— 
2028$2,250 
The estimated fair value of the Company's long-term borrowings was determined using Level 2 inputs within the fair value hierarchy, as described in Note 22. Based on quoted market prices for the same or similar issues, or on current rates offered to the Company for debt of the same remaining maturities, the fair value of the Company's long-term borrowings, not including long-term debt due within one year, was $7,995 million and $7,674 million at December 31, 2023 and 2022, respectively.

Available Committed Credit Facilities
The following table summarizes the Company's credit facilities:
Committed and Available Credit Facilities at December 31, 2023
In millionsEffective DateCommitted CreditCredit AvailableMaturity DateInterest
Five-Year Revolving Credit Facility
April 2022$2,500 $2,486 April 2027Floating Rate
2023 $1B Revolving Credit Facility
May 20231,000 1,000 May 2024Floating Rate
Total Committed and Available Credit Facilities$3,500 $3,486 
In July 2022, the Company drew down $600 million under the 2022 $1B Revolving Credit Facility in order to facilitate certain intercompany internal restructuring steps related to the M&M Divestiture. The Company repaid the borrowing in September 2022.

Terminated Intended Rogers Acquisition
In connection with the Terminated Intended Rogers Acquisition, on November 22, 2021, the Company entered into a two-year senior unsecured committed term loan agreement in the amount of $5.2 billion. In October 2022, the facility was amended to extend the lending commitments (as amended the "Amended 2021 Term Loan Facility"). On November 1, 2022, the M&M Divestiture closed and therefore, based on the terms of the Amended 2021 Term Loan Facility, the commitment was terminated.

Term Loan and Revolving Credit Facilities
On May 10, 2023, the Company entered into a new $1 billion 364-day revolving credit facility (the "2023 $1B Revolving Credit Facility"). There were no drawdowns of the facility during the year ended December 31, 2023.
On April 12, 2022, the Company entered into a new $2.5 billion five-year revolving credit facility (the "Five-Year Revolving Credit Facility"). The Five-Year Revolving Credit Facility is generally expected to remain undrawn and serve as a backstop to the Company's commercial paper and letter of credit issuance. On April 12, 2022, the Company entered into an updated $1 billion 364-day revolving credit facility (the "2022 $1B Revolving Credit Facility").

May 2020 Debt Offering
On May 1, 2020, the Company completed an underwritten public offering of senior unsecured notes (the “May 2020 Notes”) in the aggregate principal amount of $2 billion of 2.169 percent fixed rate Notes due May 1, 2023 (the “May 2020 Debt Offering”). The consummation of the N&B Transaction triggered the special mandatory redemption feature of the May 2020 Debt Offering. The Company redeemed the May 2020 Notes on May 13, 2021 and funded the redemption with proceeds from the Special Cash Payment.

Uncommitted Credit Facilities and Outstanding Letters of Credit
Unused bank credit lines on uncommitted credit facilities were approximately $721 million at December 31, 2023. These lines are available to support short-term liquidity needs and general corporate purposes including letters of credit. Outstanding letters of credit were approximately $208 million at December 31, 2023. These letters of credit support commitments made in the ordinary course of business.

Debt Covenants and Default Provisions
The Company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations, subject to certain limitations. The 2018 Senior Notes also contain customary default provisions. The Five-Year Revolving Credit Facility and the 2023 $1B Revolving Credit Facility contain a financial covenant requiring that the ratio of Total Indebtedness to Total Capitalization for the Company and its consolidated subsidiaries not exceed 0.60. At December 31, 2023, the Company was in compliance with this financial covenant. There were no material changes to the debt covenants and default provisions at December 31, 2023.

Supplier Financing
The Company and certain of its designated suppliers, at their sole discretion, participate in a supplier financing program with a financial institution serving as an intermediary. Under this program, the Company agrees to pay the financial institution the stated amount of confirmed invoices from its designated suppliers on the same terms and on the original maturity dates of the confirmed invoices, which have a weighted average payment term of approximately 110 days. The Company does not pay any annual subscription or service fee to the financial institution, nor does the Company reimburse its suppliers for any costs they incur to participate in the program. The Company’s obligations are not impacted by the suppliers’ decision to participate in this program. The Company or the financial institution may terminate the agreement upon at least 30 days’ notice.

The amount of invoices outstanding confirmed as valid under the supplier financing programs as of December 31, 2023 and 2022 was $97 million and $127 million, respectively, and is recorded in “Accounts Payable” in the Consolidated Balance Sheets.
v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES
Litigation, Environmental Matters, and Indemnifications
The Company and certain subsidiaries are involved in various lawsuits, claims and environmental actions that have arisen in the normal course of business with respect to product liability, patent infringement, governmental regulation, contract and commercial litigation, as well as possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain substances at various sites. In addition, in connection with divestitures and the related transactions, the Company from time to time has indemnified and has been indemnified by third parties against certain liabilities that may arise in connection with, among other things, business activities prior to the completion of the respective transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. The Company records liabilities for ongoing and indemnification matters when the information available indicates that it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated.

As of December 31, 2023, the Company has recorded indemnification assets of $21 million within "Accounts and notes receivable - net" and $242 million within "Deferred charges and other assets" and indemnified liabilities of $200 million within "Accrued and other current liabilities" and $263 million within "Other noncurrent obligations" within the Consolidated Balance Sheets. At December 31, 2022, the Company has recorded indemnified assets of $70 million within "Accounts and notes receivable - net" and $237 million within "Deferred charges and other assets" and indemnified liabilities of $211 million within "Accrued and other current liabilities" and $274 million within "Other noncurrent obligations" within the Consolidated Balance Sheets.

The Company’s accruals for indemnification liabilities related to the binding Memorandum of Understanding (“MOU”) between Chemours, Corteva, EIDP and the Company and to the DowDuPont ("DWDP") Separation and Distribution Agreement and the Letter Agreement between the Company and Corteva (together the “Agreements”) discussed below, are included in the balances above. Additionally, as of December 31, 2023 the Company has recognized a liability of $405 million (including interest) related to the settlement agreement between Chemours, Corteva, EIDP and DuPont related to the aqueous film-forming foams multi-district litigation, as discussed below.

PFAS Stray Liabilities: Future Eligible PFAS Costs
On July 1, 2015, EIDP, a Corteva subsidiary since June 1, 2019, completed the separation of EIDP’s Performance Chemicals segment through the spin-off of Chemours to holders of EIDP common stock (the “Chemours Separation”). On June 1, 2019, the Company completed the separation of its agriculture business through the spin-off of Corteva, Inc. (“Corteva”), including Corteva’s subsidiary EIDP.

On January 22, 2021, the Company, Corteva, EIDP and Chemours entered into the MOU pursuant to which the parties have agreed to release certain claims that had been raised by Chemours including any claims arising out of or resulting from the process and manner in which EIDP structured or conducted the Chemours Separation, and any other claims that challenge the Chemours Separation or the assumption of Chemours Liabilities (as defined in the Chemours Separation Agreement) by Chemours and the allocation thereof, subject in each case to certain exceptions set forth in the MOU. In connection with the MOU, the confidential arbitration process regarding certain claims by Chemours was terminated in February 2021. The parties have further agreed not to bring any future, additional claims regarding the Chemours Separation Agreement or the MOU outside of arbitration.

Pursuant to the MOU, the parties have agreed to share certain costs associated with potential future liabilities related to alleged historical releases of certain PFAS out of pre-July 1, 2015 conduct (“eligible PFAS costs”) until the earlier to occur of (i) December 31, 2040, (ii) the day on which the aggregate amount of Qualified Spend, as defined in the MOU, is equal to $4 billion or (iii) a termination in accordance with the terms of the MOU. PFAS refers to per- or polyfluoroalkyl substances, which include perfluorooctanoic acids and its ammonium salts (“PFOA”).

The parties have agreed that, during the term of this sharing arrangement, Qualified Spend up to $4 billion will be borne 50 percent by Chemours and 50 percent, up to a cap of $2 billion, by the Company and Corteva. The Company and Corteva will split their 50 percent of Qualified Spend in accordance with the Agreements; accordingly, the Company's portion of the $2 billion is approximately $1.4 billion. At December 31, 2023, the Company had paid Qualified Spend of approximately $170 million against its portion of the $2 billion cap. After the term of this arrangement, Chemours’ indemnification obligations under the Chemours Separation Agreement would continue unchanged.
In order to support and manage any potential future eligible PFAS costs, the parties also agreed to establish an escrow account (the "MOU Escrow Account"). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million and DuPont and Corteva shall together deposit $100 million in the aggregate into the MOU Escrow Account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million and DuPont and Corteva shall together deposit $50 million in the aggregate into the MOU Escrow Account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any calendar year beginning with 2022 through and including 2028. Additionally, if on December 31, 2028, the balance in the MOU Escrow Account (including interest) is less than $700 million, Chemours will make 50 percent of the deposits and DuPont and Corteva together will make 50 percent of the deposits necessary to restore the balance to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the replenishment terms set forth in the MOU.

Under the Agreements, Divested Operations and Businesses ("DDOB") liabilities of EIDP not allocated to or retained by Corteva or the Company are categorized as relating to either (i) PFAS Stray Liabilities, if they arise out of actions related to or resulting from the development, testing, manufacture or sale of PFAS; or (ii) Non-PFAS Stray Liabilities, (and together with PFAS Stray Liabilities, the “EIDP Stray Liabilities”).

The Agreements provide that the Company and Corteva will each bear a certain percentage of the Indemnifiable Losses, described below, rising from EIDP Stray Liabilities and that the percentage changes upon each company meeting its respective threshold of $150 million for PFAS Stray Liabilities and $200 million for EIDP Stray Liabilities. In addition, for certain Non-PFAS Liabilities, (“Specified Spend Non-PFAS Liabilities”), Corteva must spend specified amounts before costs associated with such matter will be considered Indemnifiable Losses.

The Agreements provide that the Company and Corteva each bear 50 percent of the first $300 million ( $150 million each) of total Indemnifiable Losses related to PFAS Stray Liabilities. In 2023, the companies met their respective $150 million threshold, and as a result the Company bears 71 percent of Indemnifiable Losses related to PFAS Stray Liabilities and Corteva bears 29 percent. At December 31, 2023, the Company has accrued for future Qualified Spend and Indemnifiable Losses related to PFAS Stray Liabilities accordingly.

The $150 million of Indemnifiable Losses incurred for PFAS Stray Liabilities has been credited against each company’s $200 million threshold. Corteva has met its $200 million threshold. As a result, until the Company meets its $200 million threshold, it is responsible for managing the Non-PFAS Stray Liabilities, excluding Specified Spend Non-PFAS Liabilities for which Corteva has not reached its specified spend amount, and is bearing all Indemnifiable Losses associated with such Non-PFAS Stray Liabilities. Thereafter, the Company will bear 71 percent and Corteva will bear 29 percent of Indemnifiable Losses related to such Non-PFAS Stray Liabilities. At December 31, 2023, the Company has accrued for future Indemnifiable Losses related to Non-PFAS Stray Liabilities, including Specified Spend Non-PFAS Liabilities, accordingly.

Indemnifiable Losses, as defined in the DWDP Separation and Distribution Agreement, include, among other things, attorneys’, accountants’, consultants’ and other professionals’ fees and expenses incurred in the investigation or defense of EIDP Stray Liabilities.

In connection with the MOU and the Agreements, the Company has recognized the following indemnification liabilities related to eligible PFAS costs:
Indemnified Liabilities Related to the MOU
In millionsDecember 31, 2023December 31, 2022Balance Sheet Classification
Current indemnified liabilities$87 $66 
Accrued and other current liabilities
Long-term indemnified liabilities119 120 Other noncurrent obligations
Total indemnified liabilities accrued under the MOU 1
$206 $186 
1.As of December 31, 2023 and 2022, total indemnified liabilities accrued include $139 million and $161 million, respectively, related to Chemours environmental remediation activities at their site in Fayetteville, North Carolina under the Consent Order between Chemours and the North Carolina Department of Environmental Quality (the "NC DEQ"). This excludes amounts related to the Water District Settlement Agreement.

In addition to the above, beginning the second quarter of 2023 and at December 31, 2023, the Company has recognized a liability of $405 million (including interest) related to the Water District Settlement Agreement, defined below, between Chemours, Corteva, EIDP and DuPont related to the aqueous film-forming foams multi-district litigation.
Future charges associated with the MOU will be recognized over the term of the agreement as a component of income from discontinued operations to the extent liabilities become probable and estimable.

In 2004, EIDP settled a West Virginia state court class action, Leach v. E. I. du Pont de Nemours and Company, which alleged that PFOA from EIDP’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. Members of the Leach class have standing to pursue personal injury claims for just six health conditions that an expert panel appointed under the Leach settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. In 2017, Chemours and EIDP each paid $335 million to settle the multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), thereby resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water. Post the 2017 settlement, approximately 100 cases were brought by Leach class members.

On January 21, 2021, EIDP and Chemours entered into settlement agreements with plaintiffs’ counsel representing the Ohio MDL plaintiffs providing for a settlement of all but one of these cases (the “Settlement”). The total settlement amount was $83 million in cash with each of the Company and EIDP contributing $27 million and Chemours contributing $29 million. At June 30, 2021 the Company had paid in full its $27 million contribution. The Settlement was entered into solely by way of compromise and settlement and is not in any way an admission of liability or fault by the Company, Corteva, EIDP or Chemours. The personal injury case captioned “Abbott v. E. I. du Pont de Nemours and Company” was not included in the Settlement and, following a denial of certification by the U.S. Supreme Court in November 2023 and the exhaustion of all appeal routes, the amended jury verdict of $40 million, plus interest, is shared as defined in the MOU between Chemours, Corteva and DuPont. DuPont's portion of the personal injury case settlement charge, including interest, was approximately $16 million and was paid during the fourth quarter 2023.

In connection with the Settlement, plaintiffs' counsel filed a motion to terminate the Ohio MDL, which they later requested be withdrawn. Subsequently, plaintiffs' counsel filed or indicated intent to file, several new cases into the Ohio MDL. DuPont was not a named party in the Leach case, the Ohio MDL, or the Abbott case. Neither is it a defendant in the new cases being filed into the Ohio MDL.

In November 2023, DuPont, Chemours and Corteva reached a settlement agreement with the State of Ohio designed to benefit Ohio's natural resources and the people of the State of Ohio. As part of the settlement, the companies agreed to pay the State of Ohio a combined total of $110 million, 80 percent of which the State has allocated to restoration of natural resources related to operation of the Washington Works facility. Consistent with the MOU, DuPont's share of the settlement will be approximately $39 million, which is accrued for as of December 31, 2023. Among other things, and subject to certain limitations and preservations, the settlement resolves the State's claims relating to releases of PFAS in or into the State from the Companies' facilities and claims relating to the manufacture and sale of PFAS-containing products. The settlement also resolves the State's claims related to AFFF.

In July 2021, Chemours, Corteva (for itself and EIDP) and DuPont reached a resolution with the State of Delaware for $50 million among other consideration, that avoids litigation and addresses potential natural resources damages from known historical and current releases by the companies in or affecting Delaware. In 2022, the companies paid the settlement consistent with the MOU, accordingly DuPont paid $12.5 million. The settlement provides for a potential Supplemental Payment to Delaware up to a total of $25 million, in the event certain conditions are met. The supplemental payment is to be paid subjected to the terms of the MOU. As a result of the settlement agreement with the State of Ohio reached in November 2023, a Supplemental Payment is owed to the State of Delaware. As a result, the Company has accrued approximately $9 million as of December 31, 2023 related to the Supplemental Payment.

As of December 31, 2023, there are various cases alleging damages due to PFAS which are discussed below. Such actions often include additional claims based on allegations that the transfer by EIDP of certain PFAS liabilities to Chemours resulted in a fraudulent conveyance or voidable transaction. With the exception of the fraudulent conveyance claims, which are excluded from the MOU, legal fees, expenses, costs, and any potential liabilities for eligible PFAS costs presented by the following matters will be shared as defined in the MOU between Chemours, EIDP, Corteva and DuPont.

Beginning in April 2019, several dozen lawsuits alleging water contamination from the use of PFAS-containing aqueous film-forming foams (“AFFF”) were filed against EIDP and Chemours, in additional to 3M and other AFFF manufacturers. The majority of these lawsuits were consolidated in a multi-district litigation (the “AFFF MDL”). The AFFF MDL is captioned In Re: Aqueous Film Forming Foams (AFFF) Products Liability Litigation and is pending in the United States District Court for the District of South Carolina (the “Court”). Since then, the AFFF MDL has grown and contains approximately 5,400 cases. Most of the actions in the AFFF MDL identify DuPont as a defendant only for the fraudulent transfer claims related to the
Chemours Separation and the DowDuPont separations. Generally, the AFFF MDL contains multiple types of lawsuits including, but not limited to personal injury cases, state attorneys general natural resource damages cases, and water provider contamination. DuPont has never made or sold AFFF, perfluorooctanesulfonic acid ("PFOS") or PFOS containing products.

On June 30, 2023, Chemours, Corteva, EIDP and DuPont entered a definitive agreement to comprehensively resolve all PFAS-related claims of a defined class of U.S. public water systems, including but not limited to water systems that are part of the AFFF MDL related to the use of aqueous film-forming foam, (the “Water District Settlement Agreement”) for $1.185 billion in cash. In August 2023, the Court preliminarily approved the Water District Settlement Agreement. Subsequent to the approval, during the third quarter of 2023, Chemours, EIDP, Corteva and DuPont collectively contributed $1.185 billion to a Qualified Settlement Fund (the “Water District Settlement Fund”). In accordance with the MOU, Chemours contributed about 50 percent of the settlement amount (about $592 million), and DuPont (about $400 million) and Corteva (about $193 million) together contributed the remaining 50 percent. Each of Chemours, Corteva and DuPont used its respective MOU Escrow Account deposits to fund in part their respective contributions into the Water District Settlement Fund. As of June 30, 2023, DuPont had deposited an aggregate of $100 million into the MOU Escrow Account all of which it used to fund in part its $400 million contribution to the Water District Settlement Fund. As a result, DuPont has $400 million, excluding interest, at December 31, 2023 related to these liabilities reflected in "Restricted cash and cash equivalents" on the Consolidated Balance Sheets. DuPont's aggregate MOU escrow deposits of $100 million, excluding interest, at December 31, 2022 is reflected in "Restricted cash and cash equivalents - noncurrent" on the Consolidated Balance Sheets.

The defined class is composed of all Public Water Systems, as defined in 42 U.S.C § 300f, with a current detection of PFAS and all Public Water Systems, that are currently required to monitor for PFAS under the EPA’s Fifth Unregulated Contaminant Monitoring Rule (“UCMR 5”) or other applicable federal or state law. The matter captioned City of Stuart, Florida v. 3M Company, et al.is included in the settlement. The class does not include water systems owned and operated by a State or the United States government; small systems that have not detected PFAS and are not currently required to monitor for it under federal or state requirements; and, unless they otherwise request to be included, water systems in the lower Cape Fear River Basin of North Carolina. While it is reasonably possible that the excluded systems or claims could result in additional future lawsuits, claims, assessments or proceedings, it is not possible to predict the outcome of any such matters, and as such, the Company is unable to develop an estimate of a possible loss or range of losses, if any, at this time.

As part of the preliminary approval process, the Court established, among other things, a timetable for notice to class members, a mechanism for class members to opt out of the settlement and a date for a final fairness hearing. Additionally, the preliminary approval included a stay order for pre-existing lawsuits in which the plaintiff is a class member and an injunction prohibiting the filing of new suits where the plaintiff is a class member. The Notice Administrator submitted a report on February 6, 2024 indicating that 924 of 14,167 entities on the list of potential class members submitted timely requests for exclusion. The Court issued an order on December 7, 2023, allowing water systems that elected to opt out of the settlement to rejoin the settlement class by March 1, 2024. Therefore, the number of opt-outs is not final and is subject to a court ordered review process for compliance with the opt out process. On December 14, 2023, the Court held a final fairness hearing as a predicate to issuing an order either granting or denying final approval of the Water District Settlement Agreement. The Water District Settlement Agreement addresses conditions under which the settlement might not proceed, including a walk-away right that enables Chemours, Corteva and DuPont to terminate the settlement if class member opt outs exceed specified confidential levels. The companies had sufficient information to affirm on December 22, 2023 their support of the Water District Settlement Agreement and did not exercise their walk-away right.

Chemours, Corteva and DuPont have agreed to waive the obligation to make additional deposits into the MOU Escrow Account in 2023 and have agreed to waive the obligation due September 30, 2024 if (i) between October 1, 2023 and September 30, 2024, the parties have entered into settlement agreements resolving liabilities constituting Qualified Spend under the MOU that in the aggregate exceed $100 million; (ii) each company has fully funded its respective portion share, in accordance with the MOU, of such settlements; and (iii) such settlements are consummated. If the Water District Settlement is not consummated, Chemours, Corteva and DuPont will redeposit into the MOU Escrow Account the cash each withdrew to partially fund its respective contribution to the Water District Settlement Fund.

In the third quarter 2023, the Company paid its cash contribution of $400 million to the Water District Settlement Fund. At December 31, 2023, DuPont has recorded a liability of about $405 million (including interest) in connection with the Water District Settlement Agreement, included in "Accrued and other current liabilities" within the Consolidated Balance Sheets. The $400 million pre-tax charge is recorded in discontinued operations for the year ended December 31, 2023. As of December 31, 2023 the $400 million deposited, plus interest, within the Water District Settlement Fund is reflected in "Restricted cash and cash equivalents - current" on the Consolidated Balance Sheets. The Company has presented these funds as restricted cash since their use is restricted under the Water District Settlement Agreement.
Subsequent to year end on February 8, 2024, the Court granted the plaintiffs’ motion for final approval of the Water District Settlement Agreement and final certification of settlement class. The funds that the Company contributed into the Water District Settlement Fund, including interest, will be removed from restricted cash and de-recognized, along with the associated accrued liability, after the entry of judgment becomes final and non-appealable.

There are also state attorneys general lawsuits against DuPont, outside of the AFFF MD that make claims of environmental contamination by certain PFAS compounds distinct from AFFF. Generally, the states raise common law tort claims and seek economic impact damages for alleged harm to natural resources, punitive damages, present and future costs to clean up contamination from certain PFAS compounds, and to abate the alleged nuisance. Most of these actions include fraudulent transfer claims related to the Chemours Separation and the DowDuPont separations.

In April 2021, a historic DuPont Dutch subsidiary and the Dutch entities of Chemours and Corteva, received a civil summons filed before the Court of Rotterdam, the Netherlands, on behalf of four municipalities neighboring the Chemours Dordrecht facility. The municipalities are seeking liability declarations relating to the Dordrecht site’s current and historical PFAS operations and emissions. On September 27, 2023, the Court determined that the defendants were liable to the municipalities for (i) PFOA emissions between July 1, 1984 to March 1, 1998 and (ii) removal costs if deposited emissions on the municipalities land infringes the applicable municipality’s property rights by an objective standard. Additional briefing is expected on this judgment and in accordance with local procedure, the Court will determine damages, if any, in a separate, subsequent proceeding.

On March 24, 2023, the Cape Fear Public Utility Authority (“CFPUA”) filed a lawsuit in Delaware Chancery Court against EIDP, Chemours, Corteva, and DuPont alleging that the companies engaged in a series of corporate restructurings in order to evade PFAS liabilities. CFPUA asks for the court to unwind the Chemours spin off; the DowDuPont merger and subsequent separations; to find that DuPont and Corteva have assumed PFAS liabilities from EIDP and Chemours; to enjoin the defendants from distributing, transferring, capitalizing, or disposing of any proceeds from the sale of any business, segment, division or asset; and to impose a constructive trust over any such proceeds. Upon a motion by the Plaintiff, the Court has stayed this matter. The stay will remain in effect until the Judge decides to lift it.

In addition to the above matters, the Company is a named party in various other legal matters that make claims related to PFAS, for which the costs of litigation and future liabilities, if any, are eligible PFAS costs under the MOU and Indemnification Losses under the Agreements.

There are pending cases that make claims related to PFAS that have been filed against Chemours and Corteva/EIDP in which the Company is not a named party, but for which the costs of litigation and future liabilities, if any, are or may be eligible PFAS costs under the MOU and Indemnification Losses under the Agreements.

While Management believes it has appropriately estimated the liability associated with eligible PFAS matters and Indemnifiable Losses as of the date of this report, it is reasonably possible that the Company could incur additional eligible PFAS costs and Indemnifiable Losses in excess of the amounts accrued. It is not possible to predict the outcome of any such matters due to various reasons including, among others, future actions and decisions, as well as factual and legal issues to be resolved in connection with PFAS matters. As such, at this time DuPont is unable to develop an estimate of a possible loss or range of losses, if any, above the liability accrued at December 31, 2023. It is possible that additional costs or losses could have a significant effect on the Company’s financial condition and/or cash flows in the period in which they occur; however, costs qualifying as Qualified Spend are limited by the terms of the MOU.

Other Litigation Matters
In addition to the matters described above, the Company is party to claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, governmental regulation, contract and commercial litigation, and other actions. Certain of these actions may purport to be class actions and seek damages in very large amounts. As of December 31, 2023, the Company has liabilities of $21 million associated with these other litigation matters. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company. In accordance with its accounting policy for litigation matters, the Company will expense litigation defense costs as incurred, which could be significant to the Company’s financial condition and/or cash flows in the period.
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At December 31, 2023, the Company had accrued obligations of $300 million for probable environmental remediation and restoration costs. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the Consolidated Balance Sheets. It is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

The accrued environmental obligations includes the following:
Environmental Accrued Obligations
In millionsDecember 31, 2023December 31, 2022
Potential exposure above the amount accrued 1
Environmental remediation liabilities not subject to indemnity$46 $41 $112 
Environmental remediation indemnified liabilities:
    Indemnifications related to Dow and Corteva 2
101 48 199 
    MOU related obligations (discussed above) 3
152 173 35 
    Other environmental indemnifications1 1 2 
Total environmental related liabilities$300 $263 $348 
1.The environmental accrual represents management’s best estimate of the costs for remediation and restoration with respect to environmental matters, although it is reasonably possible that the ultimate cost with respect to these particular matters could range above the amount accrued as of December 31, 2023.
2.Pursuant to the DWDP Separation and Distribution Agreement and Letter Agreement, the Company is required to indemnify Dow and Corteva for certain Non-PFAS clean-up responsibilities and associated remediation costs.
3.The MOU related obligations include the Company's estimate of its liability under the MOU for remediation activities based on the current regulatory environment.
v3.24.0.1
LEASES
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES LEASES
The Company has operating leases for real estate, an airplane, railcars, fleet, certain machinery and equipment, and information technology assets. The Company’s leases have remaining lease terms of approximately 1 year to 30 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the Company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment is included in the related lease liability in the Consolidated Balance Sheets. At December 31, 2023, the Company has future maximum payments for residual value guarantees in operating leases of $22 million with final expirations through 2034. The Company's lease agreements do not contain any material restrictive covenants.
The components of lease cost for operating leases for the years ended December 31, 2023, 2022 and 2021 were as follows:
In millions202320222021
Operating lease cost$121 $113 $105 
Short-term lease cost4 4 5 
Variable lease cost39 39 38 
Less: Sublease income 1
4 12 11 
Total lease cost$160 $144 $137 
1.Reflects income associated with subleases, not inclusive of all lessor arrangements disclosed below.

Operating cash flows from operating leases related to continuing operations were $115 million, $109 million, and $105 million for the year ended December 31, 2023, 2022 and 2021, respectively.

New operating lease assets and liabilities entered into during the year ended December 31, 2023 and 2022 were $160 million and $131 million, respectively. For the year ended December 31, 2023, this included newly acquired Spectrum leases. Supplemental balance sheet information related to leases was as follows:
In millionsDecember 31, 2023December 31, 2022
Operating Leases
 
Operating lease right-of-use assets 1
$484 $426 
Current operating lease liabilities 2
97 90 
Noncurrent operating lease liabilities 3
390 333 
Total operating lease liabilities
$487 $423 
1.Included in "Deferred charges and other assets" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.

Operating lease ROU assets and lease liabilities are recognized at the commencement date based on the present value of the fixed minimum lease payments over the lease term. As most of the Company’s leases do not provide the lessor’s implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments.
Lease Term and Discount Rate for Operating LeasesDecember 31, 2023December 31, 2022
Weighted-average remaining lease term (years)8.58.1
Weighted-average discount rate3.55 %2.76 %
Maturities of lease liabilities were as follows:
Maturity of Lease Liabilities at December 31, 2023Operating Leases
In millions
2024$112 
202585 
202666 
202753 
202842 
2029 and thereafter209 
Total lease payments$567 
Less: Interest80 
Present value of lease liabilities$487 

The Company has leases in which it is the lessor, with the largest being a result of the N&B Transaction. In connection with the N&B Transaction and the M&M Divestitures, DuPont entered into leasing arrangements with IFF and Celanese, whereby DuPont is leasing certain properties, including office spaces and R&D laboratories. These leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease agreements where the Company is the lessor have final expirations through 2036.
Total lease income was $73 million for which the net profits recognized from these leases were approximately $18 million, both recorded in "Selling, general, and administrative expenses" and "Research and development expenses" for the year-ended December 31, 2023. Contractual lease income for 2024 through 2028 ranges from $61 million to $79 million annually.
Lessor, Operating Leases LEASES
The Company has operating leases for real estate, an airplane, railcars, fleet, certain machinery and equipment, and information technology assets. The Company’s leases have remaining lease terms of approximately 1 year to 30 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the Company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment is included in the related lease liability in the Consolidated Balance Sheets. At December 31, 2023, the Company has future maximum payments for residual value guarantees in operating leases of $22 million with final expirations through 2034. The Company's lease agreements do not contain any material restrictive covenants.
The components of lease cost for operating leases for the years ended December 31, 2023, 2022 and 2021 were as follows:
In millions202320222021
Operating lease cost$121 $113 $105 
Short-term lease cost4 4 5 
Variable lease cost39 39 38 
Less: Sublease income 1
4 12 11 
Total lease cost$160 $144 $137 
1.Reflects income associated with subleases, not inclusive of all lessor arrangements disclosed below.

Operating cash flows from operating leases related to continuing operations were $115 million, $109 million, and $105 million for the year ended December 31, 2023, 2022 and 2021, respectively.

New operating lease assets and liabilities entered into during the year ended December 31, 2023 and 2022 were $160 million and $131 million, respectively. For the year ended December 31, 2023, this included newly acquired Spectrum leases. Supplemental balance sheet information related to leases was as follows:
In millionsDecember 31, 2023December 31, 2022
Operating Leases
 
Operating lease right-of-use assets 1
$484 $426 
Current operating lease liabilities 2
97 90 
Noncurrent operating lease liabilities 3
390 333 
Total operating lease liabilities
$487 $423 
1.Included in "Deferred charges and other assets" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.

Operating lease ROU assets and lease liabilities are recognized at the commencement date based on the present value of the fixed minimum lease payments over the lease term. As most of the Company’s leases do not provide the lessor’s implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments.
Lease Term and Discount Rate for Operating LeasesDecember 31, 2023December 31, 2022
Weighted-average remaining lease term (years)8.58.1
Weighted-average discount rate3.55 %2.76 %
Maturities of lease liabilities were as follows:
Maturity of Lease Liabilities at December 31, 2023Operating Leases
In millions
2024$112 
202585 
202666 
202753 
202842 
2029 and thereafter209 
Total lease payments$567 
Less: Interest80 
Present value of lease liabilities$487 

The Company has leases in which it is the lessor, with the largest being a result of the N&B Transaction. In connection with the N&B Transaction and the M&M Divestitures, DuPont entered into leasing arrangements with IFF and Celanese, whereby DuPont is leasing certain properties, including office spaces and R&D laboratories. These leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease agreements where the Company is the lessor have final expirations through 2036.
Total lease income was $73 million for which the net profits recognized from these leases were approximately $18 million, both recorded in "Selling, general, and administrative expenses" and "Research and development expenses" for the year-ended December 31, 2023. Contractual lease income for 2024 through 2028 ranges from $61 million to $79 million annually.
v3.24.0.1
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY
Share Repurchase Programs
On June 1, 2019, the Company's Board of Directors approved a $2 billion share buyback program ("2019 Share Buyback Program"), which expired on June 1, 2021. At the expiry of the 2019 Share Buyback Program, the Company had repurchased and retired a total of 29.9 million shares at a cost of $2 billion.

In the first quarter of 2021, the Company's Board of Directors authorized a $1.5 billion share buyback program, which expired on June 30, 2022 ("2021 Share Buyback Program"). In the first quarter of 2022, the Company purchased 5.1 million shares for approximately $375 million, effectively completing the program. At the expiry of the 2021 Share Buyback Program, the Company had repurchased and retired a total of 19.6 million shares for $1.5 billion.

In February 2022, the Company's Board of Directors authorized a $1.0 billion share buyback program which expires on March 31, 2023, (the “2022 Share Buyback Program”). As of September 30, 2022, the Company repurchased and retired a total of 11.9 million shares for $750 million under the 2022 Share Buyback Program. In November 2022, DuPont’s Board of Directors approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock (the “$5B Share Buyback Program", together with the 2022 Share Buyback Program, the "2022 Stock Repurchase Programs") in addition to the $250 million remaining under the Company’s existing share repurchase program.

In November 2022, DuPont entered into accelerated share repurchase ("ASR") agreements with each of three financial institutions (the "$3.25B ASR Transaction"). DuPont paid an aggregate of approximately $3.25 billion of common stock with $250 million of such repurchases under the 2022 Share Buyback Program and the remaining $3 billion under the $5B Share Buyback Program. Pursuant to the terms of the $3.25B ASR Transaction, DuPont paid an aggregate of $3.25 billion to the ASR Counterparties and received initial deliveries of 38.8 million shares in aggregate of DuPont common stock, which were retired immediately and recorded as a reduction to retained earnings of $2.6 billion. The $3.25B ASR Transaction was completed during the third quarter of 2023 with DuPont receiving and retiring an additional 8.0 million shares of DuPont common stock. In connection with the completion of the transaction the remaining $613 million based on the price of the shares at the time of delivery was settled as a forward contract indexed to DuPont common stock at the time of settlement, classified within stockholders’ equity. At the completion of the $3.25B ASR Transaction, the Company had repurchased and retired a total of 46.8 million shares at an average price of $69.44 per share.

In the third quarter of 2023, DuPont entered into new accelerated share repurchase agreements with three financial counterparties to repurchase an aggregate of $2 billion of common stock ("$2B ASR Transaction"). DuPont paid an aggregate of $2 billion to the counterparties and received initial deliveries of 21.2 million shares in aggregate of DuPont common stock, which were retired immediately and recorded as a reduction to retained earnings of $1.6 billion. The remaining $400 million was evaluated as an unsettled forward contract indexed to DuPont common stock, classified within stockholders’ equity as of December 31, 2023. The $2B ASR Transaction was funded with cash on hand.

Subsequent to year end, in the first quarter of 2024, the accelerated repurchase agreements under the $2B ASR Transaction were settled. The settlement resulted in the delivery of 6.7 million additional shares of DuPont common stock, which were retired immediately and will be recorded as a reduction of retained earnings in the first quarter of 2024. In total, the Company repurchased 27.9 million shares at an average price of $71.67 per share under the $2B ASR Transaction. The completion of the $2B ASR Transaction effectively completes the $5B Share Buyback Program and the Company's stock repurchase authorization.

Subsequent to year end, in the first quarter 2024, the Company’s Board of Directors approved a new share repurchase program authorizing the repurchase and retirement of up to $1 billion of common stock (“the $1B Program”). The $1B Program terminates on June 30, 2025, unless extended or shortened by the Board of Directors. The timing and number of shares to be repurchased will depend on factors such as the share price, economic and market conditions, and corporate and regulatory requirements. In the first quarter 2024, DuPont entered an ASR agreement with one counterparty for the repurchase of about $500 million of common stock; DuPont received initial deliveries in February 2024, of 6.0 million shares of common stock. The final number of shares to be repurchased will be based on the volume-weighted average stock price for DuPont common stock during the term of the ASR agreement, less an agreed upon discount. Final settlement is expected in the second quarter 2024.

Any additional repurchases under the $1B Program will be made from time to time on the open market at prevailing market prices or in privately negotiated transactions off the market, which may include additional accelerated share repurchase agreements. The timing and number of shares to be repurchased will depend on factors such as the share price, economic and market conditions, and corporate and regulatory requirements.
The Inflation Reduction Act of 2022 introduced a 1 percent nondeductible excise tax imposed on the net value of certain stock repurchases made after December 31, 2022. The net value is determined by the fair market value of the stock repurchased during the tax year, reduced by the fair market value of stock issued during the tax year. The Company recorded total excise tax of $21.2 million as a reduction to retained earnings for the year ended December 31, 2023, reflected within stockholders' equity and a corresponding liability within "Accounts Payable" in our Consolidated Balance Sheets as of December 31, 2023.

Common Stock
The following table provides a reconciliation of DuPont Common Stock activity for the years ended December 31, 2023, 2022 and 2021:
Shares of DuPont Common StockIssuedHeld in Treasury
In thousands
Balance at January 1, 2021734,204 — 
Issued 2,584 — 
Repurchased 1
— 224,995 
Retired 1
(224,995)(224,995)
Balance at December 31, 2021511,793 — 
Issued 2,074 — 
Repurchased
— 55,743 
Retired
(55,743)(55,743)
Balance at December 31, 2022458,124 — 
Issued1,225 — 
Repurchased
— 29,239 
Retired
(29,239)(29,239)
Balance at December 31, 2023430,110 — 
1.Includes 197 million shares of common stock that were exchanged and retired as part of the N&B Transaction.

Retained Earnings
There are no significant restrictions limiting the Company's ability to pay dividends. Dividends declared and paid to common stockholders during the years ended December 31, 2023, 2022 and 2021 are summarized in the following table:
Dividends Declared and Paid202320222021
In millions
Dividends declared to common stockholders$651 $652 $630 
Dividends paid to common stockholders$651 $652 $630 

Undistributed earnings of nonconsolidated affiliates included in retained earnings were $637 million at December 31, 2023 and $656 million at December 31, 2022.
Accumulated Other Comprehensive Loss
The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the years ended December 31, 2023, 2022 and 2021:
Accumulated Other Comprehensive LossCumulative Translation AdjPension and OPEB
Derivative Instruments 1
Total
In millions
2021
Balance at January 1, 2021$470 $(425)$(1)$44 
Other comprehensive (loss) income before reclassifications(742)422 56 (264)
Amounts reclassified from accumulated other comprehensive income— 3 — 3 
Split-off of N&B reclassification adjustment184 73 1 258 
Net other comprehensive (loss) income$(558)$498 $57 $(3)
Balance at December 31, 2021$(88)$73 $56 $41 
2022
Other comprehensive (loss) income before reclassifications(1,101)44 61 (996)
Amounts reclassified from accumulated other comprehensive income— (3)— (3)
M&M Divestiture reclassification adjustment221 (54)— 167 
Net other comprehensive (loss) income$(880)$(13)$61 $(832)
Balance at December 31, 2022$(968)$60 $117 $(791)
2023
Other comprehensive income (loss) before reclassifications46 (83)(41)(78)
Amounts reclassified from accumulated other comprehensive income — (9)— (9)
Delrin® Divestiture reclassification adjustment
(9)(23)— (32)
Net other comprehensive income (loss)$37 $(115)$(41)$(119)
Balance at December 31, 2023$(931)$(55)$76 $(910)
1. Includes cumulative translation adjustment impact associated with derivative instruments.

The tax effects on the net activity related to each component of other comprehensive income (loss) for the years ended December 31, 2023, 2022 and 2021 were as follows:
Tax Benefit (Expense)202320222021
In millions
Pension and other post-employment benefit plans$26 $16 $(122)
Derivative instruments12 (15)(18)
Tax expense from income taxes related to other comprehensive income (loss) items$38 $1 $(140)
A summary of the reclassifications out of AOCL for the years ended December 31, 2023, 2022 and 2021 is provided as follows:
Reclassifications Out of Accumulated Other Comprehensive Loss 202320222021Income Classification
In millions
Cumulative translation adjustments$(9)$221 $184 See (1) below
Pension and other post-employment benefit plans(35)(71)111 See (1) below
Tax expense (benefit) 3 14 (35)See (1) below
    Pension and other post-employment benefit plans,
    after tax
(32)(57)76 
Derivative instruments— — 1 See (1) below
Tax expense— — — See (1) below
Derivative instruments, after tax— — 1 
Total reclassifications for the period, after tax$(41)$164 $261 
1. The activity for the year ended December 31, 2023 is classified almost entirely within "(Loss) income from discontinued operations, net of tax" as part of the Delrin® Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2022 is classified almost entirely within "(Loss) income discontinued operations, net of tax" as part of the M&M Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2021 is classified almost entirely within "(Loss) income from discontinued operations, net of tax" as part of the N&B Transaction, with a portion classified within "Sundry income (expense) - net" as part of continuing operations.
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS
 12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS
The significant defined benefit pension and OPEB plans of TDCC and EIDP are summarized below. Unless otherwise noted, all values within this footnote are inclusive of balances and activity associated with discontinued operations.

Defined Benefit Pension Plans
DuPont has both funded and unfunded defined benefit pension plans covering employees in a number of non-US countries that formerly relate to both TDCC and EIDP. The United Kingdom qualified plan is the largest pension plan held by DuPont.

DuPont's funding policy is consistent with the funding requirements of each country's laws and regulations. Pension coverage for employees of DuPont's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded. During 2023, the Company contributed $66 million to its benefit plans. DuPont expects to contribute approximately $57 million to its benefit plans in 2024.

The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below:
Weighted-Average Assumptions for Pension Plans Benefit Obligations
 at December 31,		Net Periodic Costs
for the Years Ended
 20232022202320222021
Discount rate3.26 %3.71 %3.05 %1.48 %0.87 %
Interest crediting rate for applicable benefits2.00 %2.25 %2.25 %1.25 %1.25 %
Rate of compensation increase3.11 %3.27 %3.25 %3.15 %3.15 %
Expected return on plan assetsN/AN/A3.61 %2.69 %2.73 %

Other Post-employment Benefit Plans
The Company retained U.S. and foreign other post-employment benefit obligations with the Canadian plan and the U.S. long-term disabilities plan being the two largest and accounting for the majority of the Company's total other post-employment benefit obligations. In comparison to the Company's defined benefit pension plans, the Company's other post-employment benefit plans are not significant. The total other post-employment benefits projected benefit obligation was $29 million as of December 31, 2023 and $27 million as of December 31, 2022.

Assumptions
The Company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics.

Service cost and interest cost for all other plans are determined on the basis of the discount rates derived in determining those plan obligations. The discount rates utilized to measure the majority of pension and other postretirement obligations are based on the Aon AA corporate bond yield curves applicable to each country at the measurement date. DuPont utilizes the mortality tables and generational mortality improvement scales, where available, developed in each of the respective countries in which the Company holds plans.
Summarized information on the Company's pension and other postretirement benefit plans is as follows:
Change in Projected Benefit Obligations of All Plans20232022
In millions
Change in projected benefit obligations:
Benefit obligations at beginning of year$2,726 $4,286 
Service cost25 43 
Interest cost99 55 
Plan participants' contributions7 7 
Actuarial changes in assumptions and experience
132 (872)
Benefits paid(208)(233)
Acquisitions/divestitures/other 1, 2
(209)(203)
Effect of foreign exchange rates133 (354)
Termination benefits/curtailment cost/settlements(1)(3)
Benefit obligations at end of year$2,704 $2,726 
1.The year ended 2023 is primarily related to the Delrin® Divestiture.
2.The year ended 2022 is primarily related to the M&M Divestiture.
Change in Plan Assets and Funded Status of All Plans20232022
In millions
Change in plan assets:
Fair value of plan assets at beginning of year$2,596 $4,036 
Actual return on plan assets 109 (735)
Employer contributions66 79 
Plan participants' contributions7 7 
Benefits paid(208)(233)
Acquisitions/divestitures/other 1, 2
(285)(216)
Effect of foreign exchange rates139 (342)
Fair value of plan assets at end of year$2,424 $2,596 
Funded status:
Plans with plan assets$233 $364 
All other plans(513)(494)
Funded status at end of year$(280)$(130)
1.The year ended 2023 is primarily related to the Delrin® Divestiture.
2.The year ended 2022 is primarily related to the M&M Divestiture.

The following tables summarize the amounts recognized in the Consolidated Balance Sheets for all significant plans:
Amounts Recognized in the Consolidated Balance Sheets for All Significant PlansDecember 31, 2023December 31, 2022
In millions
Amounts recognized in the consolidated balance sheets:
Deferred charges and other assets$338 $376 
Assets of discontinued operations— 70 
Accrued and other current liabilities(53)(49)
Pension and other postretirement benefits - noncurrent(565)(522)
Liabilities of discontinued operations— (5)
Net amount recognized$(280)$(130)
Pretax amounts recognized in accumulated other comprehensive loss (income):
Net loss (gain)$95 $(45)
Prior service credit(8)(15)
Pretax balance in accumulated other comprehensive loss at end of year
$87 $(60)
The decrease in the Company's actuarial gains for the year ended December 31, 2023 was primarily due to the changes in weighted-average discount rates, which decreased from 3.71 percent at December 31, 2022 to 3.26 percent at December 31, 2023 and due to divestitures, partially offset by gains on assets in excess of what was expected.

The accumulated benefit obligation for all pension plans was $2.6 billion at December 31, 2023 and 2022.
Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2023December 31, 2022
In millions
Accumulated benefit obligations$700 $566 
Fair value of plan assets$138 $46 
Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2023December 31, 2022
In millions
Projected benefit obligations$743 $706 
Fair value of plan assets$154 $157 

Net Periodic Benefit Costs for All Significant Plans for the Years Ended December 31,202320222021
In millions
Net Periodic Benefit Costs:
Service cost$25 $43 $53 
Interest cost99 55 42 
Expected return on plan assets(92)(97)(105)
Amortization of prior service credit(3)(5)(5)
Amortization of unrecognized net (gain) loss(1)1 12 
Curtailment/settlement(3)(4)3 
Net periodic benefit costs (credits) - Total$25 $(7)$— 
Less: Net periodic benefit credits - Discontinued operations(6)(9)(3)
Net periodic benefit costs - Continuing operations 1
$31 $2 $3 
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):
Net loss (gain)$108 $(35)$(528)
Prior service credit— — (8)
Amortization of prior service credit3 5 5 
Amortization of unrecognized gain (loss)1 (1)(12)
Settlement gain (loss)3 4 (3)
Effect of foreign exchange rates1 5 (11)
Total recognized in other comprehensive loss (income)$116 $(22)$(557)
Noncontrolling interest
$— $— $— 
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income)$147 $(20)$(554)
1. Refer to the separate table below for details of Net Periodic Benefit Costs for Plans in Continuing Operations.
Net Periodic Benefit Costs for Plans in Continuing Operations for the Years Ended December 31,202320222021
In millions
Net Periodic Benefit Costs:
Service cost$22 $30 $33 
Interest cost93 49 39 
Expected return on plan assets(78)(73)(78)
Amortization of prior service credit(2)(4)(5)
Amortization of unrecognized net (gain) loss(1)4 11 
Curtailment/settlement(3)(4)3 
Net periodic benefit costs - Continuing operations$31 $2 $3 
Estimated Future Benefit Payments
The estimated future benefit payments of continuing operations, reflecting expected future service, as appropriate, are presented in the following table:
Estimated Future Benefit Payments at December 31, 2023
In millions
2024$182 
2025178 
2026183 
2027178 
2028181 
Years 2029-2033912 
Total$1,814 

Plan Assets
Plan assets consist primarily of equity and fixed income securities of U.S. and foreign issuers, and alternative investments such as insurance contracts, pooled investment vehicles and private market securities. At December 31, 2023, plan assets totaled $2.4 billion.

The Company establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. The assets are managed by professional investment firms unrelated to the Company. Pension trust funds are permitted to enter into certain contractual arrangements generally described as derivative instruments. Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.

Equity securities primarily included investments in large- and small-cap companies located in both developed and emerging markets around the world. Global equity securities include varying market capitalization levels. U.S. equity investments are primarily large-cap companies. Fixed income securities included investment and non-investment grade corporate bonds of companies diversified across industries, U.S. treasuries, non-U.S. developed market securities, U.S. agency mortgage-backed securities, emerging market securities and fixed income related funds. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S fixed income securities. Alternative investments primarily included investments in real estate, various insurance contracts and interest rate, equity, commodity and foreign exchange derivative investments and hedges. Other investments include cash and cash equivalents, pooled investment vehicles, hedge funds and private market securities such as interests in private equity and venture capital partnerships.

The weighted-average target allocation for plan assets of DuPont's pension plans is summarized as follows:
Target Allocation for Plan Assets at December 31, 2023DuPont
Asset Category
Equity securities2 %
Fixed income securities9 
Alternative investments25 
Hedge funds28 
Pooled investment vehicles28 
Other investments8 
Total 100 %

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.
For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. For other pension plan assets for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models.

For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Valuations of the investments are provided by investment managers or fund managers. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Valuations of insurance contracts are contractually determined and are based on exit price valuations or contract value. Adjustments to valuations are made where appropriate.

Certain pension plan assets are held in funds where fair value is based on an estimated net asset value per share (or its equivalent) as of the most recently available fund financial statements which are received on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate to arrive at an estimated net asset value per share at the measurement date. Where available, audited annual financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation. These funds are not classified within the fair value hierarchy.
The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2023 and 2022:
Basis of Fair Value MeasurementsDecember 31, 2023December 31, 2022
In millionsTotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Cash and cash equivalents$55 $55 $— $— $57 $57 $— $— 
Equity securities:
U.S. equity securities$20 $20 $— $— $43 $43 $— $— 
Non - U.S. equity securities29 29 — — 152 152 — — 
Total equity securities$49 $49 $— $— $195 $195 $— $— 
Fixed income securities:
Debt - government-issued$34 $— $34 $— $105 $— $105 $— 
Debt - corporate-issued5 — 5 — 40 — 40 — 
Total fixed income securities$39 $— $39 $— $145 $— $145 $— 
Alternative investments:
Real estate$79 $— $— $79 $75 $— $— $75 
   Insurance contracts524 — — 524 524 — — 524 
Derivatives - asset position3 — 3 — 8 — 8 — 
Derivatives - liability position— — — — — — — — 
Total alternative investments$606 $— $3 $603 $607 $— $8 $599 
Other Investments:
Pooled Investment Vehicles$681 $681 $— $— $607 $607 $— $— 
Total other investments$681 $681 $— $— $607 $607 $— $— 
Subtotal$1,430 $785 $42 $603 $1,611 $859 $153 $599 
Investments measured at net asset value:
Debt - government-issued$187 $163 
Hedge funds667 690 
Private market securities126 130 
Total investments measured at net asset value
$980 $983 
Items to reconcile to fair value of plan assets:
Pension trust receivables 1
$14    $2    
Pension trust payables 2
—    — 
Total$2,424    $2,596    
1. Primarily receivables for investment securities sold.
2. Primarily payables for investment securities purchased.
The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2023 and 2022:
Fair Value Measurement of Level 3 Pension Plan AssetsReal EstateInsurance ContractsTotal
In millions
Balance at Jan 1, 2022$75 $825 $900 
Actual return on assets:
Relating to assets held at Dec 31, 2022(2)(237)(239)
Purchases, sales and settlements, net2 (33)(31)
Transfers into Level 3— 30 30 
Transfers out of Level 3 1
— (61)(61)
Balance at Dec 31, 2022$75 $524 $599 
Actual return on assets:
Relating to assets held at Dec 31, 20232 26 28 
Purchases, sales and settlements, net2 (16)(14)
Transfers out of Level 3 2
— (10)(10)
Balance at Dec 31, 2023$79 $524 $603 
1. Related to the M&M Divestiture
2. Related to the Delrin® Divestiture

Defined Contribution Plans
The Company provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers all U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the Company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of the Company may participate. Currently, the Company contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution. The Company's matching contributions vest immediately upon contribution. The 3 percent nonmatching employer contribution vests after employees complete three years of service. The Company's contributions to the Plan were $65 million in 2023 and $72 million in 2022. 2023 is inclusive of Delrin® activity related to discontinued operations. 2022 is inclusive of M&M activity related to discontinued operations.

In addition, the Company made contributions to other defined contribution plans in 2023 in the amount of $35 million and $33 million in 2022. 2023 is inclusive of Delrin® activity related to discontinued operations. 2022 is inclusive of M&M activity related to discontinued operations.
v3.24.0.1
STOCK-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Effective with the DWDP Merger, on August 31, 2017, DowDuPont assumed all TDCC and EIDP equity incentive compensation awards outstanding immediately prior to the DWDP Merger. The TDCC and EIDP stock-based compensation plans were assumed by DowDuPont and remained in place with the ability to grant and issue DowDuPont common stock until the DWDP Distributions.

Immediately following the Corteva Distribution, DuPont adopted the DuPont Omnibus Incentive Plan ("DuPont OIP") which provides for equity-based and cash incentive awards to certain employees, directors, independent contractors and consultants. Upon adoption of the DuPont OIP, the TDCC and EIDP plans were rolled into the DuPont OIP as separate subplans and no longer granted new awards. All previously granted equity awards under these subplans have the same terms and conditions that were applicable to the awards under the TDCC and EIDP plans immediately prior to the DWDP Distributions. Due to reaching the plan term of the DuPont OIP, no further awards will be granted from the plan. Awards that are outstanding under the DuPont OIP remain outstanding in accordance with their terms.

During the second quarter of 2020, the stockholders of DuPont approved the DuPont 2020 Equity and Incentive Plan (the "2020 EIP"), which allows the Company to grant options, share appreciation rights, restricted shares, restricted stock units ("RSUs"), share bonuses, other share-based awards, cash awards, each as defined in the 2020 EIP, or any combination of the foregoing. Under the EIP, a maximum of 16 million shares of common stock are available for award as of December 31, 2023. The approval of the 2020 Plan had no effect on the Company’s ability to make future grants under the DuPont OIP in accordance with its terms, and awards that are outstanding under the DuPont OIP remain outstanding in accordance with their terms.

A description of the Company's stock-based compensation is discussed below followed by a description of TDCC and EIDP stock-based compensation.

Accounting for Stock-Based Compensation
The Company grants stock-based compensation awards that vest over a specified period or upon employees meeting certain performance and/or retirement eligibility criteria. The fair value of equity instruments issued to employees is measured on the grant date. The fair value of liability instruments issued to employees is measured at the end of each quarter. The fair value of equity and liability instruments is expensed over the vesting period or, in the case of retirement, from the grant date to the date on which retirement eligibility provisions have been met and additional service is no longer required. The Company estimates expected forfeitures.

DuPont recognized share-based compensation expense in continuing operations of $74 million, $75 million, and $67 million during the years ended December 31, 2023, 2022 and 2021, respectively. The income tax benefits related to stock-based compensation arrangements were $16 million, $16 million, and $13 million for the years ended December 31, 2023, 2022 and 2021, respectively.

Total unrecognized pretax compensation cost in continuing operations related to nonvested stock option awards of $2 million at December 31, 2023, is expected to be recognized over a weighted-average period of 1.0 year. Total unrecognized pretax compensation cost in continuing operations related to RSUs and performance based stock units ("PSUs") of $72 million at December 31, 2023, is expected to be recognized over a weighted average period of 1.7 years. The total fair value of RSUs and PSUs vested in the year ended December 31, 2023 was $72 million. The weighted average grant-date fair value of RSUs and PSUs granted during 2023 was $65.34.

At the time of the N&B separation, outstanding, unvested share-based compensation awards that were denominated in DuPont common stock and held by N&B Employees were terminated and reissued as equity awards issued under the IFF stock plan.

At the time of the M&M separation, outstanding, unvested share-based compensation awards granted in 2022 and held by Employees transferred to Celanese were terminated and reissued as equity awards under the Celanese stock plan. Pre-2022 awards held by M&M Employees were settled by DuPont based on vesting conditions noted in respective grant agreements.

DuPont 2020 Equity Incentive Plan
EIP Stock Options
The exercise price of shares subject to option is equal to the market price of the Company's stock on the date of grant. Stock option awards expire 10 years after the grant date. The plan allows retirement-eligible employees of the Company to retain any granted awards upon retirement provided the employee has rendered at least 12 months of service following the grant date.
The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards and the assumptions set forth in the table below. The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:
EIP Weighted-Average Assumptions 1
2022
Dividend yield1.8 %
Expected volatility26.4 %
Risk-free interest rate1.9 %
Expected life of stock options granted during period (years)6.0
1. No stock options were granted by the Company out of the EIP plan in 2023.

The Company determines the dividend yield by dividing the annualized dividend on DuPont's common stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to DuPont's historical experience, adjusted for expected exercise patterns of in-the-money options.

The following table summarizes stock option activity for 2023 under the EIP:
EIP Stock Options2023
Number of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2023681 $74.40 
Granted— $— 
Exercised(39)$73.26 
Forfeited/Expired(15)$73.84 
Outstanding at December 31, 2023627 $74.48 7.25$1,533 
Exercisable at December 31, 2023300 $74.19 6.44$821 
1. No awards were granted by the Company out of the EIP plan in 2023.

Additional Information about EIP Stock Options
In millions, except per share amounts20232022
Weighted-average fair value per share of options granted 1
$— $17.41 
Total compensation expense for stock options plans 2
$10 $8 
  Related tax benefit 2
$2 $2 
1. No stock options were granted by the Company out of the EIP plan in 2023.
2. These amounts represent life to date.

The aggregate intrinsic values in the table above represent the total pretax intrinsic value (the difference between the closing stock price on the last trading day of 2023 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at year end.

EIP Restricted Stock Units and Performance Based Stock Units
The Company grants RSUs to certain employees that generally vest over a three-year period and, upon vesting, convert one-for-one to DuPont common stock. A retirement eligible employee retains any granted awards upon retirement provided the employee has rendered at least 12 months of service following the grant date. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The Company grants PSUs to senior leadership under the DuPont EIP. Vesting for PSUs granted is based upon achieving certain return on invested capital ("ROIC") targets and certain adjusted corporate net income annual growth targets, weighted evenly between the metrics and modified by a relative total shareholder return ("TSR") percentile ranking goal as compared to the S&P 500. The actual award, delivered as DuPont common stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant-date fair value of the PSUs, subject to the TSR metric, is based upon the market price of the underlying common stock as of the grant date and estimated using a Monte Carlo simulation.
Nonvested awards of RSUs and PSUs are shown below:
EIP RSUs and PSUs2023
Number of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20231,258 $76.07 
Granted1,277 $65.34 
Vested(480)$73.97 
Forfeited(64)$71.01 
Nonvested at December 31, 20231,991 $69.85 

DuPont Omnibus Incentive Plan
The DuPont OIP has two subplans that have the same terms and conditions of the TDCC and EIDP plans immediately prior to the DWDP Distributions. Awards previously granted under those plans that were nonvested will now vest in each subplan. No awards were granted by the Company out of the OIP plan in 2023 or 2022. All new awards will be granted by the EIP.

OIP Stock Options
The exercise price of shares subject to option is equal to the market price of the Company's stock on the date of grant. Stock option awards expire 10 years after the grant date. The plan allows retirement-eligible employees of the Company to retain any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date.

The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards and the assumptions set forth in the table below. The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:
OIP Weighted-Average Assumptions 1
2021
Dividend yield1.6 %
Expected volatility28.3 %
Risk-free interest rate0.9 %
Expected life of stock options granted during period (years)6.0
1. No awards were granted by the Company out of the OIP plan in 2023 or 2022.

The Company determines the dividend yield by dividing the annualized dividend on DuPont's common stock by the option exercise price. A historical daily measurement of volatility (using DowDuPont stock information after the DWDP Merger date and a weighted average of TDCC and EIDP prior to DWDP Merger date) is determined based on the expected life of the option granted. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to DuPont's historical experience, adjusted for expected exercise patterns of in-the-money options.

The following table summarizes stock option activity for 2023 under the OIP:
OIP Stock Options2023
Number of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20231,959 $62.40 
Granted— $— 
Exercised(318)$61.61 
Forfeited/Expired(4)$53.50 
Outstanding at December 31, 20231,637 $62.58 6.05$23,501 
Exercisable at December 31, 20231,547 $61.98 5.98$23,129 
Additional Information about OIP Stock Options 1
In millions, except per share amounts202320222021
Weighted-average fair value per share of options granted$— $— $16.83 
Total compensation expense for stock options plans 2
$26 $25 $24 
  Related tax benefit 2
$6 $5 $5 
1. No awards were granted by the Company out of the OIP plan in 2023 or 2022.
2.These amounts represent life to date.

The aggregate intrinsic values in the table above represent the total pretax intrinsic value (the difference between the closing stock price on the last trading day of 2023 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at year end.

OIP Restricted Stock Units and Performance Based Stock Units
The Company grants RSUs to certain employees that serially vested over a three-year period and, upon vesting, convert one-for-one to DuPont common stock. A retirement eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The Company grants PSUs to senior leadership under a subplan of the DuPont OIP. Vesting for PSUs granted is based upon achieving certain return on invested capital ("ROIC") targets and certain adjusted corporate net income annual growth targets, weighted evenly between the metrics and modified by a relative total shareholder return ("TSR") percentile ranking goal as compared to the S&P 500. The actual award, delivered as DuPont common stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant-date fair value of the PSUs, subject to the TSR metric, is based upon the market price of the underlying common stock as of the grant date and estimated using a Monte Carlo simulation.

Nonvested awards of RSUs and PSUs are shown below.
OIP RSUs and PSUs2023
Number of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 2023687 $67.09 
Granted— $— 
Vested(519)$66.76 
Forfeited(5)$71.43 
Nonvested at December 31, 2023163 $68.01 

TDCC Stock Incentive Plan
In connection with the DWDP Merger, on August 31, 2017 all outstanding TDCC stock options under the TDCC 2012 Stock Incentive Plan (the "2012 Plan") were converted into stock options with respect to DowDuPont Common Stock.

TDCC Stock Options
TDCC granted stock options to certain employees, subject to certain annual and individual limits, with terms of the grants fixed at the grant date. The exercise price of each stock option equals the market price of TDCC’s stock on the grant date. Options vest from one year to three years, and had a maximum term of 10 years. To measure the fair value of the awards on the date of grant, TDCC used the Black-Scholes option pricing model. No awards were granted by the Company out of the TDCC plan during 2023, 2022 and 2021.

EIDP Equity Incentive Plan
EIDP Stock Options
The exercise price of shares subject to option is equal to the market price of EIDP's stock on the date of grant. All options vest serially over a three-year period. Stock option awards expire ten years after the grant date. The plan allowed retirement-eligible employees of EIDP to retain any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. There were no options granted out of the EIDP EIP in 2023, 2022 and 2021.
EIDP determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price. A historical daily measurement of volatility (using DowDuPont stock information after the DWDP Merger date and a weighted average of TDCC and EIDP prior to DWDP Merger date) is determined based on the expected life of the option granted. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to EIDP's historical experience, adjusted for expected exercise patterns of in-the-money options.

The following table summarizes stock option activity for 2023:
EIDP Stock Options2023
Number of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20232,407 $71.60 
Exercised(147)$39.30 
Forfeited/Expired(32)$87.02 
Outstanding at December 31, 20232,228 $73.49 3.5$5,631 
Exercisable at December 31, 20232,228 $73.49 3.5$5,631 

EIDP Restricted Stock Units
EIDP issued RSUs that serially vested over a three-year period. A retirement eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs were also granted periodically to key senior management employees. These RSUs generally vested over periods ranging from three years to five years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date. The awards have the same terms and conditions as were applicable to such equity awards immediately prior to the DWDP Merger closing date. As of December 31, 2023, there are no material nonvested awards of RSUs and no RSUs granted out of the EIDP EIP in 2023, 2022 and 2021.
v3.24.0.1
FINANCIAL INSTRUMENTS
 12 Months Ended
Dec. 31, 2023
Investments, All Other Investments [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS
The following table summarizes the fair value of financial instruments at December 31, 2023 and December 31, 2022:
Fair Value of Financial InstrumentsDecember 31, 2023December 31, 2022
In millionsCostGainLossFair ValueCostGainLossFair Value
Cash equivalents$408 $— $— $408 $2,198 $— $— $2,198 
Restricted cash equivalents 1
$411 $— $— $411 $110 $— $— $110 
Marketable securities$— $— $— $— $1,302 $— $— $1,302 
Total cash and restricted cash equivalents and marketable securities$819 $— $— $819 $3,610 $— $— $3,610 
Long-term debt including debt due within one year 2
$(7,859)$70 $(206)$(7,995)$(8,145)$227 $(58)$(7,976)
Derivatives relating to:
Net investment hedge 3
— 96 — 96 — 149 — 149 
Foreign currency 4, 5
— 26 (23)3 — 10 (35)(25)
Interest rate swap agreements 6
— — (59)(59)— — (71)(71)
Total derivatives$— $122 $(82)$40 $— $159 $(106)$53 
1.At December 31, 2023 there was $411 million of restricted cash classified as "Restricted cash and cash equivalents" in the Consolidated Balance Sheets. At December 31, 2022 there was $7 million of restricted cash classified as "Restricted cash and cash equivalents" and $103 million classified as "Restricted cash and cash equivalents - noncurrent" in the Consolidated Balance Sheets. See Note 7 for more information on restricted cash.
2.Included in the balance is a fair value hedging revaluation related to the Company's interest rate swap agreements. At December 31, 2023 and 2022 this balance was $59 million and $71 million, respectively.
3.Classified as "Deferred charges and other assets" in the Consolidated Balance Sheets.
4.Classified as "Prepaid and other current assets" and "Accrued and other current liabilities" in the Consolidated Balance Sheets.
5.Presented net of cash collateral where master netting arrangements allow.
6.Classified as "Other noncurrent obligations" in the Consolidated Balance Sheets.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The Company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the Company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps.

The Company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The Company is exposed to credit loss in the event of nonperformance by these counterparties. The Company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The Company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the Company's derivative instruments were as follows:
Notional AmountsDecember 31, 2023December 31, 2022
In millions
Derivatives designated as hedging instruments:
   Net investment hedge$1,000 $1,000 
   Interest rate swap agreements$1,000 $1,000 
Derivatives not designated as hedging instruments:
Foreign currency contracts 1
$(907)$476 
1.Presented net of contracts bought and sold.
Derivatives Designated in Hedging Relationships
Net Foreign Investment Hedge
In the second quarter of 2021, the Company entered into a fixed-for-fixed cross currency swaps with an aggregate notional amount totaling $1 billion to hedge the variability of exchange rate impacts between the U.S. Dollar and Euro. Under the terms of the cross-currency swap agreement, the Company notionally exchanged $1 billion at an interest rate of 4.73 percent for €819 million at a weighted average interest rate of 3.26 percent. The cross-currency swap is designated as a net investment hedge and expires on November 15, 2028.

The Company has made an accounting policy election to account for the net investment hedge using the spot method. The Company has also elected to amortize the excluded components in interest expense in the related quarterly accounting period that such interest is accrued. The cross-currency swap is marked to market at each reporting date and any unrealized gains or losses are included in unrealized currency translation adjustments within AOCL, net of amounts associated with excluded components which are recognized in interest expense in the Consolidated Statements of Operations.

Interest Rate Swap Agreements
In the second quarter of 2022, the Company entered into fixed-to-floating interest rate swap agreements with an aggregate notional principal amount totaling $1 billion to hedge changes in the fair value of the Company’s long-term debt due to interest rate change movements. These swaps converted $1 billion of the Company’s $1.65 billion principal amount of fixed rate notes due 2038 into floating rate debt for the portion of their terms through 2032 with an interest rate based on the Secured Overnight Financing Rate ("SOFR"). Under the terms of the agreements, the Company agrees to exchange, at specified intervals, fixed for floating interest amounts based on the agreed upon notional principal amount. The interest rate swaps are designated as fair value hedges and expire on November 15, 2032.

The interest rate swaps are carried at fair value. Fair value hedge accounting has been applied and thus, changes in the fair value of these swaps and changes in the fair value of the related hedged portion of long-term debt will be presented and will net to zero in "Sundry income (expense) – net" in the Consolidated Statements of Operations.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The Company routinely uses forward exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The Company also uses foreign currency exchange contracts to offset a portion of the Company's exposure to certain foreign currency-denominated revenues so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated revenues.

Effect of Derivative Instruments
Foreign currency derivatives not designated as hedges are used to offset foreign exchange gains or losses resulting from the underlying exposures of foreign currency-denominated assets and liabilities. The amount charged on a pretax basis related to foreign currency derivatives not designated as a hedge, which was included in “Sundry income (expense) - net” in the Consolidated Statements of Operations, was a loss of $64 million for the year ended December 31, 2023 ($32 million loss for the year ended December 31, 2022 and $40 million loss for the year ended December 31, 2021). The income statement effects of other derivatives were immaterial.
v3.24.0.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Fair Value Measurements on a Recurring Basis
The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
Basis of Fair Value Measurements on a Recurring Basis at December 31, 2023
Significant Other Observable Inputs
(Level 2)
In millions
Assets at fair value:
Cash equivalents and restricted cash equivalents 1
$364 
Derivatives relating to: 2
Net investment hedge96 
Foreign currency contracts 3
37 
Total assets at fair value$497 
Liabilities at fair value:
Long-term debt including debt due within one year 4
$7,995 
Derivatives relating to: 2
Interest rate swap agreements59 
Foreign currency contracts 3
34 
Total liabilities at fair value$8,088 
1.Time deposits included in "Cash and cash equivalents" in the Consolidated Balance Sheets are held at amortized cost, which approximates fair value. "Cash and cash equivalents" and "Restricted cash and cash equivalents" at December 31, 2023 in the Consolidated Balance Sheets includes $50 million of money market funds and $405 million deposited within a qualified settlement fund consisting of treasury bills, respectively, representing Level 1 fair value measurement investments, also held at amortized cost.
2.See Note 21 for the classification of derivatives in the Consolidated Balance Sheets.
3.Assets and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The offsetting counterparty and cash collateral amounts were $11 million and zero, respectively, for both assets and liabilities as of December 31, 2023.
4.Fair value is based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities and terms.

Basis of Fair Value Measurements on a Recurring Basis at December 31, 2022
Significant Other Observable Inputs
(Level 2)
In millions
Assets at fair value:
Cash equivalents and restricted cash equivalents 1
$2,308 
Marketable securities 2
1,302 
Derivatives relating to: 3
Net investment hedge149 
Foreign currency contracts 4
26 
Total assets at fair value$3,785 
Liabilities at fair value:
Long-term debt including debt due within one year 4
7,976 
Derivatives relating to: 2
Interest rate swap agreements71 
Foreign currency contracts 3
51 
Total liabilities at fair value$8,098 
1.Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Prepaid and other current assets" in the Consolidated Balance Sheets and held at amortized cost, which approximates fair value.
2.Time deposits classified as held to maturity, with maturities of greater than three months and less than twelve months at time of acquisition, which are recorded at amortized cost which approximates fair value.
3. See Note 21 for the classification of derivatives in the Consolidated Balance Sheets.
4. Assets and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The offsetting counterparty and cash collateral amounts were $17 million for both assets and liabilities as of December 31, 2022.
5. Fair value is based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities and terms.
For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks.

For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatility obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2023 and December 31, 2022.

Fair Value Measurements on a Nonrecurring Basis
The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:
Basis of Fair Value Measurements on a Nonrecurring Basis 1
Significant Other Unobservable Inputs (Level 3)Total Losses
In millions
At December 31, 2023
Assets at fair value:
   Goodwill$4,814 $(804)
At December 31, 2022
Assets at fair value:
    Long-lived assets, intangible assets, and other assets$55 $(94)
1.The Company did not incur any losses associated with fair value measurements on a nonrecurring basis for the year-ended December 31, 2021.

2023 Fair Value Measurements on a Nonrecurring Basis
During the fourth quarter of 2023, the Company recorded an impairment charge related to goodwill within Water & Protection. The impairment analysis was performed using Level 3 inputs within the fair value hierarchy. See Note 14 for further discussion.

2022 Fair Value Measurements on a Nonrecurring Basis
During the first quarter of 2022, the Company recorded an impairment charge related to equity method investments within Electronics & Industrial. The impairment analysis was performed using Level 3 inputs within the fair value hierarchy. See Note 6 for further discussion.
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENTS AND GEOGRAPHIC REGIONS SEGMENTS AND GEOGRAPHIC REGIONS
The Company's segments are aligned with the market verticals they serve, while maintaining integration and innovation strengths within strategic value chains. DuPont is comprised of two operating segments: Electronics & Industrial and Water & Protection. Major products by segment include: Electronics & Industrial (printing and packaging materials, photopolymers, electronic materials, specialty silicones and lubricants); and Water & Protection (nonwovens, aramids, construction materials, water filtration and purification resins, elements and membranes). The Company operates globally in substantially all of its product lines. Transfers of products between operating segments are generally valued at cost.

The revenues and certain expenses of the M&M Businesses are classified as discontinued operations in the current and historical periods. In addition, the Retained Businesses previously reported in the historic Mobility & Materials segment are reported in Corporate & Other.

The historic Mobility & Material segment costs that are classified as discontinued operations include only direct operating expenses incurred prior to the November 1, 2022 M&M Divestiture and November 1, 2023 Delrin® Divestiture. Indirect costs, such as those related to corporate and shared service functions previously allocated to the M&M Businesses, do not meet the criteria for discontinued operations and remain reported within continuing operations. A portion of these indirect costs include costs related to activities the Company will continue to undertake post-closing of the M&M Divestitures, and for which it is reimbursed (“Future Reimbursable Indirect Costs”). Future Reimbursable Indirect Costs are reported within continuing operations but are excluded from operating EBITDA as defined below. The remaining portion of these indirect costs are not subject to future reimbursement (“Stranded Costs”). Stranded Costs are reported within continuing operations in Corporate & Other and are included within Operating EBITDA.

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.

Sales are attributed to geographic regions based on customer location; long-lived assets are attributed to geographic regions based on asset location.
Net Trade Revenue by Geographic Region202320222021
(In millions) For the years ended December 31,
United States$3,914 $4,066 $3,661 
Canada271 293 263 
EMEA 1
2,203 2,193 2,229 
Asia Pacific 2
5,191 6,022 6,026 
Latin America489 443 387 
Total$12,068 $13,017 $12,566 
1.Europe, Middle East and Africa.
2. Net sales attributed to China/Hong Kong, for the years ended December 31, 2023, 2022 and 2021 were $2,206 million, $2,744 million, and $2,822 million, respectively.

Long-lived Assets by Geographic RegionDecember 31,
In millions202320222021
United States$3,559 $3,501 $3,433 
Canada54 49 51 
EMEA 1
1,336 1,271 1,301 
Asia Pacific896 883 925 
Latin America39 27 43 
Total$5,884 $5,731 $5,753 
1.Europe, Middle East and Africa.
Segment InformationElectronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
For the Year Ended December 31, 2023
Net sales$5,337 $5,633 $1,098 $12,068 
Operating EBITDA 1
1,472 1,388 82 2,942 
Equity in earnings of nonconsolidated affiliates16 35 — 51 
Restructuring and asset related charges - net 2
49 55 42 146 
Goodwill impairment charges— 804— 804
Depreciation and amortization607 507 33 1,147 
Assets of continuing operations18,622 13,750 6,180 38,552 
Investment in nonconsolidated affiliates386 280 122 788 
Capital expenditures306 240 44 590 
For the Year Ended December 31, 2022
Net sales$5,917 $5,957 $1,143 $13,017 
Operating EBITDA 1
1,836 1,431 (6)3,261 
Equity in earnings of nonconsolidated affiliates31 39 5 75 
Restructuring and asset related charges - net 2
118 17 20 155 
Depreciation and amortization 580 494 61 1,135 
Assets of continuing operations17,110 14,831 8,123 40,064 
Investment in nonconsolidated affiliates396 290 — 686 
Capital expenditures290 289 80 659 
For the Year Ended December 31, 2021
Net sales$5,554 $5,552 $1,460 $12,566 
Operating EBITDA 1
1,758 1,385 9 3,152 
Equity in earnings of nonconsolidated affiliates
41 36 8 85 
Restructuring asset related charges - net 2
8 30 12 50 
Depreciation and amortization 518 511 83 1,112 
Assets of continuing operations17,701 15,003 5,094 37,798 
Investment in nonconsolidated affiliates502 310 6 818 
Capital expenditures337 391 88 816 
1.A reconciliation of "Income from continuing operations before income taxes" to Operating EBITDA is provided in the table on the following page.
2.See Note 6 for information regarding the Company's restructuring programs and asset related charges.

Total Asset Reconciliation at December 31,202320222021
In millions
Assets of continuing operations$38,552 $40,064 $37,798 
Assets held for sale — — 245 
Assets of discontinued operations— 1,291 7,664 
Total assets$38,552 $41,355 $45,707 

Segment Capital Expenditure Reconciliation to Consolidated Financial Statements202320222021
In millions
Segment Totals$590 $659 $816 
Other 1
29 3 (28)
Total$619 $662 $788 
1.Reflects the incremental cash spent or unpaid on capital expenditures; total capital expenditures are presented on a cash basis.
Reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA202320222021
(In millions) For the years ended December 31,
Income from continuing operations, net of tax $533 $1,061 $1,207 
+(Benefit from) provision for income taxes on continuing operations(29)387 237 
Income from continuing operations before income taxes$504 $1,448 $1,444 
+Depreciation and amortization1,147 1,135 1,112 
-
Interest income 1
155 50 12 
+
Interest expense 2
396 486 503 
-
Non-operating pension/OPEB (credit) benefit 1
(9)28 30 
-
Foreign exchange (losses) gains, net 1
(73)15 (53)
+Future reimbursable indirect costs7 52 60 
-
Significant items
(961)(233)(22)
Operating EBITDA $2,942 $3,261 $3,152 
1.Included in "Sundry income (expense) - net."
2.The year ended December 31, 2022 excludes significant items, refer to details below.


The following tables summarize the pre-tax impact of significant items by segment that are excluded from Operating EBITDA above:
Significant Items by Segment for the Year Ended December 31, 2023Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$(20)$— $— $(20)
Restructuring and asset related charges - net 2
(49)(55)(42)(146)
Goodwill impairment charge 3
— (804)— (804)
Gain on divestiture 4
7 1 1 9 
Total$(62)$(858)$(41)$(961)
1. Acquisition, integration and separation costs related to the Spectrum Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Reflects a non-cash goodwill impairment charge in the Protection Reporting unit (aggregation of Safety and Shelter businesses). See Note 14 for additional information.
4. Reflected in "Sundry income (expense) - net."

Significant Items by Segment for the Year Ended December 31, 2022Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$— $— $(193)$(193)
Restructuring and asset related charges - net 2
(24)(17)(20)(61)
Asset impairment charges 3
(94)— — (94)
Gain on divestiture 4
— 37 32 69 
Terminated Intended Rogers Acquisition financing fees 5
— — (6)(6)
Employee Retention Credit 6
20 20 12 52 
Total$(98)$40 $(175)$(233)
1. Acquisition, integration and separation costs related to strategic initiatives including the sale of the Biomaterials business unit, the acquisition of Laird PM, and the termination fee of $162.5 million associated with the Terminated Intended Rogers Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Relates to an impairment of an equity method investment. See Note 6 for additional information.
4. Reflected in "Sundry income (expense) - net." See Note 4 for additional information.
5. Includes acquisition costs associated with the Terminated Intended Rogers Acquisition related to the financing agreements, specifically the structuring fees and the amortization of the commitment fees reflected in "Interest Expense."
6. Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) reflected in "Cost of sales," "Research and development expenses" and "Selling, general and administrative expenses."
Significant Items by Segment for the Year Ended December 31, 2021Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$— $— $(81)$(81)
Restructuring and asset related charges - net 2
(8)(30)(12)(50)
Merger-related inventory step-up amortization 3
(12)— — (12)
Gain on divestiture 4
2 — 141 143 
Terminated Intended Rogers Acquisition financing fees 5
— — (22)(22)
Total$(18)$(30)$26 $(22)
1.Acquisition, integration and separation costs related to strategic initiatives including the acquisition of Laird PM, the M&M Divestitures, the Terminated Intended Rogers Acquisition, and the completed and planned divestitures of the held for sale businesses included within Corporate & Other.
2. Includes Board approved restructuring plans and asset related charges. See Note 6 for additional information.
3. Includes the amortization of the fair value step-up in Laird PM's inventories as a result of the acquisition.
4. Reflected in "Sundry income (expense) - net." See Note 4 for additional information.
5. Includes acquisition costs associated with the Terminated Intended Rogers Acquisition related to the financing agreements, specifically the structuring fees and the amortization of the commitment fees reflected in "Interest Expense."
v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Net Income (Loss) $ 423 $ 5,868 $ 6,467
v3.24.0.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements of DuPont de Nemours, Inc. ("DuPont” or the "Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

The Consolidated Financial Statements include the accounts of the Company and subsidiaries in which a controlling interest is maintained. The Consolidated Financial Statements also include the accounts of joint ventures that are variable interest entities ("VIEs") in which the Company is the primary beneficiary due to the Company's power to direct the VIEs significant activities. For those consolidated subsidiaries in which the Company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the Company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The Company is also involved with certain joint ventures accounted for under the equity method of accounting that are VIEs. The Company is not the primary beneficiary, as the nature of the Company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the Company becomes the primary beneficiary. At December 31, 2023 and 2022, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Beginning in the second quarter of 2023, the Company has segregated the cash flows from discontinued operations from the cash flows from continuing operations in accordance with ASC 230, Statement of Cash Flows. The Consolidated Statements of Cash Flows have been recast for all periods to reflect the change in presentation.

DWDP Distributions
Effective August 31, 2017, E. I. du Pont de Nemours and Company ("EID") and The Dow Chemical Company ("TDCC") each merged with subsidiaries of DowDuPont Inc. (n/k/a "DuPont”) and, as a result, EID and TDCC became subsidiaries of the Company. On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary TDCC (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary EID (subsequently renamed EIDP, Inc. (n/k/a "EIDP")), (the “Corteva Distribution" and together with the Dow Distribution, the “DWDP Distributions”). Following the Corteva Distribution, DuPont holds the specialty products business as continuing operations. DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”) (for certain events prior to June 1, 2019, the Company may be referred to as DowDuPont). Beginning on June 3, 2019, the Company's common stock is traded on the New York Stock Exchange under the ticker symbol "DD."

N&B Transaction
On February 1, 2021, DuPont completed the separation and distribution of the Nutrition & Biosciences business segment (the "N&B Business"), and merger of Nutrition & Biosciences, Inc. (“N&B”), a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of International Flavors & Fragrances Inc. ("IFF"). The distribution was effected through an exchange offer (the “Exchange Offer”) and the consummation of the Exchange Offer was followed by the merger of N&B with a wholly owned subsidiary of IFF, with N&B surviving the merger as a wholly owned subsidiary of IFF (the “N&B Merger” and, together with the Exchange Offer, the “N&B Transaction”). See Note 4 for more information.

The results of operations of DuPont for the years ended December 31, 2021 reflect the historical financial results of N&B as discontinued operations. The comprehensive income related to N&B has not been segregated and is included in the Consolidated Statements of Comprehensive Income for the applicable period. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of N&B.

M&M Transactions
On November 1, 2022, DuPont completed the previously announced divestiture of the majority of its historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”), to Celanese Corporation (“Celanese”) for cash proceeds of $11.0 billion. On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). The Delrin® Divestiture and together with the M&M Divestiture, collectively the "M&M Divestitures” and the businesses in scope of the M&M Divestitures collectively the "M&M Businesses". See Note 4 for more information.
The financial position of DuPont as of December 31, 2022, present the businesses subsequently divested as part of the Delrin® Divestiture as discontinued operations. The results of operations for the year ended December 31, 2023, present the financial results of Delrin® as discontinued operations through November 1, 2023. The results of operations for the years ended December 31, 2022 and 2021, present the financial results of the M&M Businesses as discontinued operations. For the year ended December 31, 2023, the Consolidated Statements of Cash Flows present the cash flows of the Delrin® Divestiture as discontinued operations for activity. The Consolidated Statements of Cash Flows for the year ended December 31, 2022 and 2021, present the cash flows from the M&M Businesses as discontinued operations. The comprehensive income of the M&M Businesses has not been segregated and is included in the Consolidated Statements of Comprehensive Income for all periods presented. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses.
The Auto Adhesives & Fluids, MultibaseTM and Tedlar® product lines, previously reported within the historical Mobility & Materials segment, (the "Retained Businesses") are not included in the scope of the M&M Divestitures. In 2022, the Retained Businesses were realigned to Corporate & Other. The reporting changes have been retrospectively applied for all periods presented.
Basis of Presentation
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements of DuPont de Nemours, Inc. ("DuPont” or the "Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

The Consolidated Financial Statements include the accounts of the Company and subsidiaries in which a controlling interest is maintained. The Consolidated Financial Statements also include the accounts of joint ventures that are variable interest entities ("VIEs") in which the Company is the primary beneficiary due to the Company's power to direct the VIEs significant activities. For those consolidated subsidiaries in which the Company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the Company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The Company is also involved with certain joint ventures accounted for under the equity method of accounting that are VIEs. The Company is not the primary beneficiary, as the nature of the Company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the Company becomes the primary beneficiary. At December 31, 2023 and 2022, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Beginning in the second quarter of 2023, the Company has segregated the cash flows from discontinued operations from the cash flows from continuing operations in accordance with ASC 230, Statement of Cash Flows. The Consolidated Statements of Cash Flows have been recast for all periods to reflect the change in presentation.

DWDP Distributions
Effective August 31, 2017, E. I. du Pont de Nemours and Company ("EID") and The Dow Chemical Company ("TDCC") each merged with subsidiaries of DowDuPont Inc. (n/k/a "DuPont”) and, as a result, EID and TDCC became subsidiaries of the Company. On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary TDCC (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary EID (subsequently renamed EIDP, Inc. (n/k/a "EIDP")), (the “Corteva Distribution" and together with the Dow Distribution, the “DWDP Distributions”). Following the Corteva Distribution, DuPont holds the specialty products business as continuing operations. DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”) (for certain events prior to June 1, 2019, the Company may be referred to as DowDuPont). Beginning on June 3, 2019, the Company's common stock is traded on the New York Stock Exchange under the ticker symbol "DD."

N&B Transaction
On February 1, 2021, DuPont completed the separation and distribution of the Nutrition & Biosciences business segment (the "N&B Business"), and merger of Nutrition & Biosciences, Inc. (“N&B”), a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of International Flavors & Fragrances Inc. ("IFF"). The distribution was effected through an exchange offer (the “Exchange Offer”) and the consummation of the Exchange Offer was followed by the merger of N&B with a wholly owned subsidiary of IFF, with N&B surviving the merger as a wholly owned subsidiary of IFF (the “N&B Merger” and, together with the Exchange Offer, the “N&B Transaction”). See Note 4 for more information.

The results of operations of DuPont for the years ended December 31, 2021 reflect the historical financial results of N&B as discontinued operations. The comprehensive income related to N&B has not been segregated and is included in the Consolidated Statements of Comprehensive Income for the applicable period. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of N&B.

M&M Transactions
On November 1, 2022, DuPont completed the previously announced divestiture of the majority of its historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”), to Celanese Corporation (“Celanese”) for cash proceeds of $11.0 billion. On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). The Delrin® Divestiture and together with the M&M Divestiture, collectively the "M&M Divestitures” and the businesses in scope of the M&M Divestitures collectively the "M&M Businesses". See Note 4 for more information.
The financial position of DuPont as of December 31, 2022, present the businesses subsequently divested as part of the Delrin® Divestiture as discontinued operations. The results of operations for the year ended December 31, 2023, present the financial results of Delrin® as discontinued operations through November 1, 2023. The results of operations for the years ended December 31, 2022 and 2021, present the financial results of the M&M Businesses as discontinued operations. For the year ended December 31, 2023, the Consolidated Statements of Cash Flows present the cash flows of the Delrin® Divestiture as discontinued operations for activity. The Consolidated Statements of Cash Flows for the year ended December 31, 2022 and 2021, present the cash flows from the M&M Businesses as discontinued operations. The comprehensive income of the M&M Businesses has not been segregated and is included in the Consolidated Statements of Comprehensive Income for all periods presented. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses.
The Auto Adhesives & Fluids, MultibaseTM and Tedlar® product lines, previously reported within the historical Mobility & Materials segment, (the "Retained Businesses") are not included in the scope of the M&M Divestitures. In 2022, the Retained Businesses were realigned to Corporate & Other. The reporting changes have been retrospectively applied for all periods presented.
Use of Estimates in Financial Statement Preparation
Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s Consolidated Financial Statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest, which approximates fair value.
Restricted Cash and Cash Equivalents
Restricted Cash and Cash Equivalents
Restricted cash and cash equivalents represents trust assets, cash held in escrow and cash within qualified settlement funds. These funds are restricted as to withdrawal or use under the terms of certain contractual agreements. Restricted cash is classified as a current or non-current asset based on the timing and nature of when or how the cash is expected to be used.
Marketable Securities
Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments.
Fair Value Measurements
Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The Company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1–Quoted market prices in active markets for identical assets or liabilities;
Level 2–Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3–Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.
Foreign Currency Translation
Foreign Currency Translation
The Company's worldwide operations utilize the U.S. dollar ("USD") or local currency as the functional currency, where applicable. The Company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The Company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.
Interest Rate Swap Agreements and Net Foreign Investment Hedge
Interest Rate Swap Agreements
The Company has entered into a fixed-to-floating interest rate swap agreement to hedge changes in the fair value of the Company’s long-term debt due to interest rate movements. Under the terms of the agreement, the Company agrees to exchange, at specified intervals, fixed for floating interest amounts based on the agreed upon notional principal amount. The interest rate swaps are designated and carried as fair value hedges. Fair value hedge accounting has been applied and thus, changes in the fair value of these swaps and changes in the fair value of the related hedged portion of long-term debt will be presented and will net to zero in Sundry income (expense) – net in the Consolidated Statements of Operations.

Net Foreign Investment Hedge
The Company has entered into fixed-for-fixed cross currency swaps which are designated as a net investment hedge and has made an accounting policy election to account for the net investment hedge using the spot method. The Company has also elected to amortize the excluded components in interest expense in the related quarterly accounting period that such interest is accrued. The cross-currency swap is marked to market at each reporting date and any unrealized gains or losses are included in unrealized currency translation adjustments within "Accumulated other comprehensive loss" ("AOCL"), net of amounts associated with excluded components which are recognized in interest expense in the Consolidated Statements of Operations.
Inventories
Inventories
The Company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method. The Company's inventories are generally accounted for under the average cost method. The Company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

In periods of abnormally low production, certain fixed costs normally absorbed into inventory are recorded directly to cost of sales in the period incurred.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
The Company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value.

When testing goodwill for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If the carrying value of a reporting unit exceeds its fair value, an impairment loss is recognized in the amount by which the carrying value of the reporting unit exceeds its fair value, limited to the amount of goodwill at the reporting unit. The Company determines fair values for each of the reporting units using a combination of the income approach and/or market approach. Under the income approach, fair value is determined based on the net present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. Under the market approach, the Company selects peer sets based on close competitors and reviews the EBIT/EBITDA multiples to determine the fair value. When applicable, third-party purchase offers may be utilized to measure fair value. The Company applies a weighting to the market approach and income approach to determine the fair value. See Note 14 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually during the fourth quarter; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. When testing indefinite-lived intangible assets for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of indefinite-lived intangible assets is less than carrying value. If the Company chooses not to complete a qualitative assessment for indefinite-lived intangible assets or if the initial assessment indicates that it is more likely than not that the carrying value of indefinite-lived intangible assets exceeds the fair value, additional quantitative testing is required. Impairment exists when carrying value exceeds fair value. The Company's fair value methodology is primarily based on discounted cash flow techniques.
Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 20 years. The Company continually evaluates the reasonableness of the useful lives of these assets.
Impairment and Disposals of Long-Lived Assets
Impairment and Disposals of Long-Lived Assets
The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered for impairment when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss would be recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset group. The Company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies, including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed. Depreciation is recognized over the remaining useful life of the assets.
Acquisitions
Acquisitions
In accordance with ASC 805, Business Combinations, acquisitions are recorded using the acquisition method of accounting. The Company includes the operating results of acquired entities from their respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired and liabilities assumed as of the acquisition date fair value, where applicable. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired and liabilities assumed is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred.
Leases
Leases
The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract, in accordance with ASC 842, Leases. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the Consolidated Balance Sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the Consolidated Balance Sheets. Finance lease ROU assets are included in "Property, plant and equipment - net" and the corresponding lease liabilities are included in "Long-term debt" on the Consolidated Balance Sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the Consolidated Statements of Operations, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.
The Company has leases in which it is the lessor, these leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease income is recorded in "Selling, general, and administrative expenses" and "Research and development expenses".
Derivative Instruments
Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The Company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain or loss is reported in AOCL until it is cleared to earnings during the same period in which the hedged item affects earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in AOCL generally remains in AOCL until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

For derivative instruments designated as net investment hedges, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in AOCL. The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated.
Environmental Matters
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in "Accrued and other current liabilities" and "Other noncurrent obligations" at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as "Accounts and notes receivable - net."

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.
Revenue Recognition
Revenue Recognition
The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the Company determines are within the scope of Revenue from Contracts with Customers (Topic 606), the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 5 for additional information on revenue recognition.
Cost of Sales
Cost of Sales
Cost of sales primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses. No amortization of intangibles is included within costs of sales.
Research and Development
Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, and enhancement of existing products.
Selling, General and Administrative Expenses
Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.
Acquisition, Integration and Separation Costs
Acquisition, Integration and Separation Costs
Acquisition, integration and separation costs primarily consist of financial advisory, information technology, legal, accounting, consulting, other professional advisory fees and other contractual transaction payments associated with the preparation and execution of activities related to strategic initiatives.
Litigation
Litigation
Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.
Restructuring and Asset Related Charges
Restructuring and Asset Related Charges
Charges for restructuring programs generally include targeted actions involving employee severance and related benefit costs, contract termination charges, and asset related charges, which include impairments or accelerated depreciation/amortization of long-lived assets associated with such actions. Employee severance and related benefit costs are provided to employees under the Company’s ongoing benefit arrangements. These charges are accrued during the period when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. Contract termination charges primarily reflect costs to terminate a contract before the end of its term or costs that will continue to be incurred under the contract for its remaining term without economic benefit to the Company. Asset related charges reflect impairments to long-lived assets and indefinite-lived intangible assets no longer deemed recoverable and depreciation/amortization of long-lived assets, which is accelerated over their remaining economic lives.
Income Taxes
Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in "Income taxes payable" and the long-term portion is included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
Recently Adopted Accounting Guidance and Accounting Guidance Issued But Not Adopted
Recently Adopted Accounting Guidance
In September 2022, the FASB issued Accounting Standards Update No. 2022-04, "Liabilities-Supplier Finance Programs (Subtopic 405-50)" ("ASU 2022-04") to enhance transparency about the use of supplier finance programs. The new guidance requires that a buyer in a supplier finance program provides additional qualitative and quantitative disclosures about its program including the nature of the program, activity during the period, changes from period to period, and the potential magnitude of the program. The amendments in ASU 2022-04 are effective for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the amendment on rollforward information which is effective prospectively for fiscal years beginning after December 15, 2023. The Company implemented the new disclosures, other than the rollforward information, as required in the first quarter of 2023. The disclosures around rollforward information will be implemented as required for the year-ended December 31, 2024. See Note 15 for more information.

In October 2021, the FASB issued Accounting Standards Update No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”), which requires contract assets and contract liabilities (i.e., unearned revenue) acquired in a business combination to be recognized and measured in accordance with ASC 606, Revenue from Contracts with Customers. Historically, the Company has recognized contract assets and contract liabilities at the acquisition date based on fair value estimates in accordance with ASC 805, Business Combinations. ASU 2021-08 is effective for interim and annual periods beginning after December 15, 2022 on a prospective basis, with early adoption permitted. The Company implemented the guidance as required during the first interim period for the year-ended December 31, 2023. The guidance did not have a significant impact.

Accounting Guidance Issued But Not Adopted at December 31, 2023
In November 2023, the FASB issued Accounting Standards Update No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07") to improve disclosure requirements about reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The new guidance requires disclosures of significant segment expenses provided to the Chief Operating Decision Maker ("CODM") and included in reported measures of segment profit and loss. Disclosure of the title and position of the CODM is required. The guidance requires interim and annual disclosures about a reportable segment's profit or loss and assets. Additionally, the guidance requires disclosure of other segment items by reportable segment including a description of its composition. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, on a retrospective basis. The disclosures will be implemented as required for the year-ended December 31, 2024. The Company is currently evaluating the impact of adopting this guidance.

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09") to improve transparency and disclosure requirements for the rate reconciliation, income taxes paid and other tax disclosures. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, on a prospective basis. The disclosures will be implemented as required for the year-ended December 31, 2025. The Company is currently evaluating the impact of adopting this guidance.
v3.24.0.1
ACQUISITIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule Assets Acquired and Liabilities Assumed
The table below presents the provisional fair values allocated to the assets acquired and liabilities assumed. The purchase accounting and purchase price allocation for Spectrum are substantially complete. However, the Company continues to refine the preliminary valuation of certain acquired assets and liabilities assumed, principally income tax related amounts, which could impact the amount of residual goodwill recorded. The Company will finalize the amounts recognized as it obtains the information necessary to complete the analysis, but no later than one year from the date of the acquisition. Final determination of the fair values may result in further adjustments to the values presented in the following table:
Spectrum Assets Acquired and Liabilities Assumed on August 1, 2023
Estimated
fair value as previously reported 1
Measurement period adjustments 2
Estimated fair value adjusted
In millions
Fair value of assets acquired
Cash and cash equivalents$31 $— $31 
Accounts and notes receivable68 — 68 
Inventories52 — 52 
Property, plant and equipment125 — 125 
Other intangible assets1,032 (116)916 
Deferred charges and other assets34 — 34 
Total Assets Acquired$1,342 $(116)$1,226 
Fair value of liabilities assumed
Accounts payable$21 $— $21 
Income taxes payable17 — 17 
Deferred income tax liabilities206 (29)177 
Other noncurrent liabilities37 — 37 
Total Liabilities Assumed$281 $(29)$252 
Goodwill731 87 818 
Total Consideration$1,792 $— $1,792 
1.As previously reported in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023.
2.The Company recorded measurement period adjustments in the fourth quarter of 2023 to reflect changes in preliminary valuation assumptions for customer relationships. All measurement period adjustments were offset against goodwill.
Schedule of Acquisition, Integration and Separation Costs
These costs are recorded within "Acquisition, integration and separation costs" within the Consolidated Statements of Operations.
(In millions) For the years ended December 31, 202320222021
Acquisition, integration and separation costs$20 $193 $81 
v3.24.0.1
DIVESTITURES (Tables)
 12 Months Ended
Dec. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Divestitures Including Discontinued Operations
The results of operations of the M&M Businesses are presented as discontinued operations as summarized below for all periods. The M&M Divestiture is reflected through the Transaction Date and the Delrin® Divestiture is reflected through November 1, 2023:
For the Years Ended December 31,
In millions202320222021
Net sales$460 $3,532 $4,087 
Cost of sales295 2,712 2,832 
Research and development expenses3 46 61 
Selling, general and administrative expenses2 127 253 
Amortization of intangibles— 28 159 
Restructuring and asset related charges - net— — 5 
Acquisition, integration and separation costs 1
195 555 52 
Equity in earnings of nonconsolidated affiliates— (9)9 
Sundry income (expense) - net9 4 18 
(Loss) income from discontinued operations before income taxes$(26)$59 $752 
Provision for income taxes on discontinued operations31 128 155 
(Loss) income from discontinued operations, net of tax$(57)$(69)$597 
Net (loss) income from discontinued operations attributable to noncontrolling interests— (4)18 
Gain on sale, net of tax 2
480 5,024 — 
Income from discontinued operations attributable to DuPont stockholders, net of tax$423 $4,959 $579 
1. Includes costs related to the M&M Divestitures for all periods presented.
2. Gain includes purchase price adjustments related to the M&M Divestitures in 2023.
The following table summarizes the major classes of assets and liabilities of the M&M Businesses classified as held for sale presented as discontinued operations as of December 31, 2022:
In millionsDecember 31, 2022
Assets
Accounts and notes receivable - net$75 
Inventories104 
Other current assets6 
Property, plant and equipment - net256 
Goodwill405 
Other intangible assets338 
Deferred income tax assets36 
Deferred charges and other assets71 
Total assets of discontinued operations$1,291 
Liabilities
Accounts payable$78 
Accrued and other current liabilities8 
Deferred income tax liabilities53 
Pension and other post employment benefits - noncurrent5 
Other noncurrent liabilities2 
Total liabilities of discontinued operations$146 
The results of operations of N&B are presented as discontinued operations as summarized below:
(In millions) For the year ended December 31,2021
Net sales$507 
Cost of sales354 
Research and development expenses21 
Selling, general and administrative expenses47 
Amortization of intangibles38 
Restructuring and asset related charges - net1 
Integration and separation costs172 
Sundry income (expense) - net8 
Interest expense13 
Loss from discontinued operations before income taxes(131)
Benefit from income taxes on discontinued operations(21)
Loss from discontinued operations, net of tax(110)
Income from discontinued operations attributable to noncontrolling interests, net of tax— 
Non-taxable gain on split-off4,920 
Income from discontinued operations attributable to DuPont stockholders, net of tax$4,810 
Discontinued operations activity consists of the following:
For the Years Ended December 31,
In millions202320222021
M&M Divestitures$423 $4,955 $597 
N&B Transaction— — 4,810 
MOU Activity 1
(426)(74)(76)
Other 2
(68)(25)(23)
(Loss) income from discontinued operations, net of tax$(71)$4,856 $5,308 
1.Includes the activity subject to the binding Memorandum of Understanding (“MOU”) between Chemours, Corteva, EIDP and the Company. The year ended December 31, 2023 includes a charge related to the Water District Settlement Agreement, as defined in Note 16.
2.Primarily related to the DWDP Separation and Distribution Agreement and Letter Agreement between Corteva Inc ("Corteva"), E. I. du Pont de Nemours and Company ("EIDP"). For additional information on these matters, refer to Note 16.
v3.24.0.1
REVENUE (Tables)
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Net Trade Revenue
Net Trade Revenue by Segment and Business or Major Product Line202320222021
(In millions) For the years ended December 31,
Industrial Solutions 1
$2,061 $1,954 $1,890 
Interconnect Solutions1,422 1,742 1,617 
Semiconductor Technologies1,854 2,221 2,047 
Electronics & Industrial$5,337 $5,917 $5,554 
Safety Solutions$2,519 $2,649 $2,567 
Shelter Solutions1,655 1,815 1,615 
Water Solutions1,459 1,493 1,370 
Water & Protection$5,633 $5,957 $5,552 
Retained Businesses 2
$1,098 $1,067 $958 
Other 3
— 76 502 
Corporate & Other$1,098 $1,143 $1,460 
Total$12,068 $13,017 $12,566 
1.Net sales attributed to Spectrum, a component of Electronics & Industrial and presented within Industrial Solutions, was $185 million for the year ended December 31, 2023.
2.Net sales reflected in Retained Businesses includes the Auto Adhesives & Fluids, MultibaseTM and Tedlar® businesses.
3.Net sales reflected in Other include activity of certain divested businesses including Biomaterials, Clean Technologies and Solamet®.
Schedule of Contract Balances
Contract BalancesDecember 31, 2023December 31, 2022
In millions
Accounts receivable - trade 1
$1,543 $1,593 
Deferred revenue - current 2
$1 $11 
Deferred revenue - non-current 3
$22 $8 
1.Included in "Accounts and notes receivable - net" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
v3.24.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET (Tables)
 12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Charges
The following table summarizes the charges incurred by segment related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring Program Charges by Segment2023
(In millions) For the Year Ended December 31,
Electronics & Industrial$21 
Water & Protection57 
Corporate & Other32 
Total$110 
The following table summarizes the charges incurred by segment related to the 2022 Restructuring Program:
2022 Restructuring Program Charges by Segment20232022
(In millions) For the years ended December 31,
Electronics & Industrial$29 $23 
Water & Protection(2)16 
Corporate & Other8 22 
Total$35 $61 
The following table summarizes the charges incurred by segment related to the 2021 Restructuring Actions:
2021 Restructuring Actions Charges by Segment202320222021
(In millions) For the years ended December 31,
Electronics & Industrial$(1)$2 $5 
Water & Protection— 1 32 
Corporate & Other2 (3)9 
Total$1 $— $46 
Schedule of Restructuring Reserve
The following table summarizes the activities related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring ProgramSeverance and Related Benefit CostAsset Related ChargesTotal
In millions
Reserve balance at December 31, 2022$— $— $— 
Restructuring charges80 30 110 
Charges against the reserve(1)(30)(31)
Reserve balance at December 31, 2023$79 $— $79 
v3.24.0.1
SUPPLEMENTARY INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Sundry Income (Expense), Net
Sundry Income (Expense) - Net
(In millions) For the years ended December 31,202320222021
Non-operating pension and other post-employment benefit ("OPEB") (credit) costs$(9)$28 $30 
Interest income 1
155 50 12 
Net gain on divestiture and sales of other assets and investments 2, 3, 4
19 78 171 
Foreign exchange (losses) gains, net(73)15 (53)
Miscellaneous income (expenses) - net 5, 6
10 20 (15)
Sundry income (expense) - net$102 $191 $145 
1.The year ended December 31, 2023 includes interest on cash and marketable securities at a higher interest rate than the prior years and non-cash interest income of $4 million related to the $350 million Delrin® related party note receivable. Refer to Note 4 for additional information.
2.The year ended December 31, 2023 primarily reflects income related to a land sale within the Water & Protection segment and gain adjustments from previously divested businesses.
3.The year ended December 31, 2022 primarily reflects income of $26 million related to the gain on sale of the Biomaterials business unit and income of $37 million related to the sale of a land use right within the Water & Protection segment.
4.The year ended December 31, 2021 primarily reflects income of $140 million related to the gain on sale of the Solamet® business unit and $28 million related to the gain on sale of assets within the Electronics & Industrial segment.
5.The year ended December 31, 2022 includes $13 million related to government grants.
6.The year ended December 31, 2021 includes an impairment charge of approximately $15 million related to an asset sale.
v3.24.0.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes 202320222021
(In millions) For the years ended December 31,
(Loss) income from continuing operations before income taxes
Domestic$(695)$(308)$(293)
Foreign1,199 1,756 1,737 
Income from continuing operations before income taxes$504 $1,448 $1,444 
Current tax expense
Federal$80 $211 $73 
State and local9 7 17 
Foreign 246 373 406 
Total current tax expense$335 $591 $496 
Deferred tax (benefit) expense
Federal $(24)$(191)$(105)
State and local(27)(16)(79)
Foreign (313)3 (75)
Total deferred tax benefit$(364)$(204)$(259)
(Benefit from) provision for income taxes on continuing operations(29)387 237 
Net income from continuing operations$533 $1,061 $1,207 
Schedule of Effective Income Tax Rate Reconciliation
Reconciliation to U.S. Statutory Rate For the years ended December 31,
202320222021
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Equity earning effect(1.2)0.2 (0.5)
Foreign income taxed at rates other than the statutory U.S. federal income tax rate4.9 (3.9)(7.8)
U.S. tax effect of foreign earnings and dividends13.0 5.0 4.4 
Unrecognized tax benefits(0.1)1.0 0.6 
Acquisitions, divestitures and ownership restructuring activities 1
(64.4)2.5 6.3 
Exchange gains/losses 2
(1.1)0.4 (2.2)
State and local income taxes(2.8)0.2 (3.3)
Change in valuation allowance— — (0.4)
Goodwill impairments 33.5 — — 
Stock-based compensation(1.0)(0.2)0.1 
Foreign-derived intangible income (FDII)(6.0)(2.0)(2.1)
Other - net(1.6)2.5 0.3 
Effective tax rate(5.8)%26.7 %16.4 %
1.Includes a net tax benefit of $324 million and a net tax expense of $22 million in connection with internal restructurings involving foreign subsidiaries for the years ended December 31, 2023 and 2021.
2. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized.
Schedule of Deferred Tax Assets and Liabilities
Deferred Tax Balances at December 31,20232022
(In millions)
Deferred tax assets:
Tax loss and credit carryforwards 1
$870 $768 
Lease liability 116 101 
Pension and postretirement benefit obligations46 55 
Unrealized exchange (losses) gains, net(17)16 
Other accruals and reserves131 139 
Research and development218 197 
Inventory16 18 
Other – net202 146 
Gross deferred tax assets$1,582 $1,440 
Valuation allowances 1
(738)(703)
Total deferred tax assets$844 $737 
Deferred tax liabilities:
Investments 2
(204)(290)
Operating lease asset(116)(101)
Property(343)(272)
Intangibles(999)(1,123)
Total deferred tax liabilities$(1,662)$(1,786)
Total net deferred tax liability$(818)$(1,049)
1.Primarily related to recorded tax benefits and the non-realizability of tax loss and carryforwards from operations in the United States, Europe and Asia Pacific.
2.The Company reclassified a portion of its investments balance related to the impact of internal restructuring in 2023.
Schedule of Operating Loss and Tax Credit Carryforwards
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions) As of December 31,20232022
Operating loss carryforwards
Expire within 5 years$40 $34 
Expire after 5 years or indefinite expiration624 604 
Total operating loss carryforwards$664 $638 
Tax credit carryforwards
Expire within 5 years$37 $26 
Expire after 5 years or indefinite expiration169 104 
Total tax credit carryforwards$206 $130 
Total Operating Loss and Tax Credit Carryforwards$870 $768 
Schedule of Gross Unrecognized Tax Benefits
Total Gross Unrecognized Tax Benefits202320222021
(In millions)
Total unrecognized tax benefits at January 1,$470 $351 $432 
Decreases related to positions taken on items from prior years(4)(4)(18)
Increases related to positions taken on items from prior years3 4 5 
Increases related to positions taken in the current year18 164 11 
Settlement of uncertain tax positions with tax authorities(10)(10)(1)
Decreases due to expiration of statutes of limitations(9)— — 
Exchange loss (gain) 5 (9)(14)
Divestiture of N&B— — (64)
Divestiture of M&M— (26)— 
Total unrecognized tax benefits at December 31, 1
$473 $470 $351 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate of continuing operations $329 $338 $303 
Total amount of interest and penalties (benefit) recognized in "Provision for (benefit from) income taxes on continuing operations"$8 $3 $(3)
Total accrual for interest and penalties associated with unrecognized tax benefits$28 $16 $13 
1.Total unrecognized tax benefits includes $141 million, $128 million and $46 million of benefits related to discontinued operations at December 31, 2023, 2022 and 2021.
Schedule of Tax Years Subject to Examination
Tax years that remain subject to examination for the Company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2023
Earliest Open Year
Jurisdiction
Brazil2019
Canada2017
China2013
Denmark2018
Germany2015
Japan2017
The Netherlands2018
Switzerland2018
United States:
Federal income tax 1
2012
State and local income tax2012
1. The U.S. Federal income tax jurisdiction is open back to 2012 with respect to EIDP pursuant to the DWDP Tax Matters Agreement.
v3.24.0.1
EARNINGS PER SHARE CALCULATIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following tables provide earnings per share calculations for the years ended December 31, 2023, 2022 and 2021:
Net Income for Earnings Per Share Calculations - Basic & Diluted
In millions
202320222021
Income from continuing operations, net of tax$533 $1,061 $1,207 
Net income from continuing operations attributable to noncontrolling interests39 53 30 
Income from continuing operations attributable to common stockholders$494 $1,008 $1,177 
(Loss) income from discontinued operations, net of tax(71)4,856 5,308 
Net (loss) income from discontinued operations attributable to noncontrolling interests— (4)18 
(Loss) income from discontinued operations attributable to common stockholders(71)4,860 5,290 
Net income available to common stockholders$423 $5,868 $6,467 
Earnings Per Share Calculations - Basic
Dollars per share
202320222021
Earnings from continuing operations attributable to common stockholders$1.10 $2.02 $2.17 
(Loss) earnings from discontinued operations, net of tax(0.16)9.75 9.75 
Earnings available to common stockholders 1
$0.94 $11.77 $11.92 
Earnings Per Share Calculations - Diluted
Dollars per share
202320222021
Earnings from continuing operations attributable to common stockholders$1.09 $2.02 $2.16 
(Loss) earnings from discontinued operations, net of tax(0.16)9.73 9.72 
Earnings available to common stockholders 1
$0.94 $11.75 $11.89 
Share Count Information
Shares in Millions
202320222021
Weighted-average common shares - basic449.9 498.5 542.7 
Plus dilutive effect of equity compensation plans1.3 0.9 1.5 
Weighted-average common shares - diluted451.2 499.4 544.2 
Stock options, restricted stock units, and performance-based restricted stock units excluded from EPS calculations 2
2.6 4.1 2.8 
1. Earnings per share amounts are computed independently for income from continuing operations, income from discontinued operations and net income attributable to common stockholders. As a result, the per share amounts from continuing operations and discontinued operations may not equal the total per share amounts for net income attributable to common stockholders.
2. These outstanding options to purchase shares of common stock, restricted stock units and performance based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
v3.24.0.1
ACCOUNTS AND NOTES RECEIVABLE - NET (Tables)
 12 Months Ended
Dec. 31, 2023
Receivables [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
In millionsDecember 31, 2023December 31, 2022
Accounts receivable – trade 1
$1,513 $1,567 
Income tax receivable301 235 
Other 2
556 716 
Total accounts and notes receivable - net$2,370 $2,518 
1.Accounts receivable – trade is net of allowances of $40 million at December 31, 2023 and $38 million at December 31, 2022. Allowances are equal to the estimated uncollectible amounts and current expected credit loss. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.
2.Other includes receivables in relation to value added tax, indemnification assets, general sales tax and other taxes, and other receivables. No individual group represents more than ten percent of total receivables.
v3.24.0.1
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory
In millionsDecember 31, 2023December 31, 2022
Finished goods $1,184 $1,299 
Work in process 487 522 
Raw materials 350 388 
Supplies126 120 
Total inventories$2,147 $2,329 
v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Estimated Useful Lives (Years)December 31, 2023December 31, 2022
In millions
Land and land improvements1-25$449 $432 
Buildings1-502,121 1,968 
Machinery, equipment, and other1-257,306 6,714 
Construction in progress849 1,065 
Total property, plant and equipment$10,725 $10,179 
Total accumulated depreciation$4,841 $4,448 
Total property, plant and equipment - net$5,884 $5,731 

In millions202320222021
Depreciation expense$547 $545 $546 
v3.24.0.1
NONCONSOLIDATED AFFILIATES (Tables)
 12 Months Ended
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Dividend Received and Equity Earnings
The Company's dividends received from nonconsolidated affiliates is shown in the following table:
Dividends Received from Nonconsolidated Affiliates202320222021
(In millions) For the years ended December 31,
Dividends from nonconsolidated affiliates$71 $103 $98 
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes changes in the carrying amount of goodwill for the years ended December 31, 2023 and 2022.
Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Balance at December 31, 2021$9,583 $6,801 $597 $16,981 
Currency Translation Adjustment(186)(145)(5)(336)
Other— — 18 18 
Balance at December 31, 2022$9,397 $6,656 $610 $16,663 
Goodwill recognized for Spectrum Acquisition 1
818 — — 818 
Currency Translation Adjustment(10)48 5 43 
Impairment— (804)— (804)
Balance at December 31, 2023$10,205 $5,900 $615 $16,720 
1.On August 1, 2023, DuPont completed the acquisition of Spectrum, which is included in the Electronics & Industrial segment. See Note 3 for additional information.
Schedule of Other Finite Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
December 31, 2023December 31, 2022
In millionsGross
Carrying
Amount		Accum AmortNetGross Carrying AmountAccum AmortNet
Intangible assets with finite lives:
  Developed technology $2,079 $(1,092)$987 $1,955 $(913)$1,042 
  Trademarks/tradenames
924 (414)510 906 (349)557 
  Customer-related5,815 (2,329)3,486 5,454 (2,389)3,065 
  Other 28 (1)27 54 (27)27 
Total other intangible assets with finite lives$8,846 $(3,836)$5,010 $8,369 $(3,678)$4,691 
Intangible assets with indefinite lives:
  Trademarks/tradenames
804 — 804 804 — 804 
Total other intangible assets with indefinite lives$804 $— $804 $804 $— $804 
Total$9,650 $(3,836)$5,814 $9,173 $(3,678)$5,495 
Schedule of Other Indefinite Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
December 31, 2023December 31, 2022
In millionsGross
Carrying
Amount		Accum AmortNetGross Carrying AmountAccum AmortNet
Intangible assets with finite lives:
  Developed technology $2,079 $(1,092)$987 $1,955 $(913)$1,042 
  Trademarks/tradenames
924 (414)510 906 (349)557 
  Customer-related5,815 (2,329)3,486 5,454 (2,389)3,065 
  Other 28 (1)27 54 (27)27 
Total other intangible assets with finite lives$8,846 $(3,836)$5,010 $8,369 $(3,678)$4,691 
Intangible assets with indefinite lives:
  Trademarks/tradenames
804 — 804 804 — 804 
Total other intangible assets with indefinite lives$804 $— $804 $804 $— $804 
Total$9,650 $(3,836)$5,814 $9,173 $(3,678)$5,495 
Schedule of Net Intangibles by Segment
The following table provides the net carrying value of other intangible assets by segment:
Net Intangibles by SegmentDecember 31, 2023December 31, 2022
In millions
Electronics & Industrial 1
$3,521 $2,976 
Water & Protection2,206 2,424 
Corporate & Other87 95 
Total$5,814 $5,495 
1.Includes intangible assets acquired as part of the Spectrum Acquisition. See Note 3 for additional information.
Schedule of Estimated Future Amortization Expense
Total estimated amortization expense for the next five fiscal years is as follows:
Estimated Amortization Expense
In millions
2024$601 
2025$555 
2026$528 
2027$480 
2028$427 
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Short-Term Borrowings and Capital Lease Obligations
The following tables summarizes the Company's short-term borrowings, long-term debt and finance lease obligations:
Short-Term BorrowingsDecember 31, 2023December 31, 2022
(In millions)
Long-term debt due within one year$— $300 
Schedule of Long-Term Debt Instruments
Long-Term DebtDecember 31, 2023
December 31, 2022
In millionsAmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures 1:
  Final maturity 2023$— — %$300 5.72 %
  Final maturity 20251,850 4.49 %1,850 4.49 %
  Final maturity 20282,250 4.73 %2,250 4.73 %
  Final maturity 2029 and thereafter 2
3,741 5.46 %3,729 5.48 %
Other facilities:
Finance lease obligations10 1 
Less: Unamortized debt discount and issuance costs51 56 
Less: Long-term debt due within one year
— 300 
Total $7,800 $7,774 
1.Represents senior unsecured notes (the "2018 Senior Notes"), which are senior unsecured obligations of the Company.
2.Includes fair value hedging adjustment of $59 million and $71 million at December 31, 2023 and 2022, respectively, related to the Company's interest rate swap agreements. See Note 21 for additional information.
Schedule of Maturities of Long-Term Debt
Principal payments of long-term debt for the five succeeding fiscal years are as follows:
Maturities of Long-Term Debt for Next Five Years at December 31, 2023Total
In millions
2024$— 
2025$1,850 
2026$— 
2027$— 
2028$2,250 
Schedule of Line of Credit Facilities
The following table summarizes the Company's credit facilities:
Committed and Available Credit Facilities at December 31, 2023
In millionsEffective DateCommitted CreditCredit AvailableMaturity DateInterest
Five-Year Revolving Credit Facility
April 2022$2,500 $2,486 April 2027Floating Rate
2023 $1B Revolving Credit Facility
May 20231,000 1,000 May 2024Floating Rate
Total Committed and Available Credit Facilities$3,500 $3,486 
v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Indemnified Liabilities Related to the MOU
In connection with the MOU and the Agreements, the Company has recognized the following indemnification liabilities related to eligible PFAS costs:
Indemnified Liabilities Related to the MOU
In millionsDecember 31, 2023December 31, 2022Balance Sheet Classification
Current indemnified liabilities$87 $66 
Accrued and other current liabilities
Long-term indemnified liabilities119 120 Other noncurrent obligations
Total indemnified liabilities accrued under the MOU 1
$206 $186 
1.As of December 31, 2023 and 2022, total indemnified liabilities accrued include $139 million and $161 million, respectively, related to Chemours environmental remediation activities at their site in Fayetteville, North Carolina under the Consent Order between Chemours and the North Carolina Department of Environmental Quality (the "NC DEQ"). This excludes amounts related to the Water District Settlement Agreement.
Schedule of Environmental Loss Contingencies by Site
The accrued environmental obligations includes the following:
Environmental Accrued Obligations
In millionsDecember 31, 2023December 31, 2022
Potential exposure above the amount accrued 1
Environmental remediation liabilities not subject to indemnity$46 $41 $112 
Environmental remediation indemnified liabilities:
    Indemnifications related to Dow and Corteva 2
101 48 199 
    MOU related obligations (discussed above) 3
152 173 35 
    Other environmental indemnifications1 1 2 
Total environmental related liabilities$300 $263 $348 
1.The environmental accrual represents management’s best estimate of the costs for remediation and restoration with respect to environmental matters, although it is reasonably possible that the ultimate cost with respect to these particular matters could range above the amount accrued as of December 31, 2023.
2.Pursuant to the DWDP Separation and Distribution Agreement and Letter Agreement, the Company is required to indemnify Dow and Corteva for certain Non-PFAS clean-up responsibilities and associated remediation costs.
3.The MOU related obligations include the Company's estimate of its liability under the MOU for remediation activities based on the current regulatory environment.
v3.24.0.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of Lease Cost, Terms, and Discount Rates
The components of lease cost for operating leases for the years ended December 31, 2023, 2022 and 2021 were as follows:
In millions202320222021
Operating lease cost$121 $113 $105 
Short-term lease cost4 4 5 
Variable lease cost39 39 38 
Less: Sublease income 1
4 12 11 
Total lease cost$160 $144 $137 
1.Reflects income associated with subleases, not inclusive of all lessor arrangements disclosed below.
Lease Term and Discount Rate for Operating LeasesDecember 31, 2023December 31, 2022
Weighted-average remaining lease term (years)8.58.1
Weighted-average discount rate3.55 %2.76 %
Schedule of Operating Lease Assets and Liabilities Supplemental balance sheet information related to leases was as follows:
In millionsDecember 31, 2023December 31, 2022
Operating Leases
 
Operating lease right-of-use assets 1
$484 $426 
Current operating lease liabilities 2
97 90 
Noncurrent operating lease liabilities 3
390 333 
Total operating lease liabilities
$487 $423 
1.Included in "Deferred charges and other assets" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
Schedule of Maturity of Lease Liabilities
Maturities of lease liabilities were as follows:
Maturity of Lease Liabilities at December 31, 2023Operating Leases
In millions
2024$112 
202585 
202666 
202753 
202842 
2029 and thereafter209 
Total lease payments$567 
Less: Interest80 
Present value of lease liabilities$487 
v3.24.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Reconciliation of Common Stock Activity
The following table provides a reconciliation of DuPont Common Stock activity for the years ended December 31, 2023, 2022 and 2021:
Shares of DuPont Common StockIssuedHeld in Treasury
In thousands
Balance at January 1, 2021734,204 — 
Issued 2,584 — 
Repurchased 1
— 224,995 
Retired 1
(224,995)(224,995)
Balance at December 31, 2021511,793 — 
Issued 2,074 — 
Repurchased
— 55,743 
Retired
(55,743)(55,743)
Balance at December 31, 2022458,124 — 
Issued1,225 — 
Repurchased
— 29,239 
Retired
(29,239)(29,239)
Balance at December 31, 2023430,110 — 
1.Includes 197 million shares of common stock that were exchanged and retired as part of the N&B Transaction.
Schedule of Dividends Declared and Paid Dividends declared and paid to common stockholders during the years ended December 31, 2023, 2022 and 2021 are summarized in the following table:
Dividends Declared and Paid202320222021
In millions
Dividends declared to common stockholders$651 $652 $630 
Dividends paid to common stockholders$651 $652 $630 
Schedule of Accumulated Other Comprehensive Loss
The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the years ended December 31, 2023, 2022 and 2021:
Accumulated Other Comprehensive LossCumulative Translation AdjPension and OPEB
Derivative Instruments 1
Total
In millions
2021
Balance at January 1, 2021$470 $(425)$(1)$44 
Other comprehensive (loss) income before reclassifications(742)422 56 (264)
Amounts reclassified from accumulated other comprehensive income— 3 — 3 
Split-off of N&B reclassification adjustment184 73 1 258 
Net other comprehensive (loss) income$(558)$498 $57 $(3)
Balance at December 31, 2021$(88)$73 $56 $41 
2022
Other comprehensive (loss) income before reclassifications(1,101)44 61 (996)
Amounts reclassified from accumulated other comprehensive income— (3)— (3)
M&M Divestiture reclassification adjustment221 (54)— 167 
Net other comprehensive (loss) income$(880)$(13)$61 $(832)
Balance at December 31, 2022$(968)$60 $117 $(791)
2023
Other comprehensive income (loss) before reclassifications46 (83)(41)(78)
Amounts reclassified from accumulated other comprehensive income — (9)— (9)
Delrin® Divestiture reclassification adjustment
(9)(23)— (32)
Net other comprehensive income (loss)$37 $(115)$(41)$(119)
Balance at December 31, 2023$(931)$(55)$76 $(910)
1. Includes cumulative translation adjustment impact associated with derivative instruments.

The tax effects on the net activity related to each component of other comprehensive income (loss) for the years ended December 31, 2023, 2022 and 2021 were as follows:
Tax Benefit (Expense)202320222021
In millions
Pension and other post-employment benefit plans$26 $16 $(122)
Derivative instruments12 (15)(18)
Tax expense from income taxes related to other comprehensive income (loss) items$38 $1 $(140)
Schedule of Reclassifications Out of Accumulated Other Comprehensive Loss
A summary of the reclassifications out of AOCL for the years ended December 31, 2023, 2022 and 2021 is provided as follows:
Reclassifications Out of Accumulated Other Comprehensive Loss 202320222021Income Classification
In millions
Cumulative translation adjustments$(9)$221 $184 See (1) below
Pension and other post-employment benefit plans(35)(71)111 See (1) below
Tax expense (benefit) 3 14 (35)See (1) below
    Pension and other post-employment benefit plans,
    after tax
(32)(57)76 
Derivative instruments— — 1 See (1) below
Tax expense— — — See (1) below
Derivative instruments, after tax— — 1 
Total reclassifications for the period, after tax$(41)$164 $261 
1. The activity for the year ended December 31, 2023 is classified almost entirely within "(Loss) income from discontinued operations, net of tax" as part of the Delrin® Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2022 is classified almost entirely within "(Loss) income discontinued operations, net of tax" as part of the M&M Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2021 is classified almost entirely within "(Loss) income from discontinued operations, net of tax" as part of the N&B Transaction, with a portion classified within "Sundry income (expense) - net" as part of continuing operations.
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS (Tables)
 12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
Schedule of Weighted-Average Assumptions Used
The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below:
Weighted-Average Assumptions for Pension Plans Benefit Obligations
 at December 31,		Net Periodic Costs
for the Years Ended
 20232022202320222021
Discount rate3.26 %3.71 %3.05 %1.48 %0.87 %
Interest crediting rate for applicable benefits2.00 %2.25 %2.25 %1.25 %1.25 %
Rate of compensation increase3.11 %3.27 %3.25 %3.15 %3.15 %
Expected return on plan assetsN/AN/A3.61 %2.69 %2.73 %
Schedule of Pension Plans and Other Postretirement Benefits
Summarized information on the Company's pension and other postretirement benefit plans is as follows:
Change in Projected Benefit Obligations of All Plans20232022
In millions
Change in projected benefit obligations:
Benefit obligations at beginning of year$2,726 $4,286 
Service cost25 43 
Interest cost99 55 
Plan participants' contributions7 7 
Actuarial changes in assumptions and experience
132 (872)
Benefits paid(208)(233)
Acquisitions/divestitures/other 1, 2
(209)(203)
Effect of foreign exchange rates133 (354)
Termination benefits/curtailment cost/settlements(1)(3)
Benefit obligations at end of year$2,704 $2,726 
1.The year ended 2023 is primarily related to the Delrin® Divestiture.
2.The year ended 2022 is primarily related to the M&M Divestiture.
Change in Plan Assets and Funded Status of All Plans20232022
In millions
Change in plan assets:
Fair value of plan assets at beginning of year$2,596 $4,036 
Actual return on plan assets 109 (735)
Employer contributions66 79 
Plan participants' contributions7 7 
Benefits paid(208)(233)
Acquisitions/divestitures/other 1, 2
(285)(216)
Effect of foreign exchange rates139 (342)
Fair value of plan assets at end of year$2,424 $2,596 
Funded status:
Plans with plan assets$233 $364 
All other plans(513)(494)
Funded status at end of year$(280)$(130)
1.The year ended 2023 is primarily related to the Delrin® Divestiture.
2.The year ended 2022 is primarily related to the M&M Divestiture.

The following tables summarize the amounts recognized in the Consolidated Balance Sheets for all significant plans:
Amounts Recognized in the Consolidated Balance Sheets for All Significant PlansDecember 31, 2023December 31, 2022
In millions
Amounts recognized in the consolidated balance sheets:
Deferred charges and other assets$338 $376 
Assets of discontinued operations— 70 
Accrued and other current liabilities(53)(49)
Pension and other postretirement benefits - noncurrent(565)(522)
Liabilities of discontinued operations— (5)
Net amount recognized$(280)$(130)
Pretax amounts recognized in accumulated other comprehensive loss (income):
Net loss (gain)$95 $(45)
Prior service credit(8)(15)
Pretax balance in accumulated other comprehensive loss at end of year
$87 $(60)
Schedule of Accumulated Benefit Obligations in Excess of Plan Assets
Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2023December 31, 2022
In millions
Accumulated benefit obligations$700 $566 
Fair value of plan assets$138 $46 
Schedule of Pension Plans with Projected Benefit Obligations in Excess of Plan Assets
Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2023December 31, 2022
In millions
Projected benefit obligations$743 $706 
Fair value of plan assets$154 $157 
Schedule of Net Periodic Benefit Costs
Net Periodic Benefit Costs for All Significant Plans for the Years Ended December 31,202320222021
In millions
Net Periodic Benefit Costs:
Service cost$25 $43 $53 
Interest cost99 55 42 
Expected return on plan assets(92)(97)(105)
Amortization of prior service credit(3)(5)(5)
Amortization of unrecognized net (gain) loss(1)1 12 
Curtailment/settlement(3)(4)3 
Net periodic benefit costs (credits) - Total$25 $(7)$— 
Less: Net periodic benefit credits - Discontinued operations(6)(9)(3)
Net periodic benefit costs - Continuing operations 1
$31 $2 $3 
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):
Net loss (gain)$108 $(35)$(528)
Prior service credit— — (8)
Amortization of prior service credit3 5 5 
Amortization of unrecognized gain (loss)1 (1)(12)
Settlement gain (loss)3 4 (3)
Effect of foreign exchange rates1 5 (11)
Total recognized in other comprehensive loss (income)$116 $(22)$(557)
Noncontrolling interest
$— $— $— 
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income)$147 $(20)$(554)
1. Refer to the separate table below for details of Net Periodic Benefit Costs for Plans in Continuing Operations.
Net Periodic Benefit Costs for Plans in Continuing Operations for the Years Ended December 31,202320222021
In millions
Net Periodic Benefit Costs:
Service cost$22 $30 $33 
Interest cost93 49 39 
Expected return on plan assets(78)(73)(78)
Amortization of prior service credit(2)(4)(5)
Amortization of unrecognized net (gain) loss(1)4 11 
Curtailment/settlement(3)(4)3 
Net periodic benefit costs - Continuing operations$31 $2 $3 
Schedule of Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Income) Loss
Net Periodic Benefit Costs for All Significant Plans for the Years Ended December 31,202320222021
In millions
Net Periodic Benefit Costs:
Service cost$25 $43 $53 
Interest cost99 55 42 
Expected return on plan assets(92)(97)(105)
Amortization of prior service credit(3)(5)(5)
Amortization of unrecognized net (gain) loss(1)1 12 
Curtailment/settlement(3)(4)3 
Net periodic benefit costs (credits) - Total$25 $(7)$— 
Less: Net periodic benefit credits - Discontinued operations(6)(9)(3)
Net periodic benefit costs - Continuing operations 1
$31 $2 $3 
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):
Net loss (gain)$108 $(35)$(528)
Prior service credit— — (8)
Amortization of prior service credit3 5 5 
Amortization of unrecognized gain (loss)1 (1)(12)
Settlement gain (loss)3 4 (3)
Effect of foreign exchange rates1 5 (11)
Total recognized in other comprehensive loss (income)$116 $(22)$(557)
Noncontrolling interest
$— $— $— 
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income)$147 $(20)$(554)
1. Refer to the separate table below for details of Net Periodic Benefit Costs for Plans in Continuing Operations.
Net Periodic Benefit Costs for Plans in Continuing Operations for the Years Ended December 31,202320222021
In millions
Net Periodic Benefit Costs:
Service cost$22 $30 $33 
Interest cost93 49 39 
Expected return on plan assets(78)(73)(78)
Amortization of prior service credit(2)(4)(5)
Amortization of unrecognized net (gain) loss(1)4 11 
Curtailment/settlement(3)(4)3 
Net periodic benefit costs - Continuing operations$31 $2 $3 
Schedule of Estimated Future Benefit Payments
The estimated future benefit payments of continuing operations, reflecting expected future service, as appropriate, are presented in the following table:
Estimated Future Benefit Payments at December 31, 2023
In millions
2024$182 
2025178 
2026183 
2027178 
2028181 
Years 2029-2033912 
Total$1,814 
Schedule of Target Allocation for Plan Assets
The weighted-average target allocation for plan assets of DuPont's pension plans is summarized as follows:
Target Allocation for Plan Assets at December 31, 2023DuPont
Asset Category
Equity securities2 %
Fixed income securities9 
Alternative investments25 
Hedge funds28 
Pooled investment vehicles28 
Other investments8 
Total 100 %
The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2023 and 2022:
Basis of Fair Value MeasurementsDecember 31, 2023December 31, 2022
In millionsTotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Cash and cash equivalents$55 $55 $— $— $57 $57 $— $— 
Equity securities:
U.S. equity securities$20 $20 $— $— $43 $43 $— $— 
Non - U.S. equity securities29 29 — — 152 152 — — 
Total equity securities$49 $49 $— $— $195 $195 $— $— 
Fixed income securities:
Debt - government-issued$34 $— $34 $— $105 $— $105 $— 
Debt - corporate-issued5 — 5 — 40 — 40 — 
Total fixed income securities$39 $— $39 $— $145 $— $145 $— 
Alternative investments:
Real estate$79 $— $— $79 $75 $— $— $75 
   Insurance contracts524 — — 524 524 — — 524 
Derivatives - asset position3 — 3 — 8 — 8 — 
Derivatives - liability position— — — — — — — — 
Total alternative investments$606 $— $3 $603 $607 $— $8 $599 
Other Investments:
Pooled Investment Vehicles$681 $681 $— $— $607 $607 $— $— 
Total other investments$681 $681 $— $— $607 $607 $— $— 
Subtotal$1,430 $785 $42 $603 $1,611 $859 $153 $599 
Investments measured at net asset value:
Debt - government-issued$187 $163 
Hedge funds667 690 
Private market securities126 130 
Total investments measured at net asset value
$980 $983 
Items to reconcile to fair value of plan assets:
Pension trust receivables 1
$14    $2    
Pension trust payables 2
—    — 
Total$2,424    $2,596    
1. Primarily receivables for investment securities sold.
2. Primarily payables for investment securities purchased.
Schedule of Fair Value Measurement of Level 3 Plan Assets
The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2023 and 2022:
Fair Value Measurement of Level 3 Pension Plan AssetsReal EstateInsurance ContractsTotal
In millions
Balance at Jan 1, 2022$75 $825 $900 
Actual return on assets:
Relating to assets held at Dec 31, 2022(2)(237)(239)
Purchases, sales and settlements, net2 (33)(31)
Transfers into Level 3— 30 30 
Transfers out of Level 3 1
— (61)(61)
Balance at Dec 31, 2022$75 $524 $599 
Actual return on assets:
Relating to assets held at Dec 31, 20232 26 28 
Purchases, sales and settlements, net2 (16)(14)
Transfers out of Level 3 2
— (10)(10)
Balance at Dec 31, 2023$79 $524 $603 
1. Related to the M&M Divestiture
2. Related to the Delrin® Divestiture
v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted-Average Assumptions The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:
EIP Weighted-Average Assumptions 1
2022
Dividend yield1.8 %
Expected volatility26.4 %
Risk-free interest rate1.9 %
Expected life of stock options granted during period (years)6.0
1. No stock options were granted by the Company out of the EIP plan in 2023.
The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:
OIP Weighted-Average Assumptions 1
2021
Dividend yield1.6 %
Expected volatility28.3 %
Risk-free interest rate0.9 %
Expected life of stock options granted during period (years)6.0
1. No awards were granted by the Company out of the OIP plan in 2023 or 2022.
Schedule of Stock Option Activity
The following table summarizes stock option activity for 2023 under the EIP:
EIP Stock Options2023
Number of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2023681 $74.40 
Granted— $— 
Exercised(39)$73.26 
Forfeited/Expired(15)$73.84 
Outstanding at December 31, 2023627 $74.48 7.25$1,533 
Exercisable at December 31, 2023300 $74.19 6.44$821 
1. No awards were granted by the Company out of the EIP plan in 2023.

Additional Information about EIP Stock Options
In millions, except per share amounts20232022
Weighted-average fair value per share of options granted 1
$— $17.41 
Total compensation expense for stock options plans 2
$10 $8 
  Related tax benefit 2
$2 $2 
1. No stock options were granted by the Company out of the EIP plan in 2023.
2. These amounts represent life to date.
The following table summarizes stock option activity for 2023 under the OIP:
OIP Stock Options2023
Number of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20231,959 $62.40 
Granted— $— 
Exercised(318)$61.61 
Forfeited/Expired(4)$53.50 
Outstanding at December 31, 20231,637 $62.58 6.05$23,501 
Exercisable at December 31, 20231,547 $61.98 5.98$23,129 
Additional Information about OIP Stock Options 1
In millions, except per share amounts202320222021
Weighted-average fair value per share of options granted$— $— $16.83 
Total compensation expense for stock options plans 2
$26 $25 $24 
  Related tax benefit 2
$6 $5 $5 
1. No awards were granted by the Company out of the OIP plan in 2023 or 2022.
2.These amounts represent life to date.
Schedule of Nonvested Awards
Nonvested awards of RSUs and PSUs are shown below:
EIP RSUs and PSUs2023
Number of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20231,258 $76.07 
Granted1,277 $65.34 
Vested(480)$73.97 
Forfeited(64)$71.01 
Nonvested at December 31, 20231,991 $69.85 
Nonvested awards of RSUs and PSUs are shown below.
OIP RSUs and PSUs2023
Number of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 2023687 $67.09 
Granted— $— 
Vested(519)$66.76 
Forfeited(5)$71.43 
Nonvested at December 31, 2023163 $68.01 
The following table summarizes stock option activity for 2023:
EIDP Stock Options2023
Number of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20232,407 $71.60 
Exercised(147)$39.30 
Forfeited/Expired(32)$87.02 
Outstanding at December 31, 20232,228 $73.49 3.5$5,631 
Exercisable at December 31, 20232,228 $73.49 3.5$5,631 
v3.24.0.1
FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Investments, All Other Investments [Abstract]  
Schedule of the Fair Value of Financial Instruments
The following table summarizes the fair value of financial instruments at December 31, 2023 and December 31, 2022:
Fair Value of Financial InstrumentsDecember 31, 2023December 31, 2022
In millionsCostGainLossFair ValueCostGainLossFair Value
Cash equivalents$408 $— $— $408 $2,198 $— $— $2,198 
Restricted cash equivalents 1
$411 $— $— $411 $110 $— $— $110 
Marketable securities$— $— $— $— $1,302 $— $— $1,302 
Total cash and restricted cash equivalents and marketable securities$819 $— $— $819 $3,610 $— $— $3,610 
Long-term debt including debt due within one year 2
$(7,859)$70 $(206)$(7,995)$(8,145)$227 $(58)$(7,976)
Derivatives relating to:
Net investment hedge 3
— 96 — 96 — 149 — 149 
Foreign currency 4, 5
— 26 (23)3 — 10 (35)(25)
Interest rate swap agreements 6
— — (59)(59)— — (71)(71)
Total derivatives$— $122 $(82)$40 $— $159 $(106)$53 
1.At December 31, 2023 there was $411 million of restricted cash classified as "Restricted cash and cash equivalents" in the Consolidated Balance Sheets. At December 31, 2022 there was $7 million of restricted cash classified as "Restricted cash and cash equivalents" and $103 million classified as "Restricted cash and cash equivalents - noncurrent" in the Consolidated Balance Sheets. See Note 7 for more information on restricted cash.
2.Included in the balance is a fair value hedging revaluation related to the Company's interest rate swap agreements. At December 31, 2023 and 2022 this balance was $59 million and $71 million, respectively.
3.Classified as "Deferred charges and other assets" in the Consolidated Balance Sheets.
4.Classified as "Prepaid and other current assets" and "Accrued and other current liabilities" in the Consolidated Balance Sheets.
5.Presented net of cash collateral where master netting arrangements allow.
6.Classified as "Other noncurrent obligations" in the Consolidated Balance Sheets.
Schedule of Notional Amounts
The notional amounts of the Company's derivative instruments were as follows:
Notional AmountsDecember 31, 2023December 31, 2022
In millions
Derivatives designated as hedging instruments:
   Net investment hedge$1,000 $1,000 
   Interest rate swap agreements$1,000 $1,000 
Derivatives not designated as hedging instruments:
Foreign currency contracts 1
$(907)$476 
1.Presented net of contracts bought and sold.
v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of the Fair Value of Assets and Liabilities Measured on a Recurring Basis
The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
Basis of Fair Value Measurements on a Recurring Basis at December 31, 2023
Significant Other Observable Inputs
(Level 2)
In millions
Assets at fair value:
Cash equivalents and restricted cash equivalents 1
$364 
Derivatives relating to: 2
Net investment hedge96 
Foreign currency contracts 3
37 
Total assets at fair value$497 
Liabilities at fair value:
Long-term debt including debt due within one year 4
$7,995 
Derivatives relating to: 2
Interest rate swap agreements59 
Foreign currency contracts 3
34 
Total liabilities at fair value$8,088 
1.Time deposits included in "Cash and cash equivalents" in the Consolidated Balance Sheets are held at amortized cost, which approximates fair value. "Cash and cash equivalents" and "Restricted cash and cash equivalents" at December 31, 2023 in the Consolidated Balance Sheets includes $50 million of money market funds and $405 million deposited within a qualified settlement fund consisting of treasury bills, respectively, representing Level 1 fair value measurement investments, also held at amortized cost.
2.See Note 21 for the classification of derivatives in the Consolidated Balance Sheets.
3.Assets and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The offsetting counterparty and cash collateral amounts were $11 million and zero, respectively, for both assets and liabilities as of December 31, 2023.
4.Fair value is based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities and terms.

Basis of Fair Value Measurements on a Recurring Basis at December 31, 2022
Significant Other Observable Inputs
(Level 2)
In millions
Assets at fair value:
Cash equivalents and restricted cash equivalents 1
$2,308 
Marketable securities 2
1,302 
Derivatives relating to: 3
Net investment hedge149 
Foreign currency contracts 4
26 
Total assets at fair value$3,785 
Liabilities at fair value:
Long-term debt including debt due within one year 4
7,976 
Derivatives relating to: 2
Interest rate swap agreements71 
Foreign currency contracts 3
51 
Total liabilities at fair value$8,098 
1.Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" and money market funds included in "Prepaid and other current assets" in the Consolidated Balance Sheets and held at amortized cost, which approximates fair value.
2.Time deposits classified as held to maturity, with maturities of greater than three months and less than twelve months at time of acquisition, which are recorded at amortized cost which approximates fair value.
3. See Note 21 for the classification of derivatives in the Consolidated Balance Sheets.
4. Assets and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The offsetting counterparty and cash collateral amounts were $17 million for both assets and liabilities as of December 31, 2022.
5. Fair value is based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities and terms.
Schedule of the Fair Value of Assets and Liabilities Measured on a Nonrecurring Basis
The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:
Basis of Fair Value Measurements on a Nonrecurring Basis 1
Significant Other Unobservable Inputs (Level 3)Total Losses
In millions
At December 31, 2023
Assets at fair value:
   Goodwill$4,814 $(804)
At December 31, 2022
Assets at fair value:
    Long-lived assets, intangible assets, and other assets$55 $(94)
1.The Company did not incur any losses associated with fair value measurements on a nonrecurring basis for the year-ended December 31, 2021.
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Net Trade Revenue and Long-lived Assets by Geographic Region
Net Trade Revenue by Geographic Region202320222021
(In millions) For the years ended December 31,
United States$3,914 $4,066 $3,661 
Canada271 293 263 
EMEA 1
2,203 2,193 2,229 
Asia Pacific 2
5,191 6,022 6,026 
Latin America489 443 387 
Total$12,068 $13,017 $12,566 
1.Europe, Middle East and Africa.
2. Net sales attributed to China/Hong Kong, for the years ended December 31, 2023, 2022 and 2021 were $2,206 million, $2,744 million, and $2,822 million, respectively.

Long-lived Assets by Geographic RegionDecember 31,
In millions202320222021
United States$3,559 $3,501 $3,433 
Canada54 49 51 
EMEA 1
1,336 1,271 1,301 
Asia Pacific896 883 925 
Latin America39 27 43 
Total$5,884 $5,731 $5,753 
1.Europe, Middle East and Africa.
Schedule of Segment Information
Segment InformationElectronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
For the Year Ended December 31, 2023
Net sales$5,337 $5,633 $1,098 $12,068 
Operating EBITDA 1
1,472 1,388 82 2,942 
Equity in earnings of nonconsolidated affiliates16 35 — 51 
Restructuring and asset related charges - net 2
49 55 42 146 
Goodwill impairment charges— 804— 804
Depreciation and amortization607 507 33 1,147 
Assets of continuing operations18,622 13,750 6,180 38,552 
Investment in nonconsolidated affiliates386 280 122 788 
Capital expenditures306 240 44 590 
For the Year Ended December 31, 2022
Net sales$5,917 $5,957 $1,143 $13,017 
Operating EBITDA 1
1,836 1,431 (6)3,261 
Equity in earnings of nonconsolidated affiliates31 39 5 75 
Restructuring and asset related charges - net 2
118 17 20 155 
Depreciation and amortization 580 494 61 1,135 
Assets of continuing operations17,110 14,831 8,123 40,064 
Investment in nonconsolidated affiliates396 290 — 686 
Capital expenditures290 289 80 659 
For the Year Ended December 31, 2021
Net sales$5,554 $5,552 $1,460 $12,566 
Operating EBITDA 1
1,758 1,385 9 3,152 
Equity in earnings of nonconsolidated affiliates
41 36 8 85 
Restructuring asset related charges - net 2
8 30 12 50 
Depreciation and amortization 518 511 83 1,112 
Assets of continuing operations17,701 15,003 5,094 37,798 
Investment in nonconsolidated affiliates502 310 6 818 
Capital expenditures337 391 88 816 
1.A reconciliation of "Income from continuing operations before income taxes" to Operating EBITDA is provided in the table on the following page.
2.See Note 6 for information regarding the Company's restructuring programs and asset related charges.
Segment Capital Expenditure Reconciliation to Consolidated Financial Statements202320222021
In millions
Segment Totals$590 $659 $816 
Other 1
29 3 (28)
Total$619 $662 $788 
1.Reflects the incremental cash spent or unpaid on capital expenditures; total capital expenditures are presented on a cash basis.
Schedule of Total Asset Reconciliation
Total Asset Reconciliation at December 31,202320222021
In millions
Assets of continuing operations$38,552 $40,064 $37,798 
Assets held for sale — — 245 
Assets of discontinued operations— 1,291 7,664 
Total assets$38,552 $41,355 $45,707 
Schedule of Reconciliation of Income (Loss) from Continuing Operations
Reconciliation of "Income from continuing operations, net of tax" to Operating EBITDA202320222021
(In millions) For the years ended December 31,
Income from continuing operations, net of tax $533 $1,061 $1,207 
+(Benefit from) provision for income taxes on continuing operations(29)387 237 
Income from continuing operations before income taxes$504 $1,448 $1,444 
+Depreciation and amortization1,147 1,135 1,112 
-
Interest income 1
155 50 12 
+
Interest expense 2
396 486 503 
-
Non-operating pension/OPEB (credit) benefit 1
(9)28 30 
-
Foreign exchange (losses) gains, net 1
(73)15 (53)
+Future reimbursable indirect costs7 52 60 
-
Significant items
(961)(233)(22)
Operating EBITDA $2,942 $3,261 $3,152 
1.Included in "Sundry income (expense) - net."
2.The year ended December 31, 2022 excludes significant items, refer to details below.
Schedule of Significant Items by Segment
The following tables summarize the pre-tax impact of significant items by segment that are excluded from Operating EBITDA above:
Significant Items by Segment for the Year Ended December 31, 2023Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$(20)$— $— $(20)
Restructuring and asset related charges - net 2
(49)(55)(42)(146)
Goodwill impairment charge 3
— (804)— (804)
Gain on divestiture 4
7 1 1 9 
Total$(62)$(858)$(41)$(961)
1. Acquisition, integration and separation costs related to the Spectrum Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Reflects a non-cash goodwill impairment charge in the Protection Reporting unit (aggregation of Safety and Shelter businesses). See Note 14 for additional information.
4. Reflected in "Sundry income (expense) - net."

Significant Items by Segment for the Year Ended December 31, 2022Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$— $— $(193)$(193)
Restructuring and asset related charges - net 2
(24)(17)(20)(61)
Asset impairment charges 3
(94)— — (94)
Gain on divestiture 4
— 37 32 69 
Terminated Intended Rogers Acquisition financing fees 5
— — (6)(6)
Employee Retention Credit 6
20 20 12 52 
Total$(98)$40 $(175)$(233)
1. Acquisition, integration and separation costs related to strategic initiatives including the sale of the Biomaterials business unit, the acquisition of Laird PM, and the termination fee of $162.5 million associated with the Terminated Intended Rogers Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Relates to an impairment of an equity method investment. See Note 6 for additional information.
4. Reflected in "Sundry income (expense) - net." See Note 4 for additional information.
5. Includes acquisition costs associated with the Terminated Intended Rogers Acquisition related to the financing agreements, specifically the structuring fees and the amortization of the commitment fees reflected in "Interest Expense."
6. Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) reflected in "Cost of sales," "Research and development expenses" and "Selling, general and administrative expenses."
Significant Items by Segment for the Year Ended December 31, 2021Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$— $— $(81)$(81)
Restructuring and asset related charges - net 2
(8)(30)(12)(50)
Merger-related inventory step-up amortization 3
(12)— — (12)
Gain on divestiture 4
2 — 141 143 
Terminated Intended Rogers Acquisition financing fees 5
— — (22)(22)
Total$(18)$(30)$26 $(22)
1.Acquisition, integration and separation costs related to strategic initiatives including the acquisition of Laird PM, the M&M Divestitures, the Terminated Intended Rogers Acquisition, and the completed and planned divestitures of the held for sale businesses included within Corporate & Other.
2. Includes Board approved restructuring plans and asset related charges. See Note 6 for additional information.
3. Includes the amortization of the fair value step-up in Laird PM's inventories as a result of the acquisition.
4. Reflected in "Sundry income (expense) - net." See Note 4 for additional information.
5. Includes acquisition costs associated with the Terminated Intended Rogers Acquisition related to the financing agreements, specifically the structuring fees and the amortization of the commitment fees reflected in "Interest Expense."
v3.24.0.1
Schedule II—Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accounts Receivable—Allowance for Doubtful Receivables      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period $ 38 $ 28 $ 32
Additions charged to expenses 12 11 6
Deductions from reserves (10) (1) (10)
Balance at end of period 40 38 28
Inventory—Obsolescence Reserve      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 4 6 3
Additions charged to expenses 14 18 34
Deductions from reserves (10) (20) (31)
Balance at end of period 8 4 6
Deferred Tax Assets—Valuation Allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 703 700 617
Additions charged to expenses 47 125 152
Deductions from reserves (12) (122) (69)
Balance at end of period $ 738 $ 703 700
Deferred Tax Assets—Valuation Allowance | Laird Performance Materials      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Additions charged to expenses     $ 50
v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Billions
Nov. 01, 2022
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]      
Operating lease, right-of-use asset, statement of financial position [extensible enumeration]   Other Assets, Noncurrent Other Assets, Noncurrent
Operating lease, liability, current, statement of financial position [extensible enumeration]   Accrued and other current liabilities Accrued and other current liabilities
Operating lease, liability, noncurrent, statement of financial position [extensible enumeration]   Other Liabilities, Noncurrent Other Liabilities, Noncurrent
Finance lease, right-of-use asset, statement of financial position [extensible enumeration]   Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance lease, liability, noncurrent, statement of financial position [extensible enumeration]   Long-Term Debt Long-Term Debt
Minimum      
Finite-Lived Intangible Assets [Line Items]      
Definite-lived intangible assets, useful life ( in years)   1 year  
Maximum      
Finite-Lived Intangible Assets [Line Items]      
Definite-lived intangible assets, useful life ( in years)   20 years  
Mobility And Materials Businesses | Discontinued Operations, Disposed of by Sale      
Finite-Lived Intangible Assets [Line Items]      
Proceeds from divesture $ 11.0    
v3.24.0.1
ACQUISITIONS - Narrative (Details) - USD ($)
 12 Months Ended
Aug. 01, 2023
Nov. 02, 2022
Nov. 01, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]            
Goodwill       $ 16,720,000,000 $ 16,663,000,000 $ 16,981,000,000
Net sales       12,068,000,000 13,017,000,000 $ 12,566,000,000
Business acquisition, payment of termination fee         $ 162,500,000  
Spectrum Plastics Group            
Business Acquisition [Line Items]            
Consideration transferred $ 1,792,000,000          
Net upward adjustments 43,100,000          
Goodwill 731,000,000     818,000,000    
Goodwill expected to be tax deductible 0          
Spectrum Plastics Group | Industrial Solutions | Electronics & Industrial            
Business Acquisition [Line Items]            
Net sales       $ 185,000,000    
Spectrum Plastics Group | Customer-related            
Business Acquisition [Line Items]            
Acquired intangible assets $ 772,000,000          
Acquired intangible assets, useful life 20 years          
Spectrum Plastics Group | Developed technology            
Business Acquisition [Line Items]            
Acquired intangible assets $ 126,000,000          
Acquired intangible assets, useful life 15 years          
Spectrum Plastics Group | Trademarks/tradenames            
Business Acquisition [Line Items]            
Acquired intangible assets $ 18,000,000          
Acquired intangible assets, useful life 5 years          
Rogers Corporation            
Business Acquisition [Line Items]            
Expected price of acquisition     $ 5,200,000,000      
Business acquisition, payment of termination fee   $ 162,500,000        
v3.24.0.1
ACQUISITIONS - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
 5 Months Ended
Dec. 31, 2023
Aug. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Fair value of liabilities assumed        
Goodwill $ 16,720   $ 16,663 $ 16,981
Spectrum Plastics Group        
Fair value of assets acquired        
Cash and cash equivalents 31 $ 31    
Accounts and notes receivable 68 68    
Inventories 52 52    
Property, plant and equipment 125 125    
Other intangible assets 916 1,032    
Other intangible assets, adjustment (116)      
Deferred charges and other assets 34 34    
Total Assets Acquired 1,226 1,342    
Total Assets Acquired, adjustment (116)      
Fair value of liabilities assumed        
Accounts payable 21 21    
Income taxes payable 17 17    
Deferred income tax liabilities 177 206    
Deferred income tax liabilities, adjustment (29)      
Other noncurrent liabilities 37 37    
Total Liabilities Assumed 252 281    
Total Liabilities Assumed, adjustment (29)      
Goodwill 818 731    
Goodwill, adjustments 87      
Total Consideration $ 1,792 $ 1,792    
v3.24.0.1
ACQUISITIONS - Acquisition, Integration and Separation Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]      
Acquisition, integration and separation costs $ 20 $ 193 $ 81
v3.24.0.1
DIVESTITURES - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Nov. 01, 2023
Nov. 01, 2022
Dec. 31, 2021
Jun. 30, 2021
Feb. 01, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
May 31, 2022
Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Proceeds from sales of property, businesses, and ownership interests in nonconsolidated affiliates, net of cash divested           $ 1,244 $ 10,951 $ 797    
Equity investment, carrying value     $ 818     $ 788 $ 686 818    
Par value (in USD per share)           $ 0.01 $ 0.01      
(Loss) income from discontinued operations, net of tax           $ (71) $ 4,856 5,308    
Pre tax gain (loss) on disposition           9 69 143    
DuPont                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Par value (in USD per share)         $ 0.01          
Derby                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Notes receivable $ 350                  
Ownership percentage 19.90%                  
Equity investment, fair value $ 121                  
Note receivable, fair value 224                  
Equity investment, carrying value           121        
Notes receivables carrying value           228        
Non-cash interest income on notes receivable           4        
N&B | N&B                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Par value (in USD per share)         $ 0.01          
Discontinued Operations, Disposed of by Sale                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Restricted cash and cash equivalents - noncurrent                   $ 6,200
Discontinued Operations, Disposed of by Sale | N&B Notes Offering | Unsecured Debt                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Face amount of debt         $ 6,250          
Discontinued Operations, Disposed of by Sale | Mobility And Materials Businesses                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Proceeds from divesture   $ 11,000                
Cash divested adjustments   500                
Proceeds from sales of property, businesses, and ownership interests in nonconsolidated affiliates, net of cash divested   $ 10,500                
Non-taxable gain on split-off           480 5,024 0    
(Loss) income from discontinued operations, net of tax           (57) (69) 597    
Discontinued Operations, Disposed of by Sale | Delrin Business                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Proceeds from divesture 1,280                  
Cash divested adjustments 27                  
Proceeds from sales of property, businesses, and ownership interests in nonconsolidated affiliates, net of cash divested $ 1,250                  
Non-taxable gain on split-off           $ 419        
Discontinued Operations, Disposed of by Sale | Derby                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Percentage of ownership holds in subsidiaries 80.10%                  
Discontinued Operations, Disposed of by Sale | N&B                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Proceeds from divesture         $ 7,300          
Non-taxable gain on split-off               4,920    
Shares accepted and retired in exchange offer (in shares)         197,400,000          
Shares exchanged in exchange offer (in shares)         141,700,000          
(Loss) income from discontinued operations, net of tax               (110)    
Discontinued Operations, Disposed of by Sale | N&B | N&B Term Loan Facility                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Face amount of debt         $ 1,250          
Discontinued Operations, Disposed of by Sale | N&B | International Flavors & Fragrances Inc.                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Par value (in USD per share)         $ 0.125          
Discontinued Operations | N&B | International Flavors & Fragrances Inc.                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Convertible common stock, merger trigger, shares right to receive upon conversion (in shares)         1          
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Biomaterials Business Unit                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Consideration received for divestiture                 $ 240  
Pre tax gain (loss) on disposition             26      
Gain (loss) on disposition, net of tax             $ 21      
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Clean Technologies                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Proceeds from divesture     500              
Consideration received for divestiture     $ 510         510    
Pre tax gain (loss) on disposition               (3)    
Gain (loss) on disposition, net of tax               (39)    
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Solamet Business Unit                    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                    
Proceeds from divesture       $ 190            
Pre tax gain (loss) on disposition               140    
Gain (loss) on disposition, net of tax               $ 105    
v3.24.0.1
DIVESTITURES - Discontinued Operations (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
(Loss) income from discontinued operations, net of tax $ (71) $ 4,856 $ 5,308
Income from discontinued operations attributable to noncontrolling interests, net of tax $ 0 (4) 18
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] (Loss) income from discontinued operations, net of tax    
Mobility And Materials Businesses      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Benefit from income taxes on discontinued operations $ 21 127  
Mobility And Materials Businesses | Discontinued Operations, Disposed of by Sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net sales 460 3,532 4,087
Cost of sales 295 2,712 2,832
Research and development expenses 3 46 61
Selling, general and administrative expenses 2 127 253
Amortization of intangibles 0 28 159
Restructuring and asset related charges - net 0 0 5
Acquisition, integration and separation costs 195 555 52
Equity in earnings of nonconsolidated affiliates 0 (9) 9
Sundry income (expense) - net 9 4 18
(Loss) income from discontinued operations before income taxes (26) 59 752
Benefit from income taxes on discontinued operations 31 128 155
(Loss) income from discontinued operations, net of tax (57) (69) 597
Income from discontinued operations attributable to noncontrolling interests, net of tax 0 (4) 18
Non-taxable gain on split-off 480 5,024 0
Income from discontinued operations attributable to DuPont stockholders, net of tax $ 423 $ 4,959 579
N&B | Discontinued Operations, Disposed of by Sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net sales     507
Cost of sales     354
Research and development expenses     21
Selling, general and administrative expenses     47
Amortization of intangibles     38
Restructuring and asset related charges - net     1
Acquisition, integration and separation costs     172
Sundry income (expense) - net     8
Interest expense     13
(Loss) income from discontinued operations before income taxes     (131)
Benefit from income taxes on discontinued operations     (21)
(Loss) income from discontinued operations, net of tax     (110)
Income from discontinued operations attributable to noncontrolling interests, net of tax     0
Non-taxable gain on split-off     $ 4,920
v3.24.0.1
DIVESTITURES - Carrying Amount of Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Assets      
Assets held for sale $ 0 $ 1,291 $ 7,664
Discontinued Operations, Disposed of by Sale | Mobility And Materials Businesses      
Assets      
Accounts and notes receivable - net   75  
Inventories   104  
Other current assets   6  
Property, plant and equipment - net   256  
Goodwill   405  
Other intangible assets   338  
Deferred income tax assets   36  
Deferred charges and other assets   71  
Assets held for sale   1,291  
Liabilities      
Accounts payable   78  
Accrued and other current liabilities   8  
Deferred income tax liabilities   53  
Pension and other post employment benefits - noncurrent   5  
Other noncurrent liabilities   2  
Liabilities related to assets held for sale   $ 146  
v3.24.0.1
DIVESTITURES - Other Discontinued Operations Activity (Details) - Discontinued Operations, Disposed of by Sale - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Other $ (68) $ (25) $ (23)
Income from discontinued operations attributable to DuPont stockholders, net of tax (71) 4,856 5,308
M&M Divestitures      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income from discontinued operations attributable to DuPont stockholders, net of tax   4,955 597
N&B      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income from discontinued operations attributable to DuPont stockholders, net of tax 0 0 4,810
MOU Activity      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income from discontinued operations attributable to DuPont stockholders, net of tax $ (426) $ (74) $ (76)
v3.24.0.1
REVENUE (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Net sales $ 12,068 $ 13,017 $ 12,566
Accounts receivable - trade 1,543 1,593  
Deferred revenue - current 1 11  
Deferred revenue - noncurrent 22 8  
Corporate & Other      
Disaggregation of Revenue [Line Items]      
Net sales 1,098 1,143 1,460
Retained Businesses | Corporate & Other      
Disaggregation of Revenue [Line Items]      
Net sales 1,098 1,067 958
Other | Corporate & Other      
Disaggregation of Revenue [Line Items]      
Net sales 0 76 502
Electronics & Industrial      
Disaggregation of Revenue [Line Items]      
Net sales 5,337 5,917 5,554
Electronics & Industrial | Industrial Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 2,061 1,954 1,890
Electronics & Industrial | Interconnect Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 1,422 1,742 1,617
Electronics & Industrial | Semiconductor Technologies      
Disaggregation of Revenue [Line Items]      
Net sales 1,854 2,221 2,047
Water & Protection      
Disaggregation of Revenue [Line Items]      
Net sales 5,633 5,957 5,552
Water & Protection | Safety Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 2,519 2,649 2,567
Water & Protection | Shelter Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 1,655 1,815 1,615
Water & Protection | Water Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 1,459 $ 1,493 $ 1,370
Electronics & Industrial | Industrial Solutions | Spectrum Plastics Group      
Disaggregation of Revenue [Line Items]      
Net sales $ 185    
v3.24.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges - net $ 146 $ 155 $ 50
Liabilities related to restructuring programs 107 67  
Equity method investment, other than temporary impairment   94  
Equity method investment impairment charges, net of tax   65  
2023-2024 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 110    
2023-2024 Restructuring Program | Severance and Related Benefit Cost      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 80    
2023-2024 Restructuring Program | Asset Related Charges      
Restructuring Cost and Reserve [Line Items]      
Liabilities related to restructuring programs 79    
Pre-tax restructuring charges from inception-to-date 30    
2022 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 96    
2022 Restructuring Program | Severance and Related Benefit Cost      
Restructuring Cost and Reserve [Line Items]      
Liabilities related to restructuring programs 27 57  
Pre-tax restructuring charges from inception-to-date 82    
2022 Restructuring Program | Asset Related Charges      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 14    
2021 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 47    
2021 Restructuring Program | Severance and Related Benefit Cost      
Restructuring Cost and Reserve [Line Items]      
Liabilities related to restructuring programs 1 $ 7  
Pre-tax restructuring charges from inception-to-date 27    
2021 Restructuring Program | Asset Related Charges      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date $ 20    
v3.24.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET - Restructuring Program (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 146 $ 61 $ 50
2023-2024 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 110    
2022 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 35 61  
2021 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 1 0 46
Segment Totals | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 49 24 8
Segment Totals | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 55 17 30
Segment Totals | 2023-2024 Restructuring Program | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 21    
Segment Totals | 2023-2024 Restructuring Program | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 57    
Segment Totals | 2022 Restructuring Program | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 29 23  
Segment Totals | 2022 Restructuring Program | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges (2) 16  
Segment Totals | 2021 Restructuring Program | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges (1) 2 5
Segment Totals | 2021 Restructuring Program | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 0 1 32
Corporate & Other      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 42 20 12
Corporate & Other | 2023-2024 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 32    
Corporate & Other | 2022 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 8 22  
Corporate & Other | 2021 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 2 $ (3) $ 9
v3.24.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET - Schedule of Restructuring Reserve (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring Reserve [Roll Forward]      
Restructuring charges $ 146 $ 61 $ 50
2023-2024 Restructuring Program      
Restructuring Reserve [Roll Forward]      
Reserve balance at December 31, 2022 0    
Restructuring charges 110    
Charges against the reserve (31)    
Reserve balance at December 31, 2023 79 0  
Severance and Related Benefit Cost | 2023-2024 Restructuring Program      
Restructuring Reserve [Roll Forward]      
Reserve balance at December 31, 2022 0    
Restructuring charges 80    
Charges against the reserve (1)    
Reserve balance at December 31, 2023 79 0  
Asset Related Charges | 2023-2024 Restructuring Program      
Restructuring Reserve [Roll Forward]      
Reserve balance at December 31, 2022 0    
Restructuring charges 30    
Charges against the reserve (30)    
Reserve balance at December 31, 2023 $ 0 $ 0  
v3.24.0.1
SUPPLEMENTARY INFORMATION - Summary of Sundry Income (Expense) - Net (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Nov. 01, 2023
Schedule Of Sundry Income (Expense) [Line Items]        
Non-operating pension and other post-employment benefit ("OPEB") (credit) costs $ (9) $ 28 $ 30  
Interest income 155 50 12  
Net gain on divestiture and sales of other assets and investments 19 78 171  
Foreign exchange (losses) gains, net (73) 15 (53)  
Miscellaneous income (expenses) - net 10 20 (15)  
Sundry income (expense) - net 102 191 145  
Government grants   13    
Pre-tax impairment charge   94    
Corporate & Other        
Schedule Of Sundry Income (Expense) [Line Items]        
Net gain on divestiture and sales of other assets and investments     140  
Pre-tax impairment charge   0    
Water & Protection        
Schedule Of Sundry Income (Expense) [Line Items]        
Net gain on divestiture and sales of other assets and investments   37    
Electronics & Industrial        
Schedule Of Sundry Income (Expense) [Line Items]        
Net gain on divestiture and sales of other assets and investments     28  
Disposal Group, Held-for-sale, Not Discontinued Operations        
Schedule Of Sundry Income (Expense) [Line Items]        
Pre-tax impairment charge     $ 15  
Disposal Group, Held-for-sale, Not Discontinued Operations | Biomaterials Business Unit        
Schedule Of Sundry Income (Expense) [Line Items]        
Net gain on divestiture and sales of other assets and investments   $ 26    
Derby        
Schedule Of Sundry Income (Expense) [Line Items]        
Non-cash interest income on notes receivable $ 4      
Related party notes receivable       $ 350
v3.24.0.1
SUPPLEMENTARY INFORMATION - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Supplementary Information    
Accrued and other current liabilities $ 1,269.0 $ 951.0
Accrued payroll 250.0 291.0
Water District Settlement Fund    
Supplementary Information    
Accrued settlement amount 405.0  
Payments Due Annually Beginning September 2023 | DuPont and Corteva    
Supplementary Information    
Restricted cash, noncurrent $ 411.0 $ 103.0
v3.24.0.1
INCOME TAXES - Geographic Allocation of Income (Loss) and Provision for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
(Loss) income from continuing operations before income taxes      
Domestic $ (695) $ (308) $ (293)
Foreign 1,199 1,756 1,737
Income from continuing operations before income taxes 504 1,448 1,444
Current tax expense      
Federal 80 211 73
State and local 9 7 17
Foreign 246 373 406
Total current tax expense 335 591 496
Deferred tax (benefit) expense      
Federal (24) (191) (105)
State and local (27) (16) (79)
Foreign (313) 3 (75)
Total deferred tax benefit (364) (204) (259)
(Benefit from) provision for income taxes on continuing operations (29) 387 237
Income from continuing operations, net of tax $ 533 $ 1,061 $ 1,207
v3.24.0.1
INCOME TAXES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Contingency [Line Items]      
Deferred tax liability, net $ 818 $ 1,049  
Undistributed earnings of foreign subsidiaries 6,495    
Deferred tax benefit in connection with certain internal restructuring 324   $ (22)
Mobility And Materials Businesses      
Income Tax Contingency [Line Items]      
Benefit from income taxes on discontinued operations $ 21 127  
DuPont Specialty Products USA, LLC      
Income Tax Contingency [Line Items]      
Ownership percentage 100.00%    
DuPont Specialty Products, Partnership      
Income Tax Contingency [Line Items]      
Deferred tax liability, net $ 410 $ 370  
v3.24.0.1
INCOME TAXES - Reconciliation to US Statutory Rate (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]      
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
Equity earning effect (1.20%) 0.20% (0.50%)
Foreign income taxed at rates other than the statutory U.S. federal income tax rate 4.90% (3.90%) (7.80%)
U.S. tax effect of foreign earnings and dividends 13.00% 5.00% 4.40%
Unrecognized tax benefits (0.10%) 1.00% 0.60%
Acquisitions, divestitures and ownership restructuring activities (64.40%) 2.50% 6.30%
Exchange gains/losses (1.10%) 0.40% (2.20%)
State and local income taxes (2.80%) 0.20% (3.30%)
Change in valuation allowance 0.00% 0.00% (0.40%)
Goodwill impairments 33.50% 0.00% 0.00%
Stock-based compensation (1.00%) (0.20%) 0.10%
Foreign-derived intangible income (FDII) (6.00%) (2.00%) (2.10%)
Other - net (1.60%) 2.50% 0.30%
Effective tax rate (5.80%) 26.70% 16.40%
Tax benefit (expense) related to internal entity restructuring $ 324   $ (22)
v3.24.0.1
INCOME TAXES - Deferred Tax Balances (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:    
Tax loss and credit carryforwards $ 870 $ 768
Lease liability 116 101
Pension and postretirement benefit obligations 46 55
Unrealized exchange (losses) gains, net (17) 16
Other accruals and reserves 131 139
Research and development 218 197
Inventory 16 18
Other – net 202 146
Gross deferred tax assets 1,582 1,440
Valuation allowances (738) (703)
Total deferred tax assets 844 737
Deferred tax liabilities:    
Investments (204) (290)
Operating lease asset (116) (101)
Property (343) (272)
Intangibles (999) (1,123)
Total deferred tax liabilities (1,662) (1,786)
Total net deferred tax liability $ (818) $ (1,049)
v3.24.0.1
INCOME TAXES - Operating Loss and Tax Credit Carryforwards (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards $ 664 $ 638
Tax credit carryforwards 206 130
Total Operating Loss and Tax Credit Carryforwards 870 768
Expire within 5 years    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards 40 34
Tax credit carryforwards 37 26
Expire after 5 years or indefinite expiration    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards 624 604
Tax credit carryforwards $ 169 $ 104
v3.24.0.1
INCOME TAXES - Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Total unrecognized tax benefits at January 1, $ 470 $ 351 $ 432
Decreases related to positions taken on items from prior years (4) (4) (18)
Increases related to positions taken on items from prior years 3 4 5
Increases related to positions taken in the current year 18 164 11
Settlement of uncertain tax positions with tax authorities (10) (10) (1)
Decreases due to expiration of statutes of limitations (9) 0 0
Exchange loss 5    
Exchange gain   (9) (14)
Total unrecognized tax benefits at December 31, 473 470 351
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate of continuing operations 329 338 303
Total amount of interest and penalties (benefit) recognized in "Provision for (benefit from) income taxes on continuing operations" 8 3 (3)
Total accrual for interest and penalties associated with unrecognized tax benefits 28 16 13
Unrecognized tax benefits related to discontinued operations 141 128 46
N&B      
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Divestiture 0 0 (64)
Mobility And Materials Businesses      
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Divestiture $ 0 $ (26) $ 0
v3.24.0.1
EARNINGS PER SHARE CALCULATIONS - Summary of Net Income for EPS Calculations, Basic and Diluted (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]      
Income from continuing operations, net of tax $ 533 $ 1,061 $ 1,207
Net income from continuing operations attributable to noncontrolling interests 39 53 30
Income from continuing operations attributable to common stockholders 494 1,008 1,177
(Loss) income from discontinued operations, net of tax (71) 4,856 5,308
Net (loss) income from discontinued operations attributable to noncontrolling interests 0 (4) 18
(Loss) income from discontinued operations attributable to common stockholders (71) 4,860 5,290
Net income available to common stockholders $ 423 $ 5,868 $ 6,467
v3.24.0.1
EARNINGS PER SHARE CALCULATIONS - Summary of EPS Calculations, Basic (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]      
Earnings per common share from continuing operations - basic (in USD per share) $ 1.10 $ 2.02 $ 2.17
(Loss) earnings per common share from discontinued operations - basic (in USD per share) (0.16) 9.75 9.75
Earnings per common share - basic (in USD per share) $ 0.94 $ 11.77 $ 11.92
v3.24.0.1
EARNINGS PER SHARE CALCULATIONS - Summary of EPS Calculations, Diluted (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]      
Earnings per common share from continuing operations - diluted (in USD per share) $ 1.09 $ 2.02 $ 2.16
(Loss) earnings per common share from discontinued operations - diluted (in USD per share) (0.16) 9.73 9.72
Earnings per common share - diluted (in USD per share) $ 0.94 $ 11.75 $ 11.89
v3.24.0.1
EARNINGS PER SHARE CALCULATIONS - Summary of Share Count Information (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]      
Weighted-average common shares - basic (in shares) 449.9 498.5 542.7
Plus dilutive effect of equity compensation plans (in shares) 1.3 0.9 1.5
Weighted-average common shares outstanding - diluted (in shares) 451.2 499.4 544.2
Stock options, restricted stock units, and performance-based restricted stock units excluded from EPS calculations (in shares) 2.6 4.1 2.8
v3.24.0.1
ACCOUNTS AND NOTES RECEIVABLE - NET (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Receivables [Abstract]    
Accounts receivable - trade $ 1,513 $ 1,567
Income tax receivable 301 235
Other 556 716
Total accounts and notes receivable - net 2,370 2,518
Accounts receivables - trade, allowance $ 40 $ 38
v3.24.0.1
INVENTORIES (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 1,184 $ 1,299
Work in process 487 522
Raw materials 350 388
Supplies 126 120
Total inventories $ 2,147 $ 2,329
v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment $ 10,725 $ 10,179
Total accumulated depreciation 4,841 4,448
Total property, plant and equipment - net 5,884 5,731
Land and land improvements    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment 449 432
Buildings    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment 2,121 1,968
Machinery, equipment, and other    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment 7,306 6,714
Construction in progress    
Property, Plant and Equipment [Line Items]    
Total property, plant and equipment $ 849 $ 1,065
Minimum | Land and land improvements    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives (Years) 1 year  
Minimum | Buildings    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives (Years) 1 year  
Minimum | Machinery, equipment, and other    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives (Years) 1 year  
Maximum | Land and land improvements    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives (Years) 25 years  
Maximum | Buildings    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives (Years) 50 years  
Maximum | Machinery, equipment, and other    
Property, Plant and Equipment [Line Items]    
Estimated Useful Lives (Years) 25 years  
v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT - Schedule of Depreciation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]      
Depreciation expense $ 547 $ 545 $ 546
v3.24.0.1
NONCONSOLIDATED AFFILIATES (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
affiliate
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Nov. 01, 2023
Investments in and Advances to Affiliates [Line Items]        
Net investment in nonconsolidated affiliates $ 788 $ 686    
Dividends from nonconsolidated affiliates $ 71 103 $ 98  
Ownership interest affiliates | affiliate 7      
Equity investment, carrying value $ 788 $ 686 $ 818  
Equity Method Investee | Customer Concentration Risk | Revenue Benchmark        
Investments in and Advances to Affiliates [Line Items]        
Concentration risk, percentage 2.00% 2.00% 2.00%  
Equity Method Investee | Supplier Concentration Risk | Cost of Goods and Service Benchmark        
Investments in and Advances to Affiliates [Line Items]        
Concentration risk, percentage 3.00% 3.00% 4.00%  
Other Nonconsolidated Affilates | Minimum        
Investments in and Advances to Affiliates [Line Items]        
Ownership percentage 19.90%      
Other Nonconsolidated Affilates | Maximum        
Investments in and Advances to Affiliates [Line Items]        
Ownership percentage 50.00%      
Derby        
Investments in and Advances to Affiliates [Line Items]        
Ownership percentage       19.90%
Equity investment, carrying value $ 121      
Notes receivables carrying value $ 228      
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Goodwill [Roll Forward]      
Net goodwill, beginning of period $ 16,663 $ 16,981  
Goodwill recognized for Spectrum Acquisition 818    
Currency Translation Adjustment 43 (336)  
Other   18  
Impairment (804) 0 $ 0
Net goodwill, end of period 16,720 16,663 16,981
Corporate & Other      
Goodwill [Roll Forward]      
Net goodwill, beginning of period 610 597  
Goodwill recognized for Spectrum Acquisition 0    
Currency Translation Adjustment 5 (5)  
Other   18  
Impairment 0    
Net goodwill, end of period 615 610 597
Electronics & Industrial | Segment Totals      
Goodwill [Roll Forward]      
Net goodwill, beginning of period 9,397 9,583  
Goodwill recognized for Spectrum Acquisition 818    
Currency Translation Adjustment (10) (186)  
Other   0  
Impairment 0    
Net goodwill, end of period 10,205 9,397 9,583
Water & Protection      
Goodwill [Roll Forward]      
Net goodwill, end of period 4,800    
Water & Protection | Segment Totals      
Goodwill [Roll Forward]      
Net goodwill, beginning of period 6,656 6,801  
Goodwill recognized for Spectrum Acquisition 0    
Currency Translation Adjustment 48 (145)  
Other   0  
Impairment (804)    
Net goodwill, end of period $ 5,900 $ 6,656 $ 6,801
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)
$ in Millions
 12 Months Ended
Oct. 01, 2023
USD ($)
reportingUnit
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Finite-Lived Intangible Assets [Line Items]        
Number of reporting unit, qualitative testing | reportingUnit 6      
Number of reporting unit, quantitative testing | reportingUnit 2      
Goodwill   $ 16,720 $ 16,663 $ 16,981
Goodwill impairment charge   804 0 $ 0
Customer-related        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired   399 121  
Other        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired   25 53  
Developed technology        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired     390  
Trademarks/tradenames        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired     $ 210  
Water & Protection        
Finite-Lived Intangible Assets [Line Items]        
Goodwill $ 5,500 $ 4,800    
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Other Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 8,846 $ 8,369
Accum Amort (3,836) (3,678)
Net 5,010 4,691
Total other intangible assets with indefinite lives 804 804
Indefinite-lived Intangible Assets [Line Items]    
Total other intangible assets with indefinite lives 804 804
Gross Carrying Amount 9,650 9,173
Net 5,814 5,495
Trademarks/tradenames    
Finite-Lived Intangible Assets [Line Items]    
Total other intangible assets with indefinite lives 804 804
Indefinite-lived Intangible Assets [Line Items]    
Total other intangible assets with indefinite lives 804 804
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,079 1,955
Accum Amort (1,092) (913)
Net 987 1,042
Trademarks/tradenames    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 924 906
Accum Amort (414) (349)
Net 510 557
Customer-related    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 5,815 5,454
Accum Amort (2,329) (2,389)
Net 3,486 3,065
Other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 28 54
Accum Amort (1) (27)
Net $ 27 $ 27
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Intangibles by Segment (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Schedule of Intangible Assets [Line Items]    
Other intangible assets $ 5,814 $ 5,495
Corporate & Other    
Schedule of Intangible Assets [Line Items]    
Other intangible assets 87 95
Electronics & Industrial | Segment Totals    
Schedule of Intangible Assets [Line Items]    
Other intangible assets 3,521 2,976
Water & Protection | Segment Totals    
Schedule of Intangible Assets [Line Items]    
Other intangible assets $ 2,206 $ 2,424
v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2024 $ 601
2025 555
2026 528
2027 480
2028 $ 427
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Short-Term Borrowings and Capital Lease Obligations (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
Long-term debt due within one year $ 0 $ 300
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Long-Term Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Finance lease obligations $ 10 $ 1
Less: Unamortized debt discount and issuance costs 51 56
Long-term debt due within one year 0 300
Long-Term Debt 7,800 7,774
Derivative assets (liabilities), loss 82 106
Committed Credit 3,500  
Interest rate swap agreements    
Debt Instrument [Line Items]    
Derivative assets (liabilities), loss 59 71
Final maturity 2023 | Promissory Notes    
Debt Instrument [Line Items]    
Long-term debt, gross $ 0 $ 300
Weighted Average Rate 0.00% 5.72%
Final maturity 2025 | Promissory Notes    
Debt Instrument [Line Items]    
Long-term debt, gross $ 1,850 $ 1,850
Weighted Average Rate 4.49% 4.49%
Final maturity 2028 | Promissory Notes    
Debt Instrument [Line Items]    
Long-term debt, gross $ 2,250 $ 2,250
Weighted Average Rate 4.73% 4.73%
Final maturity 2029 and thereafter | Promissory Notes    
Debt Instrument [Line Items]    
Long-term debt, gross $ 3,741 $ 3,729
Weighted Average Rate 5.46% 5.48%
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Narrative (Details)
 1 Months Ended 12 Months Ended
May 10, 2023
USD ($)
Apr. 12, 2022
USD ($)
Nov. 22, 2021
USD ($)
Nov. 30, 2022
USD ($)
Jul. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Nov. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
May 01, 2020
USD ($)
Debt Instrument [Line Items]                  
Committed Credit           $ 3,500,000,000      
Remaining borrowing capacity, uncommitted           721,000,000      
Letters of credit outstanding           $ 208,000,000      
Ratio of indebtedness to net capital (not exceed)           0.60      
Payment timing of supplier finance program           110 days      
Require notice of termination for supplier financing           30 days      
Supplier finance program obligation           $ 97,000,000   $ 127,000,000  
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]           Accounts payable   Accounts payable  
Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Term     5 years            
Significant Other Observable Inputs (Level 2) | Recurring                  
Debt Instrument [Line Items]                  
Long-term debt           $ 7,995,000,000   $ 7,674,000,000  
Floating Rate Senior Notes | Unsecured Debt                  
Debt Instrument [Line Items]                  
Face amount of debt             $ 300,000,000    
2018 Senior Note Due 2023 | Senior Notes                  
Debt Instrument [Line Items]                  
Extinguishment of debt, amount       $ 2,500,000,000          
Redemption price       100.00%          
2023 $1B Revolving Credit Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Proceeds from line of credit         $ 600,000,000        
Committed Credit         $ 1,000,000,000 1,000,000,000      
2023 $1B Revolving Credit Facility | Line of Credit | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Committed Credit   $ 1,000,000,000              
Term   364 days              
2021 Term Loan Facility | Unsecured Debt | Rogers Corporation                  
Debt Instrument [Line Items]                  
Face amount of debt     $ 5,200,000,000            
Term     2 years            
Five-Year Revolving Credit Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Committed Credit           $ 2,500,000,000      
Term   5 years              
Five-Year Revolving Credit Facility | Line of Credit | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Committed Credit   $ 2,500,000,000              
Term   5 years              
Senior Unsecured Notes due 2023 | Senior Notes                  
Debt Instrument [Line Items]                  
Face amount of debt                 $ 2,000,000,000
Interest rate, percentage                 2.169%
364-Day Revolving Credit Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Committed Credit $ 1,000,000,000                
Term 364 days                
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Maturities of Long-Term Debt for Next Five Years (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Debt Disclosure [Abstract]  
2024 $ 0
2025 1,850
2026 0
2027 0
2028 $ 2,250
v3.24.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Committed and Available Credit Facilities (Details) - USD ($)
Apr. 12, 2022
Nov. 22, 2021
Dec. 31, 2023
Jul. 31, 2022
Line of Credit Facility [Line Items]        
Committed Credit     $ 3,500,000,000  
Credit Available     3,486,000,000  
Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Term   5 years    
Five-Year Revolving Credit Facility | Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Term 5 years      
Committed Credit     2,500,000,000  
Credit Available     2,486,000,000  
Five-Year Revolving Credit Facility | Revolving Credit Facility | Line of Credit        
Line of Credit Facility [Line Items]        
Term 5 years      
Committed Credit $ 2,500,000,000      
2023 $1B Revolving Credit Facility | Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Committed Credit     1,000,000,000 $ 1,000,000,000
Credit Available     $ 1,000,000,000  
2023 $1B Revolving Credit Facility | Revolving Credit Facility | Line of Credit        
Line of Credit Facility [Line Items]        
Term 364 days      
Committed Credit $ 1,000,000,000      
v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details)
$ in Millions
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2021
USD ($)
Jan. 21, 2021
USD ($)
case
Nov. 30, 2023
USD ($)
Jul. 31, 2021
USD ($)
Apr. 30, 2021
municipality
Dec. 31, 2023
USD ($)
case
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
case
Dec. 31, 2022
USD ($)
Dec. 31, 2017
USD ($)
plaintiff
case
Dec. 31, 2012
health_condition
Feb. 06, 2024
entity
Loss Contingencies [Line Items]                            
Qualified spend - eligible PFAS costs, maximum             $ 4,000.0     $ 4,000.0        
Escrow account balance - required minimum             700.0     700.0        
Indemnifiable losses threshold related to PFAS stray liabilities - per party             150.0     150.0        
Non-PFAS stray liabilities threshold             200.0     200.0        
Indemnifiable losses threshold related to PFAS stray liabilities - total             300.0     300.0        
Estimated litigation liability             21.0     21.0        
Aggregate limit of liabilities under settlement agreement             100.0     100.0        
Total environmental related liabilities             $ 300.0     $ 300.0 $ 263.0      
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]             Accrued and other current liabilities, Other Liabilities, Noncurrent     Accrued and other current liabilities, Other Liabilities, Noncurrent        
DuPont and Corteva                            
Loss Contingencies [Line Items]                            
Percentage split of PFAS liabilities under the separation agreement             50.00%     50.00%        
MOU Agreement                            
Loss Contingencies [Line Items]                            
Total indemnified liabilities accrued under the MOU             $ 206.0     $ 206.0 186.0      
Chemours, Corteva and DuPont                            
Loss Contingencies [Line Items]                            
Number of accuser municipalities | municipality           4                
Chemours                            
Loss Contingencies [Line Items]                            
Qualified spend - eligible PFAS costs percentage split             50.00%     50.00%        
Future escrow deposit, percentage split             50.00%     50.00%        
Chemours | Payments Due September 2021, September 2022                            
Loss Contingencies [Line Items]                            
Future escrow deposit             $ 100.0     $ 100.0        
Chemours | Payments Due Annually Beginning September 2023                            
Loss Contingencies [Line Items]                            
Future escrow deposit             50.0     50.0        
DuPont and Corteva                            
Loss Contingencies [Line Items]                            
Qualified spend - eligible PFAS costs, maximum             $ 2,000.0     $ 2,000.0        
Qualified spend - eligible PFAS costs percentage split             50.00%     50.00%        
Future escrow deposit, percentage split             50.00%     50.00%        
DuPont and Corteva | Payments Due September 2021, September 2022                            
Loss Contingencies [Line Items]                            
Future escrow deposit             $ 100.0     $ 100.0        
DuPont and Corteva | Payments Due Annually Beginning September 2023                            
Loss Contingencies [Line Items]                            
Future escrow deposit             50.0     50.0        
DuPont                            
Loss Contingencies [Line Items]                            
Qualified spend - eligible PFAS costs, maximum             1,400.0     1,400.0        
Payment of qualified spend amount             $ 170.0     $ 170.0        
Non-PFAS stray liabilities percent split after threshold             71.00%     71.00%        
Corteva                            
Loss Contingencies [Line Items]                            
Non-PFAS stray liabilities percent split after threshold             29.00%     29.00%        
Water District Settlement Fund                            
Loss Contingencies [Line Items]                            
Accrued settlement amount             $ 405.0     $ 405.0        
Litigation expense                 $ 400.0 $ 400.0        
Water District Settlement Fund | Subsequent Event                            
Loss Contingencies [Line Items]                            
Entities on the list of potential class members who submitted timely requests for exclusion | entity                           924
Total number of entities on the list of potential class members | entity                           14,167
Water District Settlement Fund | Chemours, Corteva and DuPont                            
Loss Contingencies [Line Items]                            
Amount awarded to other party $ 1,185.0                          
Litigation expense               $ 1,185.0            
Water District Settlement Fund | Chemours                            
Loss Contingencies [Line Items]                            
Percentage of settlement                   50.00%        
Litigation expense                   $ 592.0        
Water District Settlement Fund | DuPont and Corteva                            
Loss Contingencies [Line Items]                            
Percentage of settlement                   50.00%        
Water District Settlement Fund | DuPont                            
Loss Contingencies [Line Items]                            
Accrued settlement amount             400.0     $ 400.0        
Payment for share of settlement               $ 400.0            
Water District Settlement Fund | Corteva                            
Loss Contingencies [Line Items]                            
Litigation expense                   193.0        
State of Delaware                            
Loss Contingencies [Line Items]                            
Amount awarded to other party         $ 50.0                  
Estimated litigation liability             9.0     9.0        
State of Delaware | Supplemental Settlement                            
Loss Contingencies [Line Items]                            
Amount awarded to other party         $ 25.0                  
State of Delaware | DuPont                            
Loss Contingencies [Line Items]                            
Amount awarded to other party                     12.5      
State of Delaware | Corteva                            
Loss Contingencies [Line Items]                            
Amount awarded to other party                     12.5      
PFOA Multi-District Litigation (MDL)                            
Loss Contingencies [Line Items]                            
Number of pending lawsuits | case                       100    
PFOA Multi-District Litigation (MDL) | PFOA Matters                            
Loss Contingencies [Line Items]                            
Amount awarded to other party   $ 27.0 $ 83.0                      
Percentage of settlement       80.00%                    
Estimated litigation liability             39.0     $ 39.0        
PFOA Multi-District Litigation (MDL) | Chemours, Corteva and DuPont | PFOA Matters                            
Loss Contingencies [Line Items]                            
Amount awarded to other party       $ 110.0                    
PFOA Multi-District Litigation (MDL) | Chemours | PFOA Matters                            
Loss Contingencies [Line Items]                            
Amount awarded to other party     $ 29.0                      
PFOA Multi-District Litigation (MDL) | DuPont | PFOA Matters                            
Loss Contingencies [Line Items]                            
Amount awarded to other party   27.0                        
PFOA Multi-District Litigation (MDL) | Historical EID And Chemours                            
Loss Contingencies [Line Items]                            
Number of pending lawsuits | case     1                      
PFOA Multi-District Litigation (MDL) | Historical EID And Chemours | PFOA Matters                            
Loss Contingencies [Line Items]                            
Amount awarded to other party                       $ 335.0    
Number of health conditions under personal injury claims | health_condition                         6  
PFOA Multi-District Litigation (MDL) | Historical EID | PFOA Matters                            
Loss Contingencies [Line Items]                            
Number of plaintiffs | plaintiff                       3,550    
PFOA Multi-District Litigation (MDL) | EID | PFOA Matters                            
Loss Contingencies [Line Items]                            
Amount awarded to other party   $ 27.0                        
Personal Injury Case Settlement | MOU Agreement                            
Loss Contingencies [Line Items]                            
Payment for share of settlement             $ 16.0              
Personal Injury Case Settlement | Chemours, Corteva and DuPont | MOU Agreement                            
Loss Contingencies [Line Items]                            
Amount awarded to other party       $ 40.0                    
SC MDL                            
Loss Contingencies [Line Items]                            
Number of pending lawsuits | case             5,400     5,400        
Accounts And Notes Receivable, Other                            
Loss Contingencies [Line Items]                            
Indemnification asset             $ 21.0     $ 21.0 70.0      
Deferred Charges And Other Assets                            
Loss Contingencies [Line Items]                            
Indemnification asset             242.0     242.0 237.0      
Accrued and Other Current Liabilities                            
Loss Contingencies [Line Items]                            
Total indemnified liabilities accrued under the MOU             200.0     200.0 211.0      
Other Noncurrent Obligations                            
Loss Contingencies [Line Items]                            
Total indemnified liabilities accrued under the MOU             263.0     263.0 274.0      
Restricted Cash Equivalents | Water District Settlement Fund                            
Loss Contingencies [Line Items]                            
Accrued settlement amount             $ 400.0     $ 400.0        
Escrow deposit $ 100.0               $ 100.0   $ 100.0      
v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES - Indemnified Liabilities Related to the MOU (Details) - USD ($)
$ in Millions
 1 Months Ended
Jul. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Loss Contingencies [Line Items]      
Total environmental related liabilities   $ 300 $ 263
State of Delaware      
Loss Contingencies [Line Items]      
Amount awarded to other party $ 50    
Accrued and Other Current Liabilities      
Loss Contingencies [Line Items]      
Total indemnified liabilities accrued under the MOU   200 211
Other Noncurrent Obligations      
Loss Contingencies [Line Items]      
Total indemnified liabilities accrued under the MOU   263 274
MOU Agreement      
Loss Contingencies [Line Items]      
Total indemnified liabilities accrued under the MOU   206 186
MOU Agreement | Accrued and Other Current Liabilities      
Loss Contingencies [Line Items]      
Current indemnified liabilities   87 66
MOU Agreement | Other Noncurrent Obligations      
Loss Contingencies [Line Items]      
Long-term indemnified liabilities   119 120
Indemnification Agreement | Chemours      
Loss Contingencies [Line Items]      
Total environmental related liabilities   152 173
Indemnification Agreement | Chemours | Fayetteville      
Loss Contingencies [Line Items]      
Total environmental related liabilities   $ 139 $ 161
v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES - Environmental Accrued Obligations (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Loss Contingencies [Line Items]    
Total environmental related liabilities $ 300 $ 263
Potential exposure in excess of accrual 348  
Retained and Assumed at Divestiture    
Loss Contingencies [Line Items]    
Total environmental related liabilities 46 41
Potential exposure in excess of accrual 112  
Indemnification Agreement | Dow & Corteva    
Loss Contingencies [Line Items]    
Total environmental related liabilities 101 48
Potential exposure in excess of accrual 199  
Indemnification Agreement | Chemours    
Loss Contingencies [Line Items]    
Total environmental related liabilities 152 173
Potential exposure in excess of accrual 35  
Indemnification Agreement | Other    
Loss Contingencies [Line Items]    
Total environmental related liabilities 1 $ 1
Potential exposure in excess of accrual $ 2  
v3.24.0.1
LEASES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Lessee, Lease, Description [Line Items]      
Operating lease, payments $ 115 $ 109 $ 105
Operating lease assets and liabilities 160 $ 131  
Lease income $ 73    
Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration] Research and development expenses, Selling, general and administrative expenses    
Net profits from leases $ 18    
Residual Value Guarantees      
Lessee, Lease, Description [Line Items]      
Future maximum payments for residual value guarantees in operating leases $ 22    
Minimum      
Lessee, Lease, Description [Line Items]      
Operating lease, remaining lease term 1 year    
Contractual lease income for 2024 through 2028 $ 61    
Maximum      
Lessee, Lease, Description [Line Items]      
Operating lease, remaining lease term 30 years    
Contractual lease income for 2024 through 2028 $ 79    
v3.24.0.1
LEASES - Components of Lease Cost (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]      
Operating lease cost $ 121 $ 113 $ 105
Short-term lease cost 4 4 5
Variable lease cost 39 39 38
Less: Sublease income 4 12 11
Total lease cost $ 160 $ 144 $ 137
v3.24.0.1
LEASES - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease right-of-use assets $ 484 $ 426
Current operating lease liabilities 97 90
Noncurrent operating lease liabilities 390 333
Total operating lease liabilities $ 487 $ 423
Operating lease, right-of-use asset, statement of financial position [extensible enumeration] Other Assets, Noncurrent Other Assets, Noncurrent
Operating lease, liability, current, statement of financial position [extensible enumeration] Accrued and other current liabilities Accrued and other current liabilities
Operating lease, liability, noncurrent, statement of financial position [extensible enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
v3.24.0.1
LEASES - Lease Term and Discount Rate (Details)
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Weighted-average remaining lease term (years) 8 years 6 months 8 years 1 month 6 days
Weighted-average discount rate 3.55% 2.76%
v3.24.0.1
LEASES - Maturities of Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
2024 $ 112  
2025 85  
2026 66  
2027 53  
2028 42  
2029 and thereafter 209  
Total lease payments 567  
Less: Interest 80  
Present value of lease liabilities $ 487 $ 423
v3.24.0.1
STOCKHOLDERS' EQUITY - Narrative (Details)
$ / shares in Units, shares in Millions
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended 12 Months Ended 18 Months Ended 21 Months Ended 24 Months Ended
Feb. 15, 2024
USD ($)
counterparty
shares
Nov. 30, 2023
USD ($)
Nov. 30, 2022
USD ($)
counterparty
shares
Feb. 15, 2024
USD ($)
shares
Sep. 30, 2023
USD ($)
counterparty
shares
Mar. 31, 2022
USD ($)
shares
Feb. 15, 2024
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Jun. 01, 2021
USD ($)
shares
Feb. 28, 2022
USD ($)
Mar. 31, 2021
USD ($)
Jun. 01, 2019
USD ($)
Equity, Class of Treasury Stock [Line Items]                                  
Purchases of treasury stock                 $ 1,600,000,000 $ 3,725,000,000 $ 2,143,000,000            
Payments for repurchase of common stock     $ 3,250,000,000                            
Excise tax on purchases of treasury stock                 21,000,000                
Undistributed earnings of nonconsolidated affiliates included in retained earnings                 637,000,000 $ 656,000,000              
2019 Share Buyback Program                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount                                 $ 2,000,000,000
Stock repurchased and retired (in shares) | shares                           29.9      
Purchases of treasury stock                           $ 2,000,000,000      
2021 Share Buyback Program                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount                               $ 1,500,000,000  
Stock repurchased and retired (in shares) | shares           5.1           19.6          
Purchases of treasury stock           $ 375,000,000           $ 1,500,000,000          
2022 Share Buyback Program                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount                             $ 1,000,000,000    
Stock repurchased and retired (in shares) | shares               11.9                  
Purchases of treasury stock               $ 750,000,000                  
$5B Share Buyback Program                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount     5,000,000,000                            
Payments for repurchase of common stock   $ 3,000,000,000                              
2019 And 2021 Share Buyback Programs                                  
Equity, Class of Treasury Stock [Line Items]                                  
Remaining authorized repurchase amount     250,000,000                            
2022 Stock Repurchase Transactions                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount     $ 3,250,000,000                            
Stock repurchased and retired (in shares) | shares     38.8   8.0               46.8        
Number of counterparties | counterparty     3                            
Payments for repurchase of common stock     $ 250,000,000                            
Stock retired     $ 2,600,000,000                            
Unsettled forward contract for accelerated share repurchase         $ 613,000,000                        
Average price per share (in dollars per share) | $ / shares                         $ 69.44        
2023 Stock Repurchase Transactions                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount         $ 2,000,000,000               $ 2,000,000,000        
Stock repurchased and retired (in shares) | shares         21.2                        
Number of counterparties | counterparty         3                        
Payments for repurchase of common stock         $ 2,000,000,000                        
Stock retired         1,600,000,000                        
Unsettled forward contract for accelerated share repurchase         $ 400,000,000                        
2023 Stock Repurchase Transactions | Subsequent Event                                  
Equity, Class of Treasury Stock [Line Items]                                  
Stock repurchased and retired (in shares) | shares       6.7     27.9                    
Number of counterparties | counterparty 1                                
Average price per share (in dollars per share) | $ / shares             $ 71.67                    
2024 Stock Repurchase Transactions | Subsequent Event                                  
Equity, Class of Treasury Stock [Line Items]                                  
Authorized stock repurchase amount $ 1,000,000,000     $ 1,000,000,000     $ 1,000,000,000                    
Stock repurchased and retired (in shares) | shares 6.0                                
Payments for repurchase of common stock $ 500,000,000                                
Share Repurchase Programs                                  
Equity, Class of Treasury Stock [Line Items]                                  
Sales and excise tax payable                 21,200,000                
Excise tax on purchases of treasury stock                 $ 21,200,000                
v3.24.0.1
STOCKHOLDERS' EQUITY - Common Stock Activity (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Common stock activity      
Balance at the beginning of the year (in shares) 458,124,262    
Balance at the end of the year (in shares) 430,110,140 458,124,262  
Issued      
Common stock activity      
Balance at the beginning of the year (in shares) 458,124,000 511,793,000 734,204,000
Issued (in shares) 1,225,000 2,074,000 2,584,000
Retired (in shares) (29,239,000) (55,743,000) (224,995,000)
Balance at the end of the year (in shares) 430,110,000 458,124,000 511,793,000
Held in Treasury      
Common stock activity      
Balance at beginning of the year (in shares) 0 0 0
Repurchased (in shares) 29,239,000 55,743,000 224,995,000
Retired (in shares) (29,239,000) (55,743,000) (224,995,000)
Balance at the end of the year (in shares) 0 0 0
Held in Treasury | N&B      
Common stock activity      
Retired (in shares) (197,000,000)    
v3.24.0.1
STOCKHOLDERS' EQUITY - Dividends Declared and Paid (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]      
Dividends declared to common stockholders $ 651 $ 652 $ 630
Dividends paid to common stockholders $ 651 $ 652 $ 630
v3.24.0.1
STOCKHOLDERS' EQUITY - Summary of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance $ 24,725 $ 27,017 $ 27,050 $ 39,070
Other comprehensive (loss) income before reclassifications (78) (996) (264)  
Amounts reclassified from accumulated other comprehensive income (9) (3) 3  
Split-off and divestiture reclassification adjustment (32) 167 258  
Net other comprehensive (loss) income (119) (832) (3)  
Ending balance 24,725 27,017 27,050  
Total        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (910) (791) 41 44
Ending balance (910) (791) 41  
Cumulative translation adjustments        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (931) (968) (88) 470
Other comprehensive (loss) income before reclassifications 46 (1,101) (742)  
Amounts reclassified from accumulated other comprehensive income 0 0 0  
Split-off and divestiture reclassification adjustment (9) 221 184  
Net other comprehensive (loss) income 37 (880) (558)  
Ending balance (931) (968) (88)  
Pension and OPEB        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (55) 60 73 (425)
Other comprehensive (loss) income before reclassifications (83) 44 422  
Amounts reclassified from accumulated other comprehensive income (9) (3) 3  
Split-off and divestiture reclassification adjustment (23) (54) 73  
Net other comprehensive (loss) income (115) (13) 498  
Ending balance (55) 60 73  
Derivative instruments        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance 76 117 56 $ (1)
Other comprehensive (loss) income before reclassifications (41) 61 56  
Amounts reclassified from accumulated other comprehensive income 0 0 0  
Split-off and divestiture reclassification adjustment 0 0 1  
Net other comprehensive (loss) income (41) 61 57  
Ending balance $ 76 $ 117 $ 56  
v3.24.0.1
STOCKHOLDERS' EQUITY - Tax Benefit (Expense) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Tax expense from income taxes related to other comprehensive income (loss) items $ 38 $ 1 $ (140)
Pension and OPEB      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Tax expense from income taxes related to other comprehensive income (loss) items 26 16 (122)
Derivative instruments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Tax expense from income taxes related to other comprehensive income (loss) items $ 12 $ (15) $ (18)
v3.24.0.1
STOCKHOLDERS' EQUITY - Summary of Reclassifications Out of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income $ 462 $ 5,917 $ 6,515
Net income before tax 504 1,448 1,444
Tax expense (benefit) (29) 387 237
Reclassification out of Accumulated Other Comprehensive Loss      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (41) 164 261
Reclassification out of Accumulated Other Comprehensive Loss | Cumulative translation adjustments      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (9) 221 184
Reclassification out of Accumulated Other Comprehensive Loss | Pension and other post-employment benefit plans      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (32) (57) 76
Net income before tax (35) (71) 111
Tax expense (benefit) 3 14 (35)
Reclassification out of Accumulated Other Comprehensive Loss | Derivative instruments      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income 0 0 1
Net income before tax 0 0 1
Tax expense (benefit) $ 0 $ 0 $ 0
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Employer contributions $ 66 $ 79  
Expected contribution for next year 57    
Projected benefit obligation 2,704 2,726 $ 4,286
Accumulated benefit obligation 2,600 2,600  
DuPont plan assets total 2,400    
DuPont U.S. Retirement Savings Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Employer contributions $ 65 72  
Employer matching contribution, percent of match 100.00%    
Employer matching contribution, percent of employees' gross pay 6.00%    
Employer discretionary contribution, percent 3.00%    
Employers discretionary contribution, vesting period (in years) 3 years    
DuPont Other Contribution Plans      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Employer contributions $ 35 33  
Other Postretirement Benefits      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Projected benefit obligation $ 29 $ 27  
Pension Plans      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Discount rate 3.26% 3.71%  
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Weighted-Average Assumptions (Details) - Pension Plans
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Benefit Obligations      
Discount rate 3.26% 3.71%  
Interest crediting rate for applicable benefits 2.00% 2.25%  
Rate of compensation increase 3.11% 3.27%  
Net Periodic Costs      
Discount rate 3.05% 1.48% 0.87%
Interest crediting rate for applicable benefits 2.25% 1.25% 1.25%
Rate of compensation increase 3.25% 3.15% 3.15%
Expected return on plan assets 3.61% 2.69% 2.73%
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Change in Projected Benefit Obligation and Plan Assets and Funded Status (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Change in projected benefit obligations:      
Benefit obligations at beginning of year $ 2,726 $ 4,286  
Service cost 25 43 $ 53
Interest cost 99 55 42
Plan participants' contributions 7 7  
Actuarial changes in assumptions and experience 132 (872)  
Benefits paid (208) (233)  
Acquisitions/divestitures/other (209) (203)  
Effect of foreign exchange rates 133 (354)  
Termination benefits/curtailment cost/settlements (1) (3)  
Benefit obligations at end of year 2,704 2,726 4,286
Change in plan assets:      
Fair value of plan assets at beginning of year 2,596 4,036  
Actual return on plan assets 109 (735)  
Employer contributions 66 79  
Plan participants' contributions 7 7  
Benefits paid (208) (233)  
Acquisitions/divestitures/other (285) (216)  
Effect of foreign exchange rates 139 (342)  
Fair value of plan assets at end of year 2,424 2,596 $ 4,036
Funded status of plan (280) (130)  
Defined Benefit Plan, Funded Plan      
Change in plan assets:      
Funded status of plan 233 364  
Defined Benefit Plan, Unfunded Plan      
Change in plan assets:      
Funded status of plan $ (513) $ (494)  
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Amounts Recognized in the Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Amounts recognized in the consolidated balance sheets:    
Pension and other post-employment benefits - noncurrent $ (565) $ (522)
Net amount recognized (280) (130)
Pretax amounts recognized in accumulated other comprehensive loss (income):    
Net loss (gain) 95 (45)
Prior service credit (8) (15)
Pretax balance in accumulated other comprehensive loss at end of year 87 (60)
Deferred charges and other assets    
Amounts recognized in the consolidated balance sheets:    
Deferred charges and other assets 338 376
Assets of discontinued operations    
Amounts recognized in the consolidated balance sheets:    
Assets of discontinued operations 0 70
Accrued and other current liabilities    
Amounts recognized in the consolidated balance sheets:    
Accrued and other current liabilities (53) (49)
Liabilities of discontinued operations    
Amounts recognized in the consolidated balance sheets:    
Accrued and other current liabilities $ 0 $ (5)
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - ABO and PBO in Excess of Plan Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Retirement Benefits [Abstract]    
Accumulated benefit obligations $ 700 $ 566
Fair value of plan assets 138 46
Projected benefit obligations 743 706
Fair value of plan assets $ 154 $ 157
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Net Periodic Benefit Costs for All Significant Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Periodic Benefit Costs:      
Service cost $ 25 $ 43 $ 53
Interest cost 99 55 42
Expected return on plan assets (92) (97) (105)
Amortization of prior service credit (3) (5) (5)
Amortization of unrecognized net (gain) loss (1) 1 12
Curtailment/settlement (3) (4) 3
Non-operating pension and other post-employment benefit (OPEB) credits 25 (7) 0
Less: Net periodic benefit credits - Discontinued operations      
Net Periodic Benefit Costs:      
Non-operating pension and other post-employment benefit (OPEB) credits (6) (9) (3)
Net periodic benefit costs - Continuing operations 1      
Net Periodic Benefit Costs:      
Service cost 22 30 33
Interest cost 93 49 39
Expected return on plan assets (78) (73) (78)
Amortization of prior service credit (2) (4) (5)
Amortization of unrecognized net (gain) loss (1) 4 11
Curtailment/settlement (3) (4) 3
Non-operating pension and other post-employment benefit (OPEB) credits 31 2 3
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):      
Net loss (gain) 108 (35) (528)
Prior service credit 0 0 (8)
Amortization of prior service credit 3 5 5
Amortization of unrecognized gain (loss) 1 (1) (12)
Settlement gain (loss) 3 4 (3)
Effect of foreign exchange rates 1 5 (11)
Total recognized in other comprehensive loss (income) 116 (22) (557)
Noncontrolling interest 0 0 0
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income) $ 147 $ (20) $ (554)
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Estimated Future Benefit Payments (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Retirement Benefits [Abstract]  
2024 $ 182
2025 178
2026 183
2027 178
2028 181
Years 2029-2033 912
Total $ 1,814
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Target Allocation for Plan Assets (Details)
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 100.00%
Equity securities  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 2.00%
Fixed income securities  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 9.00%
Alternative investments  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 25.00%
Hedge funds  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 28.00%
Pooled investment vehicles  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 28.00%
Other investments  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 8.00%
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets $ 2,424 $ 2,596 $ 4,036
Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 603 599 900
Derivatives - asset position | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 3 8  
Derivatives - asset position | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - asset position | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 3 8  
Derivatives - asset position | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - liability position | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - liability position | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - liability position | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - liability position | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Defined Benefit Plan, Assets Before Pension Trust | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 1,430 1,611  
Defined Benefit Plan, Assets Before Pension Trust | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 785 859  
Defined Benefit Plan, Assets Before Pension Trust | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 42 153  
Defined Benefit Plan, Assets Before Pension Trust | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 603 599  
Defined Benefit Plan, Assets Before Pension Trust | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 980 983  
Cash and cash equivalents | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 55 57  
Cash and cash equivalents | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 55 57  
Cash and cash equivalents | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Cash and cash equivalents | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Equity securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 49 195  
Equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 49 195  
Equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
U.S. equity securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 20 43  
U.S. equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 20 43  
U.S. equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
U.S. equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Non - U.S. equity securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 29 152  
Non - U.S. equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 29 152  
Non - U.S. equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Non - U.S. equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Fixed income securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 39 145  
Fixed income securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Fixed income securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 39 145  
Fixed income securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - government-issued | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 34 105  
Debt - government-issued | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - government-issued | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 34 105  
Debt - government-issued | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - government-issued | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 187 163  
Debt - corporate-issued | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 5 40  
Debt - corporate-issued | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - corporate-issued | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 5 40  
Debt - corporate-issued | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Alternative investments | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 606 607  
Alternative investments | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Alternative investments | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 3 8  
Alternative investments | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 603 599  
Real estate | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 79 75  
Real estate | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Real estate | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Real estate | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 79 75 75
Insurance contracts | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 524 524  
Insurance contracts | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Insurance contracts | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Insurance contracts | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 524 524 $ 825
Other investments | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 681 607  
Other investments | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 681 607  
Other investments | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Other investments | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Pooled investment vehicles | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 681 607  
Pooled investment vehicles | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 681 607  
Pooled investment vehicles | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Pooled investment vehicles | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Hedge funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 667 690  
Private market securities | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 126 130  
Pension Trust Receivables | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 14 2  
Pension Trust Payables | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets $ 0 $ 0  
v3.24.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Fair Value Measurement of Level 3 Pension Plan Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year $ 2,596 $ 4,036
Fair value of plan assets at end of year 2,424 2,596
Significant Other Unobservable Inputs (Level 3)    
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year 599 900
Relating to assets held 28 (239)
Purchases, sales and settlements, net (14) (31)
Transfers into Level 3   30
Transfers out of Level 3 (10) (61)
Fair value of plan assets at end of year 603 599
Significant Other Unobservable Inputs (Level 3) | Real estate    
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year 75 75
Relating to assets held 2 (2)
Purchases, sales and settlements, net 2 2
Transfers into Level 3   0
Transfers out of Level 3 0 0
Fair value of plan assets at end of year 79 75
Significant Other Unobservable Inputs (Level 3) | Insurance contracts    
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year 524 825
Relating to assets held 26 (237)
Purchases, sales and settlements, net (16) (33)
Transfers into Level 3   30
Transfers out of Level 3 (10) (61)
Fair value of plan assets at end of year $ 524 $ 524
v3.24.0.1
STOCK-BASED COMPENSATION - Narrative (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
subplan
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense | $ $ 74 $ 75 $ 67
Income tax benefits | $ 16 16 13
Unrecognized pretax compensation cost, amount | $ $ 2    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized pretax compensation cost, period for recognition 1 year    
RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized pretax compensation cost, period for recognition 1 year 8 months 12 days    
Unrecognized pretax compensation cost, excluding options, amount | $ $ 72    
Fair value of awards vested | $ $ 72    
Weighted-average share price of awards granted (in USD per share) | $ / shares $ 65.34    
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
Equity award conversion ratio (shares) 1    
DuPont 2020 Equity and Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Capital shares reserved for future issuance (in shares) 16,000,000    
Options granted (in shares) 0    
DuPont 2020 Equity and Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense | $ $ 10 8  
Income tax benefits | $ $ 2 2  
Award requisite service period (in months) 12 months    
DuPont 2020 Equity and Incentive Plan | RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average share price of awards granted (in USD per share) | $ / shares $ 65.34    
Shares granted (in shares) 1,277,000    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum term (in years) 10 years    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period (in months) 6 months    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
Equity award conversion ratio (shares) 1    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | PSUs | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of performance target (percent) 0.00%    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | PSUs | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of performance target (percent) 200.00%    
DuPont Omnibus Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of subplans | subplan 2    
Options granted (in shares) 0    
DuPont Omnibus Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense | $ $ 26 25 24
Income tax benefits | $ $ 6 $ 5 $ 5
Award requisite service period (in months) 6 months    
Options granted (in shares) 0 0  
DuPont Omnibus Incentive Plan | RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average share price of awards granted (in USD per share) | $ / shares $ 0    
Shares granted (in shares) 0    
TDCC Stock Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum term (in years) 10 years    
Options granted (in shares) 0 0 0
TDCC Stock Incentive Plan | Stock Options | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 1 year    
TDCC Stock Incentive Plan | Stock Options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options granted (in shares) 0 0 0
EIDP Equity Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period (in months) 6 months    
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan | Stock Options | Grants Between 2016 and 2018      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 10 years    
EIDP Equity Incentive Plan | RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period (in months) 6 months    
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan | RSUs | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan | RSUs | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 5 years    
v3.24.0.1
STOCK-BASED COMPENSATION - Weighted-Average Assumptions (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
DuPont 2020 Equity and Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 0    
DuPont 2020 Equity and Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield   1.80%  
Expected volatility   26.40%  
Risk-free interest rate   1.90%  
Expected life of stock options granted during period (years)   6 years  
DuPont Omnibus Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 0    
DuPont Omnibus Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield     1.60%
Expected volatility     28.30%
Risk-free interest rate     0.90%
Expected life of stock options granted during period (years)     6 years
Granted (in shares) 0 0  
v3.24.0.1
STOCK-BASED COMPENSATION - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Additional Information about Stock Options      
Total compensation expense for stock options plans $ 74,000 $ 75,000 $ 67,000
Related tax benefit $ 16,000 $ 16,000 $ 13,000
DuPont 2020 Equity and Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at the beginning of the period (in shares) 681,000    
Granted (in shares) 0    
Exercised (in shares) (39,000)    
Forfeited/Expired (in shares) (15,000)    
Outstanding at the end of the period (in shares) 627,000 681,000  
Weighted Average Exercise Price (per share)      
Outstanding, weighted average exercise price, beginning balance (USD per share) $ 74.40    
Granted, weighted average exercise price (in USD per share) 0    
Exercised, weighted average exercise price (in USD per share) 73.26    
Forfeited/Expired, weighted average exercise price (in USD per share) 73.84    
Outstanding, weighted average exercise price, ending balance (USD per share) $ 74.48 $ 74.40  
Options outstanding, weighted average remaining contractual term 7 years 3 months    
Options outstanding, aggregate intrinsic value (in USD) $ 1,533    
Options exercisable, Number of options (in shares) 300,000    
Options exercisable, weighted average exercise price per share (in USD per share) $ 74.19    
Options exercisable, weighted average remaining contractual term 6 years 5 months 8 days    
Options exercisable, aggregate intrinsic value (in USD) $ 821    
DuPont 2020 Equity and Incentive Plan | Stock Options      
Additional Information about Stock Options      
Weighted-average fair value per share of options granted (in USD per share) $ 0 $ 17.41  
Total compensation expense for stock options plans $ 10,000 $ 8,000  
Related tax benefit $ 2,000 $ 2,000  
DuPont Omnibus Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at the beginning of the period (in shares) 1,959,000    
Granted (in shares) 0    
Exercised (in shares) (318,000)    
Forfeited/Expired (in shares) (4,000)    
Outstanding at the end of the period (in shares) 1,637,000 1,959,000  
Weighted Average Exercise Price (per share)      
Outstanding, weighted average exercise price, beginning balance (USD per share) $ 62.40    
Granted, weighted average exercise price (in USD per share) 0    
Exercised, weighted average exercise price (in USD per share) 61.61    
Forfeited/Expired, weighted average exercise price (in USD per share) 53.50    
Outstanding, weighted average exercise price, ending balance (USD per share) $ 62.58 $ 62.40  
Options outstanding, weighted average remaining contractual term 6 years 18 days    
Options outstanding, aggregate intrinsic value (in USD) $ 23,501    
Options exercisable, Number of options (in shares) 1,547,000    
Options exercisable, weighted average exercise price per share (in USD per share) $ 61.98    
Options exercisable, weighted average remaining contractual term 5 years 11 months 23 days    
Options exercisable, aggregate intrinsic value (in USD) $ 23,129    
DuPont Omnibus Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted (in shares) 0 0  
Additional Information about Stock Options      
Weighted-average fair value per share of options granted (in USD per share) $ 0 $ 0 $ 16.83
Total compensation expense for stock options plans $ 26,000 $ 25,000 $ 24,000
Related tax benefit $ 6,000 $ 5,000 $ 5,000
TDCC Stock Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted (in shares) 0 0 0
EIDP Equity Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at the beginning of the period (in shares) 2,407,000    
Granted (in shares) 0 0 0
Exercised (in shares) (147,000)    
Forfeited/Expired (in shares) (32,000)    
Outstanding at the end of the period (in shares) 2,228,000 2,407,000  
Weighted Average Exercise Price (per share)      
Outstanding, weighted average exercise price, beginning balance (USD per share) $ 71.60    
Exercised, weighted average exercise price (in USD per share) 39.30    
Forfeited/Expired, weighted average exercise price (in USD per share) 87.02    
Outstanding, weighted average exercise price, ending balance (USD per share) $ 73.49 $ 71.60  
Options outstanding, weighted average remaining contractual term 3 years 6 months    
Options outstanding, aggregate intrinsic value (in USD) $ 5,631,000    
Options exercisable, Number of options (in shares) 2,228,000    
Options exercisable, weighted average exercise price per share (in USD per share) $ 73.49    
Options exercisable, weighted average remaining contractual term 3 years 6 months    
Options exercisable, aggregate intrinsic value (in USD) $ 5,631,000    
v3.24.0.1
STOCK-BASED COMPENSATION - Nonvested Award Activity (Details) - RSUs and PSUs
shares in Thousands
 12 Months Ended
Dec. 31, 2023
$ / shares
shares
Weighted Average Grant Date Fair Value [Abstract]  
Granted, grant date fair value (in USD per share) $ 65.34
DuPont 2020 Equity and Incentive Plan  
Number of Shares [Roll Forward]  
Nonvested awards, beginning of the period (in shares) | shares 1,258
Granted (in shares) | shares 1,277
Vested (in shares) | shares (480)
Forfeited (in shares) | shares (64)
Nonvested awards, end of the period (in shares) | shares 1,991
Weighted Average Grant Date Fair Value [Abstract]  
Nonvested awards, grant date fair value, beginning of the period (in USD per share) $ 76.07
Granted, grant date fair value (in USD per share) 65.34
Vested, grant date fair value (in USD per share) 73.97
Forfeited, grant date fair value (in USD per share) 71.01
Nonvested awards, grant date fair value, end of the period (in USD per share) $ 69.85
DuPont Omnibus Incentive Plan  
Number of Shares [Roll Forward]  
Nonvested awards, beginning of the period (in shares) | shares 687
Granted (in shares) | shares 0
Vested (in shares) | shares (519)
Forfeited (in shares) | shares (5)
Nonvested awards, end of the period (in shares) | shares 163
Weighted Average Grant Date Fair Value [Abstract]  
Nonvested awards, grant date fair value, beginning of the period (in USD per share) $ 67.09
Granted, grant date fair value (in USD per share) 0
Vested, grant date fair value (in USD per share) 66.76
Forfeited, grant date fair value (in USD per share) 71.43
Nonvested awards, grant date fair value, end of the period (in USD per share) $ 68.01
v3.24.0.1
FINANCIAL INSTRUMENTS - Schedule of Fair Value of Financial Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]    
Cash equivalents, Cost $ 408 $ 2,198
Restricted cash equivalents 411 110
Marketable securities, Cost 0 1,302
Marketable securities Gain 0 0
Marketable securities Loss 0 0
Marketable securities, Fair Value 0 1,302
Total cash and restricted cash equivalents and marketable securities, Cost 819 3,610
Total cash and restricted cash equivalents and marketable securities, Gain 0 0
Total cash and restricted cash equivalents and marketable securities, Loss 0 0
Total cash and restricted cash equivalents and marketable securities, Fair Value 819 3,610
Long-term debt including debt due within one year, Cost (7,859) (8,145)
Long term debt including debt due within one year, Gain 70 227
Long term debt including debt due within one year, Loss (206) (58)
Long term debt including debt due within one year, Fair Value (7,995) (7,976)
Derivative assets (liabilities), Cost 0 0
Derivative assets (liabilities), Gain 122 159
Derivative assets (liabilities), loss (82) (106)
Derivative assets (liabilities), fair value 40 53
Restricted cash, current 411  
Restricted cash equivalents, noncurrent   $ 103
Restricted Cash Equivalents, Noncurrent, Statement of Financial Position [Extensible Enumeration]   Restricted cash and cash equivalents - noncurrent
Restricted cash equivalents, current   $ 7
Net investment hedge    
Debt Securities, Available-for-sale [Line Items]    
Derivative assets (liabilities), Cost 0 0
Derivative assets (liabilities), Gain 96 149
Derivative assets (liabilities), loss 0 0
Derivative assets (liabilities), fair value 96 149
Foreign Currency    
Debt Securities, Available-for-sale [Line Items]    
Derivative assets (liabilities), Cost 0 0
Derivative assets (liabilities), Gain 26 10
Derivative assets (liabilities), loss (23) (35)
Derivative assets (liabilities), fair value 3 (25)
Interest rate swap agreements    
Debt Securities, Available-for-sale [Line Items]    
Derivative assets (liabilities), Cost 0 0
Derivative assets (liabilities), Gain 0 0
Derivative assets (liabilities), loss (59) (71)
Derivative assets (liabilities), fair value $ (59) $ (71)
v3.24.0.1
FINANCIAL INSTRUMENTS - Notional Amounts (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Designated as Hedging Instrument | Net investment hedge | Foreign Currency    
Derivative [Line Items]    
Derivative, notional amount, net $ 1,000 $ 1,000
Designated as Hedging Instrument | Fair Value Hedging | Interest rate swap agreements    
Derivative [Line Items]    
Derivative, notional amount, net 1,000 1,000
Not Designated as Hedging Instrument | Foreign Currency    
Derivative [Line Items]    
Derivative, notional amount, net $ (907) $ 476
v3.24.0.1
FINANCIAL INSTRUMENTS - Narrative (Details)
€ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Interest rate swap agreements | Floating Rate Note Due 2038            
Derivatives, Fair Value [Line Items]            
Face amount of debt       $ 1,000    
Interest rate swap agreements | Fixed Rate Notes Due 2038            
Derivatives, Fair Value [Line Items]            
Face amount of debt       1,650    
Designated as Hedging Instrument | Foreign Currency | Net investment hedge            
Derivatives, Fair Value [Line Items]            
Derivative, notional amount         $ 1,000 € 819
Derivative, fixed interest rate         4.73% 4.73%
Derivative, average fixed interest rate         3.26% 3.26%
Designated as Hedging Instrument | Interest rate swap agreements | Fair Value Hedging            
Derivatives, Fair Value [Line Items]            
Derivative, notional amount       $ 1,000    
Not Designated as Hedging Instrument | Foreign Currency | Other Nonoperating Income (Expense)            
Derivatives, Fair Value [Line Items]            
Foreign currency contracts, gain (loss) $ (64) $ (32) $ (40)      
v3.24.0.1
FAIR VALUE MEASUREMENTS - Fair Value Measurements on a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets at fair value:    
Marketable securities $ 0.0 $ 1,302.0
Liabilities at fair value:    
Long term debt including debt due within one year, Fair Value 7,995.0 7,976.0
Offsetting counterparty and cash collateral netting amount for assets 11.0 17.0
Offsetting counterparty and cash collateral netting amount for liabilities 0.0 17.0
Water District Settlement Fund    
Liabilities at fair value:    
Accrued settlement amount 405.0  
Recurring | Significant Other Observable Inputs (Level 2)    
Assets at fair value:    
Cash equivalents and restricted cash equivalents 364.0 2,308.0
Marketable securities   1,302.0
Total assets at fair value 497.0 3,785.0
Liabilities at fair value:    
Long term debt including debt due within one year, Fair Value 7,995.0 7,976.0
Total liabilities at fair value 8,088.0 8,098.0
Money market funds 50.0  
Recurring | Significant Other Observable Inputs (Level 2) | Designated as Hedging Instrument | Foreign currency contracts    
Assets at fair value:    
Derivative asset 96.0  
Recurring | Significant Other Observable Inputs (Level 2) | Designated as Hedging Instrument | Interest rate swap agreements    
Liabilities at fair value:    
Foreign currency contracts 59.0 71.0
Recurring | Significant Other Observable Inputs (Level 2) | Designated as Hedging Instrument | Net investment hedge    
Assets at fair value:    
Derivative asset   149.0
Recurring | Significant Other Observable Inputs (Level 2) | Not Designated as Hedging Instrument | Foreign currency contracts    
Assets at fair value:    
Derivative asset 37.0 26.0
Liabilities at fair value:    
Foreign currency contracts $ 34.0 $ 51.0
v3.24.0.1
FAIR VALUE MEASUREMENTS - Fair Value Measurements on a Nonrecurring Basis (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Total Losses   $ (94)  
Goodwill impairment charge $ 804 0 $ 0
Goodwill      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Goodwill impairment charge 804    
Long-lived assets, intangible assets, and other assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Total Losses   (94)  
Significant Other Unobservable Inputs (Level 3) | Nonrecurring | Goodwill      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets at fair value: $ 4,814    
Significant Other Unobservable Inputs (Level 3) | Nonrecurring | Long-lived assets, intangible assets, and other assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets at fair value:   $ 55  
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Net Trade Revenue and Long-lived Assets by Geographic Region (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Segment Reporting [Abstract]      
Number of operating segments | segment 2    
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 12,068 $ 13,017 $ 12,566
Assets 5,884 5,731 5,753
United States      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 3,914 4,066 3,661
Assets 3,559 3,501 3,433
Canada      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 271 293 263
Assets 54 49 51
EMEA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 2,203 2,193 2,229
Assets 1,336 1,271 1,301
Asia Pacific      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 5,191 6,022 6,026
Assets 896 883 925
Latin America      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 489 443 387
Assets 39 27 43
China/Hong Kong      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 2,206 $ 2,744 $ 2,822
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Segment Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Net sales $ 12,068 $ 13,017 $ 12,566
Operating EBITDA 2,942 3,261 3,152
Equity in earnings of nonconsolidated affiliates 51 75 85
Restructuring and asset related charges - net 146 155 50
Goodwill impairment charge 804 0 0
Depreciation and amortization 1,147 1,135 1,112
Assets of continuing operations 38,552 41,355 45,707
Investment in nonconsolidated affiliates 788 686 818
Capital expenditures 590 659 816
Continuing Operations      
Segment Reporting Information [Line Items]      
Operating EBITDA 2,942 3,261 3,152
Depreciation and amortization 1,147 1,135 1,112
Assets of continuing operations 38,552 40,064 37,798
Corporate & Other      
Segment Reporting Information [Line Items]      
Net sales 1,098 1,143 1,460
Operating EBITDA 82 (6) 9
Equity in earnings of nonconsolidated affiliates 0 5 8
Restructuring and asset related charges - net 42 20 12
Goodwill impairment charge 0    
Depreciation and amortization 33 61 83
Investment in nonconsolidated affiliates 122 0 6
Capital expenditures 44 80 88
Corporate & Other | Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations 6,180 8,123 5,094
Electronics & Industrial      
Segment Reporting Information [Line Items]      
Net sales 5,337 5,917 5,554
Electronics & Industrial | Segment Totals      
Segment Reporting Information [Line Items]      
Net sales 5,337 5,917 5,554
Operating EBITDA 1,472 1,836 1,758
Equity in earnings of nonconsolidated affiliates 16 31 41
Restructuring and asset related charges - net 49 118 8
Goodwill impairment charge 0    
Depreciation and amortization 607 580 518
Investment in nonconsolidated affiliates 386 396 502
Capital expenditures 306 290 337
Electronics & Industrial | Segment Totals | Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations 18,622 17,110 17,701
Water & Protection      
Segment Reporting Information [Line Items]      
Net sales 5,633 5,957 5,552
Water & Protection | Segment Totals      
Segment Reporting Information [Line Items]      
Net sales 5,633 5,957 5,552
Operating EBITDA 1,388 1,431 1,385
Equity in earnings of nonconsolidated affiliates 35 39 36
Restructuring and asset related charges - net 55 17 30
Goodwill impairment charge 804    
Depreciation and amortization 507 494 511
Investment in nonconsolidated affiliates 280 290 310
Capital expenditures 240 289 391
Water & Protection | Segment Totals | Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations $ 13,750 $ 14,831 $ 15,003
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Total Asset Reconciliation (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting [Abstract]      
Assets of continuing operations $ 38,552 $ 40,064 $ 37,798
Assets held for sale 0 0 245
Assets of discontinued operations 0 1,291 7,664
Total Assets $ 38,552 $ 41,355 $ 45,707
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Segment Information Reconciliation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting [Abstract]      
Capital expenditures, segment totals $ 590 $ 659 $ 816
Capital expenditures, other 29 3 (28)
Capital expenditures, total $ 619 $ 662 $ 788
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Reconciliation of Operating EBITDA (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Income from continuing operations, net of tax $ 533 $ 1,061 $ 1,207
(Benefit from) provision for income taxes on continuing operations (29) 387 237
Income from continuing operations before income taxes 504 1,448 1,444
Depreciation and amortization 1,147 1,135 1,112
Interest income 155 50 12
Interest expense 396 492 525
Non-operating pension/OPEB (credit) benefit 9 (28) (30)
Significant items 961 233 22
Operating EBITDA 2,942 3,261 3,152
Continuing Operations      
Segment Reporting Information [Line Items]      
Depreciation and amortization 1,147 1,135 1,112
Interest income 155 50 12
Interest expense 396 486 503
Non-operating pension/OPEB (credit) benefit (9) 28 30
Foreign exchange (losses) gains, net (73) 15 (53)
Future reimbursable indirect costs 7 52 60
Significant items (961) (233) (22)
Operating EBITDA $ 2,942 $ 3,261 $ 3,152
v3.24.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Significant Items by Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs $ (20.0) $ (193.0) $ (81.0)
Restructuring and asset related charges - net (146.0) (61.0) (50.0)
Goodwill impairment charges (804.0) 0.0 0.0
Asset impairment charges   (94.0)  
Merger-related inventory step-up amortization     (12.0)
Gain on divestiture 9.0 69.0 143.0
Terminated Intended Rogers Acquisition financing fees   (6.0) (22.0)
Employee Retention Credit   52.0  
Total (961.0) (233.0) (22.0)
Business acquisition, payment of termination fee   162.5  
Segment Totals | Electronics & Industrial      
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs (20.0) 0.0 0.0
Restructuring and asset related charges - net (49.0) (24.0) (8.0)
Goodwill impairment charges 0.0    
Asset impairment charges   (94.0)  
Merger-related inventory step-up amortization     (12.0)
Gain on divestiture 7.0 0.0 2.0
Terminated Intended Rogers Acquisition financing fees   0.0 0.0
Employee Retention Credit   20.0  
Total (62.0) (98.0) (18.0)
Segment Totals | Water & Protection      
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs 0.0 0.0 0.0
Restructuring and asset related charges - net (55.0) (17.0) (30.0)
Goodwill impairment charges (804.0)    
Asset impairment charges   0.0  
Merger-related inventory step-up amortization     0.0
Gain on divestiture 1.0 37.0 0.0
Terminated Intended Rogers Acquisition financing fees   0.0 0.0
Employee Retention Credit   20.0  
Total (858.0) 40.0 (30.0)
Corporate & Other      
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs 0.0 (193.0) (81.0)
Restructuring and asset related charges - net (42.0) (20.0) (12.0)
Goodwill impairment charges 0.0    
Asset impairment charges   0.0  
Merger-related inventory step-up amortization     0.0
Gain on divestiture 1.0 32.0 141.0
Terminated Intended Rogers Acquisition financing fees   (6.0) (22.0)
Employee Retention Credit   12.0  
Total $ (41.0) $ (175.0) $ 26.0